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ABSTRACT 
 A common approach to treating many illnesses is through targeting a specific protein. 
Gene-related illnesses, however, are particularly difficult to treat and targeting the gene with small 
molecules for drug development is an alternative approach. This is an attractive area because it 
provides new and potential methods for regulating the expression of diseased-genes. Dicationic 
diamidines are a class of small molecules which bind in the DNA minor groove where most gene 
control proteins, such as transcription factors, do not interact. These small molecules can modulate 
various processes through allosteric interactions and provide therapeutic potential. Typically, these 
compounds have an inherent selectivity towards sites rich in A∙T base pairs (bps). Many synthetic 
efforts are used to design diamidines specific to target mixed-site sequences (G∙C-containing) but 
 
 
these efforts remain challenging. To overcome this obstacle, our recognition repertoire must be 
extended to include G∙C bps and distinguishability among A∙T bp sites.  
Many biophysical methods can be used to investigate small molecule-DNA interactions 
and the development of competition mass spectrometry, in particular, has helped do this. 
Competition electrospray ionization mass spectrometry (ESI-MS) is a powerful, novel screening 
technique used to identify biomolecular interactions. This method identifies important information 
such as stoichiometry, relative binding affinity, and cooperativity and can be used for a number of 
analyses. It is particularly useful when applied as a competition assay to quickly and accurately 
pinpoint the preferred target site of a compound among many DNA sequences. Our competition 
ESI-MS methodology has been used to investigate the sequence specific interaction of diamidines 
with DNA and discover binding sites for synthetic compounds. Combining ESI-MS with other 
biophysical techniques has successfully identified patterns of recognition and the selectivity of 
DNA minor groove binding compounds. With this information, we have developed a detailed 
understanding of the variations in sequences and their effects on compound recognition. This will 
ultimately lead to more sequence specific, rationally designed compounds with fewer off-target 
effects. 
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1 
1 INTRODUCTION 
1.1 DNA and the minor groove 
The central dogma of molecular biology is the simplest explanation of how genetic 
information is passed on. Simply put, DNA is transcribed to RNA which is then translated to 
protein. Within this process, however, are many intricacies. DNA – short for deoxyribonucleic 
acid – is the carrier of genetic information but is itself a highly complex system. For example, 
Figure 1.1 illustrates a canonical B-form DNA double-helix strand. The DNA is composed of two 
complementary strands of nucleotides joined together by hydrogen bond interactions. Nucleotide 
sequences are read from the O5’ to O3’ direction and read as 5’ to 3’ (Figure 1.1C). Due to the 
specific configuration of the helical duplex, two particular formations occur which are referred to 
as the major and minor grooves (Figures 1.1B & C). The major groove is often found as having a 
deep and wide groove which is where many proteins bind, or interact, with the DNA. On the other 
hand, the minor groove is often identified as having a deep and narrow groove. Figure 1.1C shows 
two examples of thymine∙adenine (T∙A) and cytosine∙guanine (C∙G) complementary base pairs 
and the locality of the major and minor grooves per base pair. For G∙C base pairs, three hydrogen 
bond interactions occur. The amino group of C and keto group of G extend into the major groove 
while the keto group of C and amino groups of G point into the minor groove. For A∙T base pairs, 
only two hydrogen bond interactions are formed. Here, the methyl group of T and keto group of 
A protrude into the major groove while a second keto group of T sits in the minor groove. 
1.2 Classical minor groove binding agents 
The minor groove of DNA has become an increasingly interesting area of focus in the drug 
design community. Many DNA-binding proteins target the major groove leaving the minor groove 
exposed. An exposed minor groove opens the prospect to using small molecules to target the minor 
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Figure 1.1 DNA and the minor groove. 
(A) Central dogma of molecular biology, (B) dsDNA with major and minor grooves and (C) A∙T 
and G∙C base pairs.  
 
groove and modulate genetic processes. Several cartoon examples are shown in Figure 1.2. The 
top example, labeled as 1a and 1b illustrates the uses of a small molecule acting as an inhibitor. 
First, the small molecule binds in the minor groove (1a) and in doing so causes some type of 
allosteric or conformational change in the DNA shape or structure (1b). A second possible 
inhibition pathway follows the same DNA sequence except here, the protein is able to bind first 
with the DNA (2a). In this scenario, the protein interacts with the major groove of the DNA leaving 
the backside of minor groove accessible to a small molecule. Here, (2b) the small molecule binds 
with DNA and causes the protein to dissociate (2c) via allosteric interactions. A third possible 
approach, not illustrated in Figure 1.2, also involves the enhancement or upregulation of DNA-
protein interactions through small molecule binding. 
 A classical minor groove binding compound has several key characteristics and three 
examples are shown in Figure 1.3. Both Netropsin and Distamycin are naturally occurring 
polyamides derived from bacteria while DB75 [1] is a synthetic dicationic diamidine made by Dr. 
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Figure 1.2 Small molecule inhibition of protein-DNA interactions. 
(1a-1b) Direct inhibition of DNA-protein interaction by small molecule binding and (2a-2c) 
indirect inhibition of DNA-protein interaction through allostery. 
 
David W. Boykin and co-workers at Georgia State University. The shape, length, and charge of a 
minor groove binding molecule are critical for binding interactions. As shown with the three 
examples below, a crescent shape, end positive charges, and hydrogen bond donor/acceptor groups 
are all crucial for high affinity binding with DNA. Positive charges on the compound are also 
important as it allows for electrostatic interactions with the negative phosphate backbone of the 
DNA which helps stabilize binding. Likewise, hydrogen bond donor and acceptor groups on the 
compound with the bases increase binding affinity and specificity. Evidence of minor groove 
binding is shown in Figure 1.4 with a crystal structure of DB75 in a 5’-AATT-3’ binding site.[2] 
This example clearly demonstrates not only hydrogen bond and electrostatic interactions, but also 
a shape complementary to the minor groove. The length of the small molecule is equally important. 
For instance, if the compound is too short it may lose specificity; too long or if bulky substituents 
are present, it can also reduce specificity through increasing insolubility and/or obstruction into 
the minor groove. 
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Figure 1.3 Classical minor groove binding compounds. 
Netropsin and Distamycin are naturally occurring polyamide groove binders and DB75 is a 
synthetic, dicationic diamidine. 
 
 
Figure 1.4 X-ray crystal structure of DB75 with 5'-AATT-3'. 
Binding of DB75 with d(CGCGAATTCGCG)2. PDB ID: 227D. 
 
1.3 Electrospray ionization mass spectrometry and DNA 
1.3.1 Background 
The continued development of electrospray ionization (ESI) methods and the extensive 
improvements in commercial mass spectrometry (MS) instruments over the last two decades have 
brought ESI-MS experiments into the forefront of analysis of bio-macromolecules and their 
complexes. The majority of ESI-MS reports on biological systems to date have involved proteins 
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but nucleic acids are attracting increasing attention. Early studies on double-helical DNA involved 
establishing conditions for preserving the duplex in the gas phase and evaluating different volatile 
solution buffers/salts for optimum ESI-MS conditions.[3] There are numerous reports on duplex 
stability [3-5], dissociation to single strands [6-8], effects of ESI conditions [9, 10], solution 
composition [11-14] and nucleic acid sequence [7,15]. These key studies and more have provided 
a strong foundation for ESI experiments on nucleic acid-small molecule complexes. 
1.3.2 Small molecule studies by ESI-MS 
The early studies on ESI-MS requirements for stable duplex [3, 16] quickly evolved into important 
studies on DNA complexes with metal ions [7, 17], organic compounds [18, 19] and proteins [20, 
21]. Studies of organic systems complement extensive solution biophysical studies that have two 
important goals: (i) develop a better understanding of the fundamental features of nucleic acid 
interactions and (ii) design nucleic acid-targeting agents for biotechnology and therapeutics. 
Compounds that bind in the DNA minor groove have a variety of structural features that affect 
their affinity, stoichiometry and sequence specificity. All of these features, as well as cooperativity 
for compounds with a stoichiometry greater than one, can be investigated by ESI-MS methods. 
The earliest reports of DNA complexes by ESI-MS were with the polyamide minor groove binder, 
Distamycin A.[16, 22] The complex was intact in the gas phase and gave a 1:1 binding 
stoichiometry for a 12 base pair duplex that had an AAATTT base sequence binding site at low 
ratios of Distamycin to DNA complex. As the ratio of Distamycin to duplex was increased, a 2:1 
bound species was observed and these results are in agreement with solution experimental 
findings.[23-25] The excellent agreement between species present and their ratio dependencies 
was a significant example that nucleic acid complex stoichiometry, cooperativity and relative 
affinities could be determined by ESI-MS. 
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Figure 1.5 Cartoon of electrospray ionization of DNA. 
Droplets of DNA in solution are ejected from a capillary at high voltage towards a counter 
electrode. The electric potential causes the droplets to disperse into smaller particles until the 
solvent evaporates. The particles will then be carried toward a mass analyzer where they will be 
separated by a mass-over-charge ratio (m/z). 
 
The successful, initial studies of small molecule-DNA complexes moved into ESI-MS 
experiments with a well-known variety of agents and a wide variety of minor groove binders of 
quite different structure.[26, 27] All of the results with minor groove binders gave excellent 
agreement with the solution studies. It is now quite clear that ESI-MS experiments, when properly 
conducted, will provide complementary and very useful results for analysis of DNA-small 
molecule complexes. The method is quite versatile and experiments can be rapidly conducted so 
that it is an attractive addition to other powerful, biophysical approaches for DNA complex 
analysis. The ability to quickly analyze non-covalent complexes, with good sensitivity and low 
sample consumption, as well as the variety of information provided, makes ESI-MS a very 
valuable tool. 
1.3.3 Application to other systems 
ESI-MS is often used for characterizing small, organic molecules but has become a 
powerful tool for large biomolecular systems. For small molecule-DNA investigations, excellent 
consistency using ESI-MS and other biophysical methods has been found. Competition ESI-MS 
is particularly appealing since multiple interactions between ligand and DNA can be analyzed  
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Figure 1.6 Adjustment of DNAs to achieve different molecular weights for ESI-MS. 
Target base pair sites in the stem of the DNA are preserved. (A) DNA with unadjusted molecular 
weights; (B) complex and unbound DNA peaks are not distinguishable upon addition of ligand 
due to overlapping peaks for free DNA and DNA-ligand complexes (e.g., black and red); (C) 
modifications in the hairpin loop by incorporation of various bases allows the DNA stem to be 
preserved while creating distinguishable molecular weights; (D) complexes and free DNA become 
easily identifiable. T = thymidine, C = cytidine, U = deoxyuridine. 
 
simultaneously. Analyzing interactions between a single DNA and a single ligand is not efficient 
for screening a library of compounds. With a competition method, a large number of interactions 
can be studied in much less time than with the conventional approach of one DNA and one ligand. 
Valuable information is gathered quickly with regards to preferential binding of a ligand to DNA. 
Although several of the studies described later will focus primarily on the binding of small 
molecule ligands to DNA, this technique is not limited to these specific interactions and can be 
appled to other biomolecules of interest, including proteins [4, 20, 28-31], carbohydrates [32, 33] 
and other types of nucleic acids such as RNA [34-44] and peptide nucleic acids [45-47]. 
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1.4 Protein complexes with nucleic acids by ESI-MS 
The ETS family of transcription factors (TF) comprises a major class of transcriptional 
regulators across many species, including humans.[48] Humans also express various oncogenic 
mutations of the ETS TFs that are associated, for example, with bone, breast, and prostate 
tumors.[49, 50] All ETS TFs have similar DNA binding domains that are highly conserved in 
structure with a 5’-GGAA/T-3’ consensus central binding site.[51] Genomic analyses have 
identified the ETS member PU.1 as a pioneering transcription factor [52] that can overcome 
chromatin packaging to bind chromosomal DNA. Because of the special properties of PU.1, it is 
important to understand how DNA recognition by PU.1 is differentiated from other ETS proteins. 
There is, thus, an essential need for a broad range of methods and studies, including ESI-MS, to 
address the physical mechanisms of sequence recognition by the PU.1 TF. 
Targeting TF-DNA complexes, either for inhibition or enhancement, is very attractive for 
the treatment of a number of different diseases. This could be done by targeting the TF or the DNA 
binding domain. Unfortunately, it has proved very difficult to target TFs and they are frequently 
referred to as “undruggable”.[53, 54] An alternative is to target the DNA binding domain of the 
TF with designed small molecules and this approach is gaining increasing attention. ESI-MS has 
developed into a very attractive method to evaluate both small molecule binding to specific DNA 
sequences as well as for their effects on TF-DNA complexes. The wealth of important obtainable 
information illustrates the power of ESI-MS in both the characterization of TF-DNA complexes 
and in the discovery and development of TF inhibitors. Although ESI-MS studies of protein-DNA 
complexes are relatively rare, a number of studies have appeared in recent years and it is likely 
that many more are in progress. 
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1.5 Purpose of dissertation 
Much of the work described in this dissertation focuses on extending the minor groove 
recognition repertoire through sequences with additional G∙C bps and distinguishability among 
variable A∙T bp regions. With several minor groove binder and DNA interaction model systems, 
a novel screening method using ESI-MS was developed to identify new DNA-small molecule 
interactions. Beginning with well-characterized minor groove binders with known DNAs, ESI-MS 
conditions were varied to find optimal conditions for detecting these systems. Once optimal 
conditions were chosen, sequences were strategically designed to not only interact with minor 
groove binding compounds, but also to be detectable by ESI-MS (details describing the design will 
be discussed in the the following chapter). This ESI-MS screening method was then applied to the 
discovery of new target binding sites for newly synthesized compounds and/or in expanding of 
target binding sites for existing compounds. A combination of other biophysical techniques were 
used to validate and/or complement results obtained by ESI-MS including thermal melting (Tm), 
circular dichroism (CD), molecular dynamics (MD), and surface plasmon resonance (SPR). Our 
ESI-MS method has been applied to the study of DNA-protein complexes, RNA-small molecule 
interactions, quadruplex-DNA complexes and DNA-aminoglycoside interactions; however, only 
a portion of our findings will be discussed in the remaining chapters. 
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2.1 Abstract 
Minor groove binding compounds have been shown to induce changes in global DNA 
conformation, allosterically inhibiting DNA-protein interactions necessary for transcriptional 
processes. Many minor groove binders are specific for A·T base pairs but have little preference 
over alternating A/T or A-tract sequences. Few compounds, other than polyamides, show 
selectivity for mixed sequences with A·T and G·C base pairs. Electrospray ionization mass 
spectrometry (ESI-MS) can provide insight on the stoichiometry and relative affinities in minor 
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groove recognition of different DNA sequences with a library of minor groove binders. A goal in 
our current research is to develop new compounds that recognize mixed sequences of DNA. In an 
effort to optimize screening for compounds that target mixed A·T and G·C base pair sequences of 
DNA, ESI-MS was used to study the competitive binding of compounds with a mixed set of DNA 
sequences. The method identified preferred binding sites, relative affinities, and concentration-
dependent binding stoichiometry for the minor groove binding compounds Netropsin and DB75 
with A·T-rich sequences, and DB293 with ATGA and AT sites. 
2.2 Key words 
Electrospray ionization mass spectrometry; Minor groove binders; Minor groove 
recognition; Mixed DNA sequences, Selectivity 
2.3 Abbreviations 
Base pairs (bps); Deoxyribonucleic acid (DNA); Dissociation equilibrium constant (KD); 
Electrospray ionization mass spectrometry (ESI-MS); Mass-over-charge ratio (m/z); Minor groove 
(MG); Netropsin (Net); Surface plasmon resonance (SPR) 
2.4 Introduction 
Non-polyamide minor groove (MG) binders target A·T-rich sites with variable distinction 
among A·T sequences.[1] Netropsin (Net) and DB75 (Figure 2.1) are MG binding compounds 
which bind with 1:1 stoichiometry to A·T-rich sites.[2, 3] Polyamides can selectively target G·C 
base pairs (bps) in a DNA sequence, but few non-polyamide MG binders target mixed sequence 
sites. DB293 (Figure 2.2) is the first dicationic diamidine to strongly recognize a sequence with 
mixed bp.[4] It binds in the MG of ATGA sequences as an antiparallel stacked dimer with positive 
cooperativity. Using the known interactions of Net, DB75, and DB293 as reference points, we are 
developing a mixed sequence method to screen DNA-MG binders using electrospray ionization 
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spectrometry (ESI-MS). Because of its improved versatility, ESI-MS has widely increased its 
utility for studying biomacromolecules and is ideal for characterizing systems with non-covalent 
interactions. We report a method that provides rapid screening of MG compound libraries for 
interactions, which can be easily characterized based on differences in structure and DNA 
sequence. To the best of our knowledge, this is the first example using ESI-MS to screen the 
competitive interaction of ligands with multiple DNA sequences in a single sample. Using this 
approach, we can begin to define a basis for specificity of drug binding at a target sequence. With 
enough DNAs, this method can screen target sites and complexes of interest. Information including 
relative binding affinity, stoichiometry, and binding cooperativity can be determined. 
2.5 Results 
2.5.1 Testing the experimental conditions and ESI-MS method with known minor 
groove binders 
Net is a well-understood MG binder which forms high-affinity 1:1 complexes with the 
A·T-rich sequences selected for our experiments.[2] Figure 2.1B is a deconvoluted spectrum of 
AAATTT and R1 sequences at a molar ratio of [0:1] Net:DNA, and both DNA sequences have 
single peaks with similar intensity and minimal background noise. Adding Net to form a molar 
ratio of [1:1] Net to AAATTT led to a large decrease in peak intensity for the oligonucleotide 
compared to R1 and the appearance of a peak corresponding to a 1:1 Net:DNA complex, which 
indicates strong binding between Net and AAATTT. A [2:1] sample showed an additional decrease 
in parent peak intensity, indicating that Net had completely saturated the binding site of the 
AAATTT. Even at a [2:1] ratio, no 2:1 species was observed. This indicated that binding is 1:1, as 
expected. Similar to Net, DB75 is also a well-characterized MG binder that binds with high affinity 
as a monomer to A·T-rich regions. Experiments were performed using both MG binders with 
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Figure 2.1 Spectra of mixed DNA sequences forming complexes with DB75 and Netropsin.  
(A) DNA sequences used to simultaneously test binding of multiple sequences: ATATAT, AAATTT, 
ATGA, and R1. Concentration of DNA is 5 μM. (B-D) Spectra of DNA and Net binding with 
increasing ligand concentrations. Ligand-to-DNA ratios are [0:1], [1:1], and [2:1], 
respectively. (E-G) Spectra show the competitive binding of Net and DB75 with multiple DNA 
sequences. Respective ratios are shown at [0.5:1], [1:1], and [2:1]. Free DNA is indicated by 
a sequence name above the corresponding peak (AAATTT, m/z 7,921.5) and ligand-DNA complex 
as name + n (AAATTT + Net, m/z 8,352.5). 
 
ATATAT, AAATTT, and R1 to test competitive binding. Equal concentrations of DB75 and Net 
were added at a mole to mole ratio of [0.5:1] for a single ligand to DNA. At this ratio, the tallest 
peak corresponded to 1:1 AAATTT with Net. Smaller peaks show ATATAT + Net and ATATAT 
+ DB75 complexes, but no binding is detected for AAATTT + DB75 (Figure 2.1E). An increase 
in ligand concentration to [1:1] showed a different pattern in complex formation where AAATTT 
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+ Net was the most abundant. Peak intensities increased to roughly 50 % for ATATAT + DB75 
and ATATAT + Net, while a new peak for AAATTT + DB75 was detected (Figure 2.1F). Upon 
further increasing ligand concentrations to [2:1], a new series of peaks appeared and free ATATAT 
or AAATTT decreased (Figure 2.1G). The tallest peak became AAATTT + Net, and the intensity 
of ATATAT + Net surpassed ATATAT + DB75. The peaks corresponding to the parent 
nucleotides disappeared, indicating complete complexation. This increase in intensity for the 
ATATAT + Net complex likely occurred once all free AAATTT was consumed due to the high 
affinity of Net for AAATTT. Residual Net could then saturate the ATATAT binding site. The high 
binding affinity of Net for AT sequences is apparent, as is the competitive binding of Net over 
DB75 for AT sequences. Surprisingly, as the concentration was increased, new peaks were 
detected for DB75 + R1. DB75, known to bind strongly in the MG of AT sequences, has also been 
reported to intercalate weakly with G·C sites, which is likely the case for R1 + DB75 at increased 
concentrations. The intercalated binding of DB75 occurs because the stronger binding Net 
saturates the A·T-rich MG site. As the free concentration of DB75 reaches a high level, 
intercalation at the available G·C sites then ensues. All of the results with Net and DB75 are in 
good agreement with published results but also provide new insight into the interactions of these 
compounds with different DNA sequences. 
2.5.2 Using DB293 to test monomer versus dimer binding 
Previous work with DB293 indicates it forms a cooperatively stacked dimer with ATGA 
and a 1:1 complex with AATT. Thus, the binding of DB293 provides a more complex ESI-MS 
test system.[4] Solutions of DB293 were mixed with R1, AAATTT, and ATATAT, as well as 
ATGA (Figure 2.2). Initially, only monomer complexes with ATATAT and AAATTT are formed 
at a [1:1] ratio with little preference for either sequence. At a [2:1] ratio, a 1:1 species between 
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Figure 2.2 Using DB293 to test monomer versus dimer binding.  
Spectra of mixed DNA sequences titrated with DB293. Unbound DNA is indicated by a sequence 
name above the corresponding peak (ATGA, m/z 6,686.5) and ligand-DNA complex as name+n 
(ATGA+2, m/z 7,375.0). DNA concentration is 5 μM for each sequence. Molar ratios of [0:1], 
[1:1], [2:1], and [4:1] correspond to (A-D), respectively. 
 
 
both A·T sequences and DB293 is again observed. For ATGA and DB293, no 1:1 complex is 
detected but a 2:1 species is observed. The lack of a 1:1 complex between DB293 and ATGA is 
indicative of strong cooperative dimer binding and is in agreement with biosensor-SPR results.[4] 
When the concentration of DB293 was doubled to a [4:1] ratio, the pattern remained the same. R1 
showed no interaction with DB293 at any of the ligand concentrations. The peak at 7,375.5 m/z 
not only indicates a 2:1 complex for DB293 with ATGA, but having the highest intensity suggests 
a greater affinity for the cooperative dimer with ATGA over monomer formation with ATATAT 
and AAATTT sequences. 
2.5.3 DNA and DNA-complexes are stable 
We adjusted each parameter individually to monitor for changes in ligand binding and 
signal intensity for the DNA-MG binder systems (Figure 2.3). There were no changes in signal 
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intensity which indicates the ESI-MS conditions used in this work are appropriate. We have found 
that relatively weak complexes (i.e. KD > 0.1 mM), such as external electrostatic complexes, are 
easily dissociated during injection of the sample and into the gas phase, which filters the results 
and emphasizes more specific and relative strong complexes over nonspecific binding. The raw, 
deconvoluted spectra show multiple charged species (Figure 2.4) for free DNA and DNA-
complexes with the most abundant charge states having net charges of -4, -5, and -6. For these 
systems, the peaks observed correspond to DNA with partially neutralized backbones. 
Neutralization occurs during the electrospray process through interaction of the ammonium ions 
with the phosphate backbone. The degree of neutralization and net charge depends on ammonium 
acetate concentration, size of the DNA, and the conditions used which were chosen based on earlier 
reports.[5, 6] 
2.5.4 Sensitivity of DNA and DNA-complexes 
Differences in the complex conformation following ionization was an initial concern, 
meaning the complex detected in the gas phase may not reflect the complex found in solution. A 
conformational change could, therefore, have an effect on the response and relative binding 
affinity. For example, after the first DB293 compound binds with ATGA, it is believed that the 
MG widens to accommodate the second, more favorable molecule. This is a conformational 
change in the microstructure of the ATGA minor groove and yet, response factors for systems that 
undergo microstructural changes are similar.[7, 8] This assumption for similar response allows an 
easy comparison of the peaks. The relative affinities of free DNA and DNA-complexes are, thus, 
approximated by monitoring changes in relative intensities before and after addition of the 
compound. Additionally, molecular dynamics simulations of DNA-MG binder complexes in 
vacuo have been reported using conditions to mimic the environment in a mass spectrometer.[9]  
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Figure 2.3 Peak comparison of R1, ATATAT, AAATTT, and Net-DNA complexes.  
DNA sequences and Net concentrations each 5 µM. Top row (A) capillary voltage, (B) collision 
energy, and (C) cone voltage conditions. Bottom row (D) desolvation temperature, (E) extraction 
voltage, and (F) source temperature conditions. Peaks in order of least to greatest m/z: R1, 
ATATAT, ATATAT + Net, AAATTT, and AAATTT + Net. 
 
The simulations suggested little conformational difference between solution and gaseous 
environments as long as the DNA charge is low in the gas phase (bound ions). This provides 
additional support that the relative affinities of the DNA-complexes observed using ESI-MS are 
comparable to those found by other methods. The actual process of solution to gas phase can pose 
some difficulty for solutions requiring an aqueous environment. A more volatile solvent, such as 
methanol, is often times added to samples to increase the transition, and as a result the signal/noise 
ratio (S/N). With our conditions, addition of MeOH (up to 20% v/v) led to some reduction in the 
amount of complex observed with a concomitant increase in free DNA. The addition of MeOH 
did, however, result in some general improvement in S/N. Due to the lower boiling point of 
methanol, only a small percentage is required to facilitate transition into the gas phase. The use of  
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Figure 2.4 Raw, convoluted data to observe competitive binding of Net with R1 and AAATTT.  
Concentrations of AAATTT, R1, and Net are 5 μM each. Titration ratio is expressed as [1:1] where 
molar ratio is Net to AAATTT. The most abundant species are the -4, -5, and -6 charge states. 
 
methanol raised concerns regarding the appropriate amount to add and possible effects the solvent 
could have on the DNA structure. The binding mechanism for MG binders in contingent on the 
shape and width of the MG and the selectivity of these compounds is also dependent on solvent 
effects. Based on our findings, solutions containing variable methanol concentrations did not show 
significant conformational effects based on the amount of complex observed. 
2.6 Discussion 
Using a mixed set of DNA sequences, we can quickly and accurately evaluate relative 
affinities, stoichiometry, and cooperativity. These tests show that ESI-MS not only detects binding 
using control DNAs and MG binders, but also enables competition among ligands and DNAs to 
be observed. ESI-MS can screen multiple sequences simultaneously, and alternative binding 
modes for MG binding compounds can be detected. Our intention for developing this method is to 
complement information obtained by other techniques such as footprinting or next-generation 
assays. The goal is to determine differences in binding for compounds with a closely related set of 
sequences having systematic variations. The DNA has a known binding site, in addition to 
sequence variants (e.g., ATAT, AATT, and AAAA), so we can focus on sequence specificity and 
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compound selectivity. The strongest binding ligands will interact with available binding sites first, 
which makes this a true competitive assay.  
Analyzing interactions between ligand and a single DNA is not efficient. One can study 
any number of interactions in the same time it takes to study one. The key is in ligands and 
sequences which form complexes with distinguishable molecular weights. By using sequences 
with like compositions, the sensitivities of DNA and DNA complexes are also similar; thus, 
limitations such as response factors are overlooked.[6, 8] This feature allows direct comparison of 
unbound DNA and complexes to determine the relative binding affinity. It further demonstrates 
that our method to investigate the competitive and selective binding between multiple, mixed 
DNA-ligand interactions in a single sample not only is more efficient but also provides important 
new information with DNA interactions. 
2.7 Conclusion 
We have developed a novel approach to observe competitive binding and to screen for 
DNA-ligand interactions. To the best of our knowledge, this is the first example using ESI-MS to 
simultaneously examine ligand binding with multiple DNA sequences. Our findings show 
excellent consistency between ESI-MS and other biophysical methods. This technique has many 
favorable features: it is rapid and convenient and requires small amounts of sample. It allows direct 
comparison of relative binding affinities in addition to stoichiometry and cooperativity. Using this 
innovative method, one could theoretically screen dozens of sequences and obtain a large amount 
of information from a single sample, reducing reagents used and time spent cleaning between 
sample runs. More importantly, this method is not limited to DNA and small molecules and can 
be applied to other biomacromolecular interactions including proteins, RNA, and carbohydrates. 
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2.8 Experimental protocol 
2.8.1 DNA and compounds 
Ligand stock solutions were prepared in doubly distilled water at a concentration of 1 mM. 
DNA sequences were purchased from Integrated DNA Technologies (IDT, Coralville, IA). Based 
on the predicted amount of DNA provided by IDT, DNAs were dissolved to concentrations near 
1 mM in doubly distilled water. All sequences were converted to ammonium acetate salts by three 
times dialysis in 150 mM NH4OAc vacuum-filtered buffer (0.22 µM Millipore filter, pH 6.7) using 
a 1000 Da cut-off membrane (Spectrum Laboratories, Rancho Dominguez, CA). Following 
dialysis, concentrations of DNA were spectroscopically determined at 260 nm with extinction 
coefficients calculated using the nearest-neighbor method.[7] Sequences were denatured at 95 °C 
and immediately quenched on ice to initiate hairpin formation. Ligand and dialyzed DNA solutions 
were stored at 4 °C. Titration experiments were performed with a mixed set of DNA in a solution 
with a total volume of 100 μL. DNAs were diluted to 5 μM each in 150 mM NH4OAc (pH 6.7) 
and stored at 4 °C. Titration ratios are expressed as compound-to-single-DNA, instead of 
compound-to-total-DNA concentration. For example, 20 μM DB293 to 5 μM ATGA is expressed 
as a [4:1] ratio. R1 was used as a reference because it contained no known target sequence. 
2.8.2 Electrospray ionization mass spectrometry 
ESI-MS experiments were performed using a Waters (Milford, MA) Micromass Q-TOF in 
negative ion mode using the MassLynx 4.1 software. Conditions were chosen based on published 
methods [5] and optimized as shown in Figure 2.3. Capillary voltage, 2200 V; sample cone 
voltage, 30 V; extraction cone voltage, 3 V; source block temperature, 70 °C; desolvation 
temperature, 100 °C, and sample injection flow rate, 5 μL/min. A volatile solvent, such as MeOH, 
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is often added to facilitate solution-to-gas phase transition, however, the addition of a solvent was 
not necessary using our conditions. 
The actual process of solution to gas phase can pose some difficulty for solutions requiring 
an aqueous environment. A more volatile solvent, such as methanol, is often times added to 
samples to increase the transition, and as a result the signal/noise ratio (S/N). With our conditions, 
addition of MeOH (up to 20% v/v) led to some reduction in the amount of complex observed with 
a concamitant increase in free DNA. The addition of MeOH did, however, result in some general 
improvement in S/N. Due to the lower boiling point of methanol, only a small percentage is 
required to facilitate transition into the gas phase. The use of methanol raised concerns regarding 
the appropriate amount to add and possible effectes the solvent could have on the DNA structure. 
The binding mechanism for MG binders in contingent on the shape and width of the MG and the 
selectivity of these compounds is also dependent on solvent effects. Based on our findings, 
solutions containing variable methanol concentrations did not show significant conformational 
effects based on the amount of complex observed. 
The instrument was flushed with 150 mM NH4OAc prior to sample injection. Scans were 
collected every 1.0 sec for 10 min with the final 2 min averaged. Raw spectra of the free DNA and 
DNA-complexes showed multiply charged species ranging 300 – 3000 m/z and the most abundant 
peaks belonged to -4, -5, and -6 charge states (Figure 2.4). Spectra were deconvoluted using the 
Maximum Entropy 1 function which calculates the molecular ion (M) based on the equations 
below, where H is the proton molecular weight, m’ and m” are specific m/z values, and z’ is the 
charge state for m’.  
z’ = (m”− H) / (m’ – m”) (1) 
M = z’ (m’ + H)  (2) 
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and writing. 
 
 
3.1 Abstract 
Small molecule targeting of the DNA minor groove is a promising approach to modulate 
genomic processes necessary for normal cellular function. For instance, dicationic diamidines, a 
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well-known class of minor groove binding compounds, have been shown to inhibit interactions of 
transcription factors binding to genomic DNA. The applications of these compounds could be 
significantly expanded if we understand sequence specific recognition of DNA better and could 
use the information to design more sequence specific compounds. Aside from polyamides, minor 
groove binders typically recognize DNA at A-tract or alternating A·T base pair sites. Targeting 
sites with G·C base pairs, referred to here as mixed base pair sequences, is much more difficult 
than those rich in A·T base pairs. Compound 1 is the first dicationic diamidine reported to 
recognize a mixed base pair site. It binds in the minor groove of ATGA sequences as a dimer with 
positive cooperativity. Due to the well-characterized behavior of 1 with ATGA and A·T-rich 
sequences, it provides a paradigm for understanding the elements that are key for recognition of 
mixed sequence sites. Electrospray ionization mass spectrometry (ESI-MS) is a powerful method 
to screen DNA complexes formed by analogues of 1 for specific recognition. We also report a 
novel approach to determine patterns of recognition by 1 for cognate ATGA and ATGA-mutant 
sequences. We found that functional group modifications and mutating the DNA target site 
significantly affect binding and stacking, respectively. Both compound conformation and DNA 
sequence directionality are crucial for recognition. 
3.2 Key words 
Dimerization; DNA recognition; Mass spectrometry; Minor groove binder; Mixed DNA sequence 
3.3 Abbreviations 
Deoxyribonucleic acid (DNA); Electrospray ionization mass spectrometry (ESI-MS); Association 
constant (KA); Minor groove binder (MGB); Mass-over-charge (m/z); Surface plasmon resonance 
(SPR) 
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3.4 Introduction 
Genetic processes are regulated by transcription factors (TF) that target specific DNA 
sequences. Typically, conformational changes or other processes, such as hydration, that yield 
strong interactions with bases in the recognition site are involved in binding.[1-3] A major goal of 
fields from chemical biology to therapeutic development is control of gene expression through TF 
modulation by small molecules that target DNA.[4, 5] Instead of targeting the major groove, like 
most TFs, a more effective approach involves using small molecules to form a complex in the 
minor groove of DNA and allosterically modulate transcription factor binding.[6-9] Both 
inhibition and enhancement of TF complexes are possible with this approach. Typical minor 
groove binding compounds are relatively planar, crescent-shaped structures which match the 
geometry of the minor groove. Reversible binders typically have positively charged groups and 
form non-covalent interactions with DNA sites through electrostatic, hydrogen bonds, and van der 
Waals contacts. Although most minor groove binding structural types have a high affinity for A-
tract and multiple A·T sequences, they do not distinguish well between various A·T base pair 
sequences.[10, 11]  
Polyamides (PA), the paradigm minor groove binding compounds which can recognize 
mixed or A·T and G·C-containing sequences pose difficulties with solubility, aggregation, and 
synthetic costs.[12, 13] Dicationic diamidines are a class of minor groove binding drugs which 
have overcome many of the issues encountered by PAs, but lack the sequence specific targeting 
characteristics of PAs. A breakthrough compound for dicationic diamidines is compound 1 
(Figure 3.1) since it recognizes a target site with a G·C base pair in addition to A·T.[14-16] It is 
exceptional since it dimerizes in the minor groove of ATGA sequences with positive cooperativity, 
in spite of being a dication. Earlier reports revealed two binding constants for the dimer, the second  
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Figure 3.1 Structures of dicationic diamidine minor groove binding compounds used to 
investigate dimer formation in mixed-sequence sites.  
Compound 1 is a reference compound known to dimerize in the mixed sequence site ATGA. 
Compound 2 is a classical minor groove binding compound known to recognize A·T-rich sites. 
Compounds 3 to 8 are analogues of 1. Molecular weights are listed below the respective structures. 
 
KA value considerably higher (> 20-fold) than the first, demonstrating positive cooperativity in 
binding of 1.[15] The first diamidine molecule is believed to insert itself in the minor groove 
followed by slight widening in the groove width to accommodate the second, energetically more 
favorable molecule. The second 1 molecule inserts itself into the groove and participates in π-π 
stacking with the first molecule in an antiparallel fashion. Surprisingly, the four positive charges, 
which would be expected to repel each other due to their close proximities, do not inhibit the 
cooperative binding. 
A similar and symmetric ligand, compound 2, is a well characterized dicationic diphenyl 
diamidine which behaves as a classical minor groove binding compound by recognizing A·T-rich 
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sequences with 1:1 stoichiometry.[17] A single, asymmetric modification from benzimidazole to 
phenyl is the only difference between 1 and 2. Both compounds recognize A·T sequences but 1 
has a higher affinity for dimer formation with ATGA. Alternatively, variation in the flanking 
sequence of the target site has also been demonstrated to affect the binding affinity of small 
molecules in the minor groove.[15] For instance, the binding affinity of 1 for ATGA can be 
affected by sequences flanking the target binding site. These examples provide important insights 
into structural and sequence-dependent effects of minor groove recognition. 
A current research goal is to identify how variations in compound structure can affect the 
relative affinity for specific DNA sequences and how different sequences will be recognized by a 
single compound. Due to the large number of potential drug candidates and DNA sequences, a 
robust method to screen DNA and small molecule interactions is essential. Electrospray ionization 
mass spectrometry (ESI-MS) is a powerful method to investigate minor groove binder-DNA 
complexes.[18-21] It has been demonstrated that ESI-MS can be used for studying biological 
macromolecular systems such as DNA complexes because the soft ionization conditions used 
allow the non-covalent interactions that occur to remain essentially intact.[22-26] Necessary 
information such as stoichiometry and relative binding affinities can be determined directly, 
rapidly, and with little material. It is especially useful when examining interactions between DNA 
and small molecules. We recently reported a high-throughput method using ESI-MS to 
simultaneously screen multiple DNA-minor groove binder interactions.[27] This technique is 
advantageous over other screening methods because ESI-MS is gentle enough to detect complexes 
yet powerful enough to sort out similar complexes. The complexes detected are of minor groove 
binding compounds having relatively high binding affinities so that they can be detected at low 
concentrations. Previously, we reported the versatility of our ESI-MS method by demonstrating 
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the cooperative dimer-forming nature of 1 with ATGA as well as monomer binding for A·T-rich 
sites.  
Our goal in this report is to identify the features of 1 that make it ideal for dimerization 
with an ATGA sequence. Interactions of structurally similar compounds are compared with a 
mixed set of multiple DNA sequences since small modifications can affect minor groove 
recognition. The motifs chosen have the potential for dimer formation based on their similarities 
to the parent compound 1. Next, DNA-minor groove binder complexes are studied using the parent 
compound, 1, and mutated target sequences. This is a novel approach to gain insight into how 1 
forms a sequence specific dimer in the minor groove. It allows a better understanding of how 
sequence composition and directionality can affect the selectivity of 1 using cognate and variant 
ATGA sequences and the method can identify other compounds and sequences for mixed-site 
dimers. 
3.5 Compound design 
Visually, the structural and conformational characteristics of 1 are typical for heterocyclic 
cations that bind specifically in the minor groove at A∙T sequence sites. With 1, however, two 
molecules can form a unique, antiparallel stacked tetracationic dimer in the minor groove and 
recognize an ATGA sequence with positive cooperativity.[14] The phenyl-furan-benzimidazole 
system clearly has features that optimize stacking in sequences having a wider minor groove and 
altering these functional groups can modulate dimerization.[28-29] It is not clear that 1 is the 
optimum structure for this recognition mode or what other sequences could be recognized in a 
similar complex. To address these questions and better understand the molecular features that are 
required for the cooperative dimer complex, a number of analogues of 1 were prepared. The effects 
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of structural and chemical changes on minor groove recognition of the ATGA target site and 
related sequences were then investigated with ESI-MS. 
Modifications of the furan group give 3, 4, and 5 (Figure 3.1). Analogue 4 contains an 
imidazole where one nitrogen is adjacent to the benzimidazole, while 3 is an isomer of 4 in which 
the nitrogen is positioned away from the benzimidazole and the third analogue, 5, is a pyrazole 
substituted system. For this class of compounds, modifying the furan group from a single hydrogen 
bond acceptor to a system containing both a donor and an acceptor should better define the stacking 
effects and hydrogen bonding found in ATGA recognition. The benzimidazole-amidine of 1 
provides a strong minor groove recognition module. The indole analogue 6 provides structural 
similarity to both 1 and DAPI [30] and the indole can preserve strong binding to the minor groove 
in A·T sequences, but its effects on dimer formation are unknown. In functional groups with 
multiple nitrogens, this modification may affect the stacking and/or hydrogen bonding required 
for dimerization. 
Lastly, two compounds have additions at the phenyl groups which lengthen the structure 
by including a second benzimidazole between the phenyl and amidine. Analogues 7 and 8 are 
isomers and differ in the benzimidazole-phenyl connectivity at the para- and meta-phenyl 
positions, respectively. This modification was chosen to determine how length, hydrogen bonding 
capability, and curvature of the moiety could affect DNA-ATGA interactions, and specifically 
dimer formation. 
3.6 Results 
3.6.1 Structural effects on selective recognition using analogues of 1 
To begin our investigation of the effects of different functional groups and substitutions on 
minor groove recognition, a test was conducted using 1 as a reference with a mixed set of DNA 
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sequences including ATATAT, AAATTT, and ATGA (Figure 3.2) since the binding affinities 
and modes of these sequences have been extensively studied with 1.  
A titration assay was performed with increasing concentrations of 1 to DNA and the spectra 
are shown in Figure 3.3. For each titration, the concentrations are expressed as a mole to mole 
ratio of 1 to a single DNA sequence to evaluate competition among the DNAs for ligand binding. 
This procedure allows lower concentrations of ligand to be used and enhances the preferred 
binding for one sequence over another. The spectrum in Figure 3.3A shows only DNA, where no 
1 was included. Peaks are labeled as the “sequence name” over the corresponding molecular 
weight (m/z). In the following titrations (Figures 3.3B and 3.3C) where 1 is added, peaks begin 
to show for complexes formed between DNA and ligand. For example, a complex formed between 
1 and AAATTT is shown at m/z 8,266 and labeled as AAATTT + (1) 1, where the integer in 
parentheses is the stoichiometric value for one molecule of 1 bound to AAATTT. In Figure 3.3B, 
the binding of two 1 compounds to ATGA is observed which indicates dimerization of the ligand 
with ATGA as expected. It is interesting to note that no 1:1 binding of compound 1 with ATGA is 
detected, which is reasonable since the affinity of the second molecule is more than 10-fold greater 
than binding of the first molecule.[15] The monomeric binding of 1 binding with AAATTT and 
ATATAT sequences and dimeric binding to ATGA is in agreement with the literature. The most 
distinctive characteristic of 1 is its ability to selectively bind as a cooperative dimer with ATGA 
while forming only monomer complexes with A·T-rich sequences. These results are clearly 
observed in Figure 3.3, further illustrating the positive cooperativity of 1 with ATGA by ESI-MS. 
To expand our understanding of how structural modifications of the 1 motif affects 
recognition in the DNA minor groove, the analogues of 1 were screened with the same mixed set 
of DNAs previously tested with 1. The structural conformation of each analogue can vary  
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Figure 3.2 Mixed hairpin DNA sequences used to screen interactions for monomer and dimer-
forming complex interactions with multiple sequences.  
Top row: ATATAT, AAATTT, and ATGA test sequences; bottom row: R1 and R2 as reference DNA 
sequences. 
 
considerably depending on the modification made, and the intrinsic groove width for each DNA 
depends on the base pair sequence. The groove width of A-tract sequences are the most narrow of 
sequences compared to alternating A·T sites, followed by mixed sequence sites, and G·C-rich 
sequences having the widest groove. Therefore, interaction between DNA and ligand is contingent 
on the inherent minor groove width matching the conformational space of the ligand(s). The A·T-
rich sequences would be expected to bind the ligand as a monomer while the mixed sequence site, 
ATGA, should be able to recognize two ligands. The minor groove of the R1 sequence is too wide 
and has the steric effects of the G·C hydrogen bond in the minor groove making it difficult to 
recognize small molecules, such as our dicationic diamidines, by the R1 reference sequence. As 
aforementioned, complexes formed are labeled as “sequence name” + (n) ligand, where (n) is the 
stoichiometric value for one ligand molecule bound to DNA. Screening of the analogues first 
began with the compounds extended in length, 7 and 8. With 7 at a [1:1] ratio, only small peaks 
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Figure 3.3 Example ESI-MS spectra of compound 1 titrated with multiple DNA sequences.  
Free DNA sequences are apparent by the sequence “name” above the corresponding peak (e.g., 
AAATTT m/z 7921.5) and ligand–DNA complex as “name + (n ligands bound) ligand name” (e.g., 
ATGA+(2) 1, m/z 7375). Concentrations of 1 are expressed as a mole-to-mole ratio for 1-to-DNA 
and range [0:1] to [2:1]. Note that the positive cooperative nature of 1 binding to ATGA is 
indicated by increasing peak for the dimer species and no detectable 1:1 species. (A) [0:1], (B) 
[1:1] and (C) [2:1]. 
 
for AAATTT + (1) 7 and ATATAT + (1) 7 were detected (data not shown). A two-fold increase 
in ligand concentration showed higher peak intensities for AAATTT and ATATAT. In Figure 
3.4A, a [4:1] titration of 7 with mixed sequences showed large peak intensities for 7 with the A·T 
sequences, but no ATGA complex. Alternatively, no complexes with ATGA, ATATAT, or 
AAATTT sequences were detected with 8, an isomer of 7. Formation of complexes is contingent 
on the compound having a complementary shape to fit in the minor groove. For instance, based on
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Figure 3.4 Spectra of DNA sequences titrated with analogues 3 - 8.  
Unbound DNAs are indicated by the sequence “name” above the respective peak (e.g. AAATTT, 
m/z 7921.5) and ligand–DNA complex as “name + (n ligands bound) ligand name” (e.g., 
AAATTT+(1) 3, m/z 8265.5). Molar ratios are expressed as [4:1] where ligand is to DNA. (A) 7, 
(B) 8, (C) 4, (D) 5, (E) 6 and (F) 3. 
 
the intrinsic helical nature of the DNA minor groove, and due to the extreme curvature of 8, one 
would expect to find a weakened interaction with any DNA (Figure 3.4B), as observed. 
In our investigation of compound conformational space affecting recognition of ATGA, 
derivatives with the furan replaced by other five atom heterocycles were evaluated. A titration with 
the imidazole, 4, at [1:1] detected no complex interactions. On increasing concentrations of 4 to 
[2:1], 1:1 binding for AAATTT and ATATAT and 2:1 stoichiometry with ATGA were observed 
with similar intensities for both A·T complexes (data not shown). After further increasing the 
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concentration of 4 to [4:1], dimerization was enhanced and the peak intensity for ATGA increased 
relative to AAATTT + (1) 4 and ATATAT + (1) 4. In this case, the intensity for the A·T sequences 
were comparable to one another (Figure 3.4C). A higher peak intensity of 4 with ATGA was 
observed with nearly equal intensities to A·T complexes. It is important to note that upon 
increasing the concentration of 4, specifically from [1:1] to [2:1], only dimer complexes between 
4 and ATGA were observed. The lack of any detectable 1:1 species illustrates the positive and 
cooperative binding behavior of 4 with ATGA. 
Analogue 5, which also has a central nitrogen heterocycle, was examined with the mixed 
DNA set. At lower concentrations of 5, a small peak for a complex formed with ATATAT was 
detected along with cooperative dimer binding with ATGA. Unlike its isomer 4, 5 showed a small 
peak at a molar ratio of [1:1] corresponding to ATATAT + (1) 5. At a [2:1] ratio, a complex with 
AAATTT was identified, but with less affinity than with ATGA and ATATAT. A 2:1 complex 
with 5 and ATGA was detectable with a higher intensity than AAATTT and ATATAT + (1) 5. By 
again doubling the concentration of 5 to [4:1], the intensity of ATGA + (2) 5 increased to more 
than double that of free ATGA, and increases in both ATATAT and AAATTT complexes were 
observed (Figure 3.4D). Based on the spectra shown in Figures 3.4C & 3.4D, ATGA recognition 
as a dimer appears stronger with the pyrazole system found in 5 over the imidazole arrangement 
of 4. However, neither of these two systems is preferred over the furan found in 1 based on results 
obtained using ESI-MS with mixed sequences.[27] 
Due to its structural similarity to 1, the indole-substituted analogue, 6, would be expected 
to recognize ATGA as a dimer. At a mole:mole ratio of [1:1], a small complex peak for ATATAT 
+ (1) 6 was detected. As the concentration was increased to [2:1], monomers with both A·T  
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Figure 3.5 Mixed DNA sequence results with 3.  
Spectrum expanded between the range m/z 7,250 to 7,950 to highlight the unexpected dimerization 
of two molecules of 3 bound to R1. The molar ratio shown is [4:1]. 
 
sequences were observed with comparable intensities, but no complexes formed with ATGA. 
Finally, after again doubling the concentration of 6, a peak corresponding to ATGA + (2) 6 was 
detected with the intensity of nearly half that of free ATGA but with no 1:1 ATGA peak (Figure 
3.4E). Analogue 6 exhibits 1:1 stoichiometry with ATATAT and AAATTT; however, the highest 
complex peak corresponded to ATATAT + (1) 6 instead of the ATGA complex. Unlike 1 at lower 
concentrations, 6 formed monomeric complexes with near equal proportions from A·T complexes. 
Increasing concentrations of 6 showed cooperative dimerization with ATGA, but the preference 
for A·T sequences was greater than ATGA. This set of DNAs with 6 indicates that substituting the 
benzimidazole with an indole negatively affects the relative affinity for ATGA recognition as a 
stacked dimer versus monomer A·T binding by a surprisingly large amount. 
To investigate the relationship between ATGA recognition and the arrangement of 
hydrogen bond donors/acceptors, 3, an isomer of 4, was screened with the DNA set. The titration 
at [1:1] displayed a pattern similar to that found with 5 with only a small peak for ATATAT + (1) 
3. Peak intensities from a [2:1] titration showed cooperative binding between ATGA and two 
molecules of 3 with a higher relative intensity than ATATAT + (1) 3. Doubling the concentration 
for 3 to [4:1] showed a dramatic increase in dimerization with ATGA (Figure 3.4F), an increase 
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in ATATAT + (1) 3, and a new peak corresponding to AAATTT + (1) 3. The absence of any 
detectable 1:1 species again highlights the positive and cooperative behavior of 3 with ATGA. 
However, at [4:1] there was an additional – and relatively high – peak at m/z 7,680.5. Unexpectedly 
for this minor groove binding series, the new peak matches a 2:1 stoichiometry for a 3 complex 
with the reference DNA, R1 (Figure 3.5). This reference sequence has none of the usual diamidine 
minor groove binding sites and showed no interaction with the other compounds found in Figure 
3.1. 
As expected with 3 and DNA, monomer binding with the A·T sequences was observed at 
lower concentrations. At higher concentrations, cooperative dimerization with ATGA was 
observed with a higher abundance relative to the A·T sequences. The peak corresponding to two 
3 molecules and R1, with higher relative intensity than complexes with the A·T sequences was, 
however, unexpected and was not observed with the isomer 4. The dimeric binding of 3 to R1 is 
likely attributed to a common TGA, found in both ATGA and the CTGA in R1. The cooperativity 
of binding from 3 is comparable to 1 with ATGA. Structural similarity would suggest similar 
interactions with the mixed set of DNAs since 4 and 3 are isomers of each other with only the inner 
imidazole reversed. Surprisingly, however, 3 showed a higher specificity for ATGA than 4 and 1, 
in addition to dimerization with R1. This rather significant difference in complex formation with 
3 and 4 was certainly unexpected and illustrates the power of the ESI-MS mixed DNA sequences 
approach to discover new binding modes and sequences. 
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Figure 3.6 Comparison of compound 1 and analogues 3, 4, 5, and 6. 
Left illustrates the electrostatic potential map for the compounds with increasing electronegativity 
(navy to red). The right column shows a side view of the twists experienced in the overall 
structures. Molecules were minimized and electrostatic potential maps calculated using Spartan. 
 
3.6.2 Molecular modeling of the compounds illustrates the effect of structural 
conformation on minor groove recognition 
In an effort to explain the compound differences in recognition of ATGA, ab initio 
calculations and molecular modeling were performed to better understand the conformation of 1 
and its analogues and understand how slight differences in composition can affect overall 
conformation (Figure 3.6). The conformation and curvature of 3 are very similar to 1 and yet, 
interestingly, the behavior of 3 is different from its 4 isomer. The planarity of 3 matches that of 1 
as does the electrostatic potential map. These qualities of 3 innately enhance its ability to stack as  
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Figure 3.7 Models of compound 3 recognizing the mixed sequences ATGA as a dimer. 
(A) The spaced-filled model illustrates the stacked dimer formation of 3 in the minor groove of 
ATGA. (B) Side view of the stacked compounds. The curvature of the bottom molecule (orange) 
turns in towards the floor of the minor groove whereas the top molecule (green) faces out toward 
the solvent. (C) The stacked 3 dimer interactions with the base pairs 5’-ATGA-3’ and 3’-TCAT-
5’. H-bond interactions between the base pairs are shown as dashed lines with distances in Å. 
 
a dimer with mixed sequences including sequences with multiple G·C base pairs (i.e. CTGA of 
R1). Structural information of 4 and 5 were also compared to 1. Surprisingly, the electrostatic 
potential map for 5 is very similar to 1 but the overall structures do not match. A model of 5 shows 
a twist in the dihedral angle between the phenyl and pyrazole ring systems. This twist likely arises 
from the hydrogens of the phenyl and pyrazole groups in close enough proximity to clash which 
is relieved by a 20° rotation. A twist of the same degree is also observed in 4 between its phenyl 
and imidazole groups. As with 5, 4 likely experiences clashing between the phenyl and imidazole 
hydrogens. It appears that a mostly planar conformation, such as that found in 1 and 3, is necessary 
for strong dimerization in the minor groove of ATGA. Compromising this planarity appears to 
hinder the ability of 5 and 4 to recognize ATGA presumably due to the conformational changes 
required to fit the minor groove, particularly as a stacked system. For instance, modifying the core 
imidazole system in 3 to 4 results in a decreased curvature for 4 compared to 3 which has a more 
crescent shape. 
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A model for two molecules of 3 bound in the minor groove of ATGA is illustrated in 
Figure 3.7 and is based on our current understanding of the interactions between 1 and ATGA.[31] 
Figure 3.7A is a model portraying the stacked recognition for two molecules of 3 in the ATGA 
minor groove. The 5′-ATGA-3′ is represented in cyan while the complementary 5′-TCAT-3′ is 
purple. A side view (Figure 3.7B) of the two stacked molecules illustrates the antiparallel, stacked 
nature of the compounds. The bottom ligand, in orange, binds in an orientation in which the 
benzimidazole-amidine motif is at the 3′ end of 5′-ATGA-3′. The N-H group of the central 
imidazole is solvent accessible while the nitrogen faces the floor of the minor groove to act as a 
hydrogen bond acceptor with the amino group of G (Figure 3.7C). The N-H of the benzimidazole 
faces the floor of the minor groove while the attached amidine can hydrogen bond with the keto 
oxygen of T (adjacent to C) on the complementary strand. The top ligand, shown as green, is 
orientated with the phenyl-amidine group at the 5′ end of 5′- TCAT-3′ with the curvature facing 
away from the ATGA minor groove. This arrangement moves the amidine groups apart and helps 
prevent electrostatic repulsion. The adjacent amidine is also capable of forming a hydrogen bond 
with the carbonyl oxygen of T of the 3′ end of 3′-TACT-5′. This indicates that rearrangement of 
nitrogens in the central ring system clearly has an overall effect on binding with ATGA. Reversing 
the central imidazole ring in 3 so that the two nitrogens are facing the benzimidazole-amidine 
system increases its curvature to more closely match the contour of the minor groove and improves 
its affinity for mixed DNA sequences. 
3.6.3 DNA sequence and directionality influence selective recognition 
An alternative approach to investigate minor groove binding is with the modification of a 
known target sequence to understand sequence specificity of a single compound and was inspired 
by the surprising interaction of 3 with R1 (CTGA). Figure 3.8 shows a scheme of the cognate  
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Figure 3.8 ATGA cognate and sequence variants used to examine the sequence specificity of 1.  
Base pairs flanking the target sites were maintained to allow similar response. Loops were 
modified for distinguishability using ESI-MS. 
 
 
 
Figure 3.9 Spectra of ATGA cognate and ATGA mutant sequences with compound 1. 
Free DNA sequences range m/z 6650–7750 (left) and compound 1–DNA complexes m/z 7250–
7975 (right). Both spectra belong to the same titration sample having a molar ratio of [4:1]. Peak 
intensities for the complexes are relative to the peak for ATGA + (2) 1. 
 
ATGA and ATGA-mutant sequences studied simultaneously with 1. Strong and separated peak 
intensities were observed for complexes of 1 with ATGA and ATGA-mutant sequences at lower 
concentrations. Complex peaks had lower intensities compared with peaks of free DNA, but 
dimerization was observed with ATGA, TTGA, and ATAA. Additional peaks were present for 
ATAA + (1) 1 and ATGT + (1) 1. Peak intensities for ATAA + (1) 1 and TTGA + (2) 1 were 
comparable to ATGA + (2) 1. At a [4:1] ratio, the peak for ATGA + (2) 1 showed the highest 
abundance of the dimer complexes (Figure 3.9). It was followed next, in decreasing order, by 
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TTGA, ATAA, and ATGT dimer complexes. Monomer complexes were also detected for ATAA, 
ATGT, and TTGA; however, peak intensities for ATGT + (1) 1 and TTGA + (1) 1 were difficult 
to distinguish from background noise. The cooperative binding of ATGA is evident by 2:1 
complexes and no 1:1 interactions detected. Of the DNA sequences which have both monomer 
and dimer complexes, the intensity for ATAA + (1) 1 was greater than ATAA + (2) 1. This differs 
from TTGA where the peak for 2:1 was greater than 1:1. Intensities for ATGT + (1) 1 and ATGT 
+ (2) 1 were nearly equal to each other and no complex between AGTA and 1 was observed. 
The strong, cooperative binding of 1 with ATGA indicates a preference over all other 
similar sequence variants and is clearly optimized for dimer formation. As evident in Figure 3.9, 
smaller peaks occurred between 1 and ATAA in 1:1 and 2:1 stoichiometries, with a slight 
preference for the monomer complex, indicating low cooperativity for dimer formation. 
Dimerization was shown with TTGA at a higher relative abundance. A 1:1 complex with TTGA 
is also detected, but with lower intensity and only at higher concentrations. Peaks were visible for 
both monomer and dimer-ATGT complexes at m/z 7,322 and 7,668.5, respectively. However, the 
intensities were low and signals nearly merged with the background. The strongest dimer-forming 
complexes were ATGA and TTGA in which peak intensities continued to increase as the 
concentration of 1 increased. 
3.6.4 Additional evidence for DNA complex formation with 1 and analogues by 
thermal melting and circular dichroism 
Thermal melting is a robust method to qualitatively measure the stability of DNA and DNA 
complexes and offers valuable insight on single complexes for comparison with our ESI-MS 
competition experiments. The ΔTm values (Table 3.1) suggest ATGA has a higher affinity for 6 
over 4 and 5. The preference of 3 for ATGA over R1 (i.e. CTGA) is in agreement with the results  
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Table 3.1 ΔTm values of dimer-forming compounds with select DNA sequences. 
Changes in thermal stability are color-coordinated based on increase in the melting temperature 
(white-orange). Thermal melting studies were performed in triplicate ± 0.5 ºC. 
 
 
Table 3.2 ΔTm values of 1 with ATGA and mutant sequences. 
ΔTm values of 1 with ATGA and mutant sequences. Values shown were performed at a molar ratio 
of [4:1] of 1 to DNA. Changes in thermal stability are color-coordinated based on increase in the 
melting temperature (white-orange). Thermal melting studies were performed in triplicate ± 0.5 
°C 
 
 
shown in Figures 3.4F & 3.5. This is expected since the hydrogen bonding pattern necessary for 
recognition will be disrupted when substituting adenosine to cytidine (ATGA → CTGA). The peak 
intensities and ΔTm values for 1 and its analogues with initial mixed sequences are compared in 
Figure 3.10A with a superimposed model of the compounds (Figure 3.10B) to illustrate 
differences in structural conformations. The values for 1 and ATGA were taken from previously 
published results using ESI-MS.[27] A comparison of ΔTm values for 1 with ATGA (Table 3.2) 
shows that 1 prefers TTGA and ATGA over ATGT and AGTA. This is consistent with the results  
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Figure 3.10 Comparison of relative abundances and thermal melting. 
(A) Comparison of the relative peak intensities (3%) for complexes and ΔTm values (0.5 ºC) for 
mixed DNA sequences with 1 and the dimer-forming analogues 3-6. ΔTm values (secondary y-
axis) are for dimer complexes formed between ligands and ATGA at a [4:1] molar ratio. (B) 
Structural variability and spatial arrangement for dimer-forming compounds are shown by 
superimposing the molecules over their mutual phenyl-amidines; 1 (tan), 3 (blue), 4 (green), 5 
(orange), and 6 (pink). 
 
obtained using ESI-MS, as shown in Figure 3.9, which indicates that the choice and arrangement 
of base pairs in the target site plays a key role in forming complexes between the parent compound 
1 and DNA. 
It is interesting to see that the DNA complexes formed are well-defined. The binding 
behavior established by 1 translates well for some of its analogues with ATGA recognition. 
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Specifically, cooperative binding is observed with increasing concentrations of ligand where the 
complexes formed between ATGA and 1 or its analogues show only 2:1 dimer ligand to DNA 
complexation. Any 1:1 complexes formed are at very low concentrations and, therefore, not 
detected. This illustrates that as concentrations of ligand are increased, so does the amount of 
complexes detected. The results correlate well with the thermal melting studies which allows the 
relative affinities of DNA and DNA-ligand complexes to be directly compared. 
The overall structure of DNA and DNA complexes can be evaluated using circular 
dichroism spectroscopy (CD). CD studies are useful in examining the global conformation of DNA 
and other biomolecules. Studies were performed to compare the conformation of ATGA to its 
mutated sequences (Figure 3.11). Curves were normalized and superimposed to facilitate the 
comparison. No change in CD signal was detected when comparing ATGT or AGTA to our 
cognate sequence, and only minute differences in the normalized signals of ATAA and TTGA 
were observed when compared to ATGA. The spectra showed that ATGA and its mutant 
sequences were very similar in their overall DNA conformations. Based on the structural 
similarities of ATGT and AGTA when compared to ATGA, it is becomes more clear that it is 
sequence which plays a direct role for recognition by 1. The slight variation in the CD curves are 
likely attributed to the individual base pair stacking which will affect the DNA microstructure but 
not the overall conformation. This may offer an explanation as to why interaction of 1 with ATAA 
can occur by both monomerization and dimerization since the microstructures between ATAA and 
mixed sites will be different. 
3.7 Discussion 
This report indicates that several features of the DNA complexes of 1 and analogues with 
DNA are critical in whether the compounds bind as a cooperative dimer or monomer. For DNA,  
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Figure 3.11 Comparison of ATGA and ATGA-mutant sequence CD spectra. 
Normalized spectra (red) and ATGA-mutant sequences (black) comparing hairpin DNA 
conformation. Note that the overall DNA conformation remains the same. 
 
the groove width and sequences of hydrogen bond donors and acceptors on the base pair edges at 
the floor of the minor groove are crucial. For the compounds, the stacking ability in the correct 
conformation to place hydrogen bond donors and acceptors to match the groups on DNA are 
necessary. These features are illustrated in Figure 3.7 and are based on the known binding mode 
of 1 with ATGA.[14, 15] Because of the complexity of these factors, experimental methods are 
required to determine whether the compounds bind as cooperative dimers, monomers, or if binding 
occurs at all. To do this in a competitive format for evaluating a large number of DNA sequences 
and compounds as rapidly as possible while using little sample, we have established the 
competitive ESI-MS method. Our method provides detailed insight into the features necessary to 
form a stacked cooperative dimer with DNA. We have discovered an entirely new and unexpected 
binding mode for 3. This is the first report of recognition by a synthetic, non-polyamide compound 
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for a multiple G·C sequence such as R1 with positive cooperativity. The analogue, 3, forms not 
only a strong cooperative dimer complex with ATGA, but also forms a strong cooperative dimer 
with CTGA in R1. The core site, CTGA, has none of the traditional sites found in sequences 
recognized by 1 or similarly designed compounds. Steric hindrance from the hydrogen bond 
between the carbonyl group of cytidine and the amino group of guanidine in the minor groove 
likely affects the stacking ability of 3 and yet the compound is still capable of forming a strong 
positive cooperative dimer complex with CTGA. It is also interesting to see that the isomer of 3, 
4, is unable to bind CTGA and binds weakly with ATGA. A seemingly subtle reorientation of the 
central imidazole places it in a way so that the compound is unable to form hydrogen bonds with 
the bases in the minor groove. The strategic placement of groups that act as hydrogen bond donors 
or acceptors is key for stacked binding in the minor groove and these complexes are detected using 
a competitive ESI-MS method. This important discovery provides a new paradigm for rationally 
designed, synthetic compounds to recognize mixed and/or G·C-rich sequences. 
Parent compound 1 binds in the minor groove of ATGA as a dimer and recognizes A·T-
rich sequences as a monomer. In contrast to this generalization, detection of ATAA as both 
monomer and dimer by 1 expands our understanding of earlier evidence of dimerization of 1 at an 
ATAA site.[15] For A·T-rich sequences, the minor groove of A-tracts is distinguished by a 
narrower groove width while alternating A·T sequences, including those with the TpA step, are 
wider.[10, 33] Monomer and dimer binding should be possible for an ATAA sequence due to the 
TpA step and wider minor groove. Based on the dual recognition of ATAA by 1 as a monomer 
and dimer and with nearly equal intensities, the ATAA minor groove is more closely related to 
alternating A·T sequences than A-tracts. Binding of 1 to ATAA as a monomer can slightly narrow 
the groove width while binding as a dimer can slightly widen the groove. 
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For our mixed sequence mutants, the melting temperature of the free DNAs fall within ± 
1.0 °C of ATGA and so the particular arrangement of the base pairs in these sequences does not 
have a large effect on the thermal stability of free DNA. The sequence arrangement, however, has 
an effect on binding of 1. For instance, mutation of the cognate sequence to read GT in the 5′ to 3′ 
direction within AGTA or ATGT, results in a significant decrease in binding of 1 compared to 
ATGA. Footprinting studies with 1 and a single mutation from ATGA to AGTA have shown 
similar results with no AGTA recognition.[16] Additionally, as evident with TTGA at the 5′ end 
when A is replaced by T, cooperative binding of 1 is present, but decreased. These results suggest 
that because the base pair composition is very well maintained (G·C and A·T content), it is the 
stacking of the base pairs AA∙TT vs. AT∙AT that influences changes in minor groove 
microstructure and affects the affinity and binding mode of 1. Further investigations are necessary 
to identify minor groove microstructures for sequences with similar structures to ATGA. 
Based on the ESI-MS studies of 1 with several DNAs, we can now see that it binds as a 
highly cooperative dimer to ATGA-like sequences but as a monomer to A-tract sequences. Based 
on the structural similarity of benzimidazole and indole groups, we expected the indole analogue 
of 1, 6, to bind as a similar cooperative dimer. With a few exceptions, however, dimerization 
among minor groove binders containing an indole system is rare.[29, 32] Most indole-containing 
minor groove binders recognize A·T sequences strictly as a monomer. For instance, DAPI, the 
most thoroughly studied indole-containing compound, binds A·T sequences as a monomer 
only.[30] More interestingly, however, is the higher affinity of 6 over 1 for ATGA which is 
unexpected since the curvature and conformation of the benzimidazole and indole systems are 
essentially the same (Figure 3.6). Biosensor-SPR studies (not published) have shown that 6 binds 
as a strong dimer to ATGA with a higher affinity over 1 which is in agreement with the thermal 
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melting studies, however, the results from ESI-MS are not completely consistent. In the mass 
spectra, the 6-ATGA relative peak abundances are not as high as one would anticipate based on 
the results with 1. At this time, it is not completely understood why the 6-DNA peaks, which 
includes 6 with ATGA and both A·T sequences, are less than expected. This is especially 
surprising since there has been excellent correlation between ESI-MS and thermal melting with 1 
and the other analogues. One possible explanation may be technique-related in which the 
compound interacts with the injection tubing so that the total concentration of 6 in the sample 
solution decreases below the expected amount. A lower concentration of 6 would then result in 
less 6 complex formed and lower abundances of 6-DNA complexes detected. 
To examine competition for DNA sites by 1 and analogues using ESI-MS, proper care must 
be taken to ensure that the molecular weights of the small molecules and their complexes, and all 
possible stoichiometries, are distinguishable. On the other hand, another approach is to examine 
the binding of a single compound with an array of target sequences and their mutations. Different 
DNA sequences can be examined simultaneously in this way as long as the molecular weights of 
the DNAs and complexes are distinguishable. A combination of an ATGA cognate sequence, 
ATGA-mutant sequences, and a reference DNA (R2) were screened with 1. To obtain different 
molecular weights for the variants, such as ATGA and AGTA which have the same stem molecular 
weights, the hairpin loops of the DNAs were altered with different numbers of thymidine and 
cytidine or by incorporation of a deoxyuridine so that the flanking base pairs were preserved. 
In the spectra shown, peaks of the systems correspond well to their expected molecular 
weights (i.e. m/z) for free DNA and DNA-ligand complexes. The ionization process of ESI-MS 
results in multiply charged species and for the raw data, every system shows multiple, charge 
states. Due to the nature of the analyte and negative mode analysis, the most abundant charge states 
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range between -3 and -6. These lower net charges indicate the DNA backbone becomes partially 
neutralized during the electrospray process during which ammonium ions transfer a proton to the 
phosphate backbone and the ammonia molecules evaporate. The amount of neutralization occurred 
depends on the size of the DNA, concentration of ammonium ions, and instrument parameters 
used.[18, 37] Positively charged dicationic diamidines help in neutralizing the backbone, however, 
the presence of ligand does not affect the overall charge after forming a complex. For instance, 
peaks remain the most abundant in -4 and -5 charge states for both free AAATTT and AAATTT 
+ (1) 1 complexes. The spectral peaks are transformed via deconvolution – the ability to transform 
multiple charge peaks into the single peak, zero charge molecular ion species. Deconvolution 
greatly simplifies the spectra for optimum visualization and is achieved by multiplying the charge 
of the species by its respective m/z. 
Lower DNA concentrations such as 2.5 μM have been tested and not surprisingly, there is 
little difference in the peak intensities when comparing 2.5 μM of DNA versus 5 μM of DNA. The 
level of cooperativity is still observed, and is in agreement with earlier reports from our group 
demonstrating the cooperative binding of 1 to ATGA by ESI-MS using 5 μM of DNA.[27] For 
our systems, there is a general preference for using 5 μM of DNA since it results in a larger signal 
for the DNA and/or complexes over using 2.5 μM. A spectrum using 2.5 μM concentrations of 
DNA with compound 1 is shown in Figure 3.12. Due to the nature of compounds 1 – 8 and other 
dicationic diamidines, an unknown amount of ligand is often lost during the injection process. At 
times, the ligand will presumably become stuck and remain fixed to the inside of the injection 
tubing, therefore reducing the total ligand concentration. This phenomenon has been experienced 
on multiple occasions and requires thorough cleanings of the instrument between different 
samples. Samples containing DNA only (no compound) are routinely injected before beginning  
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Figure 3.12 Spectrum of DNA and 1 run using 2.5 µM concentration of DNA. 
Sample concentration ratio is shown at [2:1]. No methanol or solvents were added. 
 
any new analysis to check for and remove residual ligand through binding of free DNA. Results 
can be successfully quantified using ESI-MS, as long as the specific response sensitivity and the 
concentrations are accurately known. It is possible to determine an equilibrium binding constant 
for DNA and small molecule systems and there are examples in literature demonstrating this.[36, 
38] The ability to determine binding constants for dicationic diamidines is primarily limited to the 
loss of ligand during injection and response factors for the DNA and complexes, and these 
limitations influence our preference to use ESI-MS for qualitative purposes only. 
Other methods can also be used, with or without ESI-MS, to efficiently screen for DNA 
binding compounds. For instance, thermal melting studies are commonly used to screen for 
binding of ligand to DNA. Additional techniques can include fluorescence assays, competitive 
dialysis experiments,[34] and separation techniques such as gel electrophoresis [35]. While these 
methods can provide important information, they can often demand more time and sample than 
ESI-MS. The ESI-MS technique reported here is rapid and convenient, requires little sample, and 
can provide quantitative information.[36] However, the most important feature from this method 
is that it can offer quick insight into the preferential binding of ligands based on compound 
structure and/or DNA sequence. With this, one can determine the stoichiometry, relative affinity, 
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the binding mode (cooperative vs. non-specific) and it can even be used to determine heterodimeric 
binding. 
3.8 Conclusion 
Mixed DNA sequence investigations using ESI-MS has allowed the discovery of important 
features of 1 and analogues with ATGA and mutant sequences. For specificity and cooperative 
binding affinity to ATGA, these results show that at this point, 1 is the optimum compound. The 
results also show that 3 binds very well to ATGA but has many other strong interactions. A 
surprising result is that 3 binds quite well as a 2:1 dimer species to the G·C sequence, R1, which 
was selected because heterocyclic dicationic diamidines have not been observed to bind to such 
G·C-rich sequences. Analogue 4, the imidazole isomer of 3, does not bind as well to ATGA and 
does not bind at all to R1. The surprising binding of 3 needs additional investigation. 
For sequence specificity, the sequence ATAA is capable of binding 1 as both a monomer 
and dimer, despite containing no G or C bases in the target site. In sequences containing a G·C 
base pair, the order of base pairs played a strong role in recognition by 1 such that the GpT and 
TpG steps had surprisingly different binding modes. Sites with TG have a preference for 1, 
whereas, GT sites tend to avoid forming complexes. Overall, ATGA remains the preferred site for 
cooperative 2:1 binding of 1 and these results further illustrate that sequence is crucial for minor 
groove recognition. 
3.9 Experimental procedures 
3.9.1 Materials 
Compounds 1,[28] 2,[39] and 3 [40] were synthesized using previously reported methods, 
and syntheses for the new analogues 4 – 8 are available in the Electronic Supporting Information 
of Laughlin S, et al. Chemistry, 2015, 24 (14): 5528-5539. All compound stock solutions were 
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prepared in doubly distilled water at a concentration of 1 mM. DNA sequences were purchased 
from Integrated DNA Technologies (IDT, Coralville, IA). Based on the predicted amount of DNA 
provided by IDT, DNAs were dissolved in doubly distilled water (1 mM). All sequences were 
converted to ammonium acetate salts by three steps of dialysis in 0.15 M ammonium acetate 
vacuum-filtered buffer (0.22 μM Millipore filter, pH 6.7) using a 1000 Da cut-off membrane 
(Spectrum Laboratories, Rancho Dominguez, CA). Following dialysis, concentrations of DNA 
were spectroscopically determined at 260 nm with extinction coefficients calculated using the 
nearest-neighbor method.[41] Sequences were denatured at 95 °C and immediately quenched on 
ice to initiate hairpin formation. Ligand stock solutions and dialyzed DNAs were stored at 4 °C. 
Titration experiments were performed with a mixed set of DNAs in a single Eppendorf 
tube (100 μL, total volume). Ammonium acetate buffer was used due to its volatility under mass 
spectrometric conditions.[18, 23] DNAs were diluted (5 μM, 0.15 M ammonium acetate buffer, 
pH 6.7) with the appropriate concentration of ligand, vortexed, and stored at 4 °C until injection. 
Ratios with no surrounding punctuations refer to stoichiometry (i.e. 1:1 is ligand:DNA) whereas 
titration ratios are enveloped by brackets. For example, titration ratios are written as [n:m], where 
n and m are empirical concentrations of ligand and DNA, respectively. Titration ratios were 
prepared as compound-to-single-DNA. The ligand-to-single-DNA approach is more desirable for 
competitive binding analyses using multiple DNA sequences and avoids higher ratios being 
prepared. Two distinct hairpin DNA sequences were used to compare the formation and relative 
abundances of free DNA and DNA-complexes to a reference peak. For experiments with 1 and its 
analogues, R1 was used because it contained no known target sequence. R2 was later used as a 
reference to compare 1 with mutant DNA sequences due to the reference base pair composition 
which consisted of GC base pairs only in the DNA stem. 
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3.9.2 Electrospray ionization mass spectrometry 
ESI-MS experiments were performed using a Waters Micromass Q-TOF (Waters, Milford, 
MA) in negative ion mode and MassLynx 4.1 software. Capillary voltage was set to 2500 V, 
sample cone voltage to 30 V, and extraction cone voltage at 3 V. Source block temperature was 
set to 70 °C and desolvation temperature at 100 °C. Prior to injection, the instrument was flushed 
with ammonium acetate buffer (0.15 M). Samples were injected at a rate of 5 μL∙min-1 and run for 
several minutes until the MassLynx chromatogram reached stabilization. Scanned peaks ranged 
m/z 300-3000 and the most abundant peaks observed belonged to -3 to -6 charge states. Scans were 
averaged over the last 2 min of analysis. Spectra were deconvoluted for comparative purposes. 
Deconvolution was achieved through multiplying peak intensities (m/z) by the charge (z) using the 
Maximum Entropy 1 Function (MassLynx 4.1). 
3.9.3 Thermal melting 
Thermal melting studies were performed in cacodylate buffer (0.01 M cacodylic acid, 1 
mM EDTA, 0.1 M NaCl, pH 7.1) using a Cary 300 UV-Vis spectrophotometer (Varian, Walnut 
Creek, CA) and a 1 cm quartz cuvette. Compound concentrations were chosen to give the desired 
ratio of compounds to hairpin DNA (3 μM). Scans were run from 25 °C to 95 °C at a rate of 0.5 
°C∙min-1. 
3.9.4 Circular dichroism 
Circular dichroism studies were performed using DNA prepared in cacodylate buffer (5 
μM, 0.01 M cacodylic acid, 1 mM EDTA, 0.1 M NaCl, pH 7.1) using a Jasco J-810 
Spectropolarimeter (Jasco Analytical Instruments Inc., Easton, MD) and a 1 cm quartz cuvette. 
Scans were performed at a rate of 50 nm∙min-1 from 320 nm to 220 nm, acquired in triplicate, and 
averaged. 
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3.9.5 Molecular modeling 
Ab initio calculations were performed in Spartan 10. Structures were minimized in the 
equilibrium geometry setting using a Hartree-Fock wavefunction and 6-31G* basis set. Molecules 
were set to dications in a vacuum environment. Canonical B-form doubled stranded DNA was 
built using the Sybyl software and coordinates saved as PDB file. Hydrogen atoms were added to 
DNA using xLeap, solvated within a 10.0 Å TIP3PBOX waterbox, and neutralized by sodium 
ions. DNA minimization was achieved using AMBER99 force fields. DNA was visualized in 
VMD and coordinates were saved. The DNA sequence was then visualized and modeled with 
compound 3 using Chimera 1.8.1. 
3.10 References 
1. Wang S, Linde MH, Munde M, Carvalho VD, Wilson WD, Poon GM. Mechanistic 
heterogeneity in site recognition by the structurally homologous DNA-binding domains of 
the ETS family transcription factors Ets-1 and PU.1 J. Biol. Chem. 2014, 289: 21605–
21616. 
 
2. Lefstin JA, Yamamoto KR. Allosteric effects of DNA on transcriptional regulators. Nature 
1998, 392: 885– 888. 
 
3. Sharma H, Yu S, Kong J, Wang J, Steitz TA. Structure of apo-CAP reveals that large 
conformational changes are necessary for DNA binding. Proc. Natl. Acad. Sci. USA. 2009, 
106: 16604–16609. 
 
4. Darnell JE. Transcription factors as targets for cancer therapy. Nat. Rev. Cancer. 2002, 2: 
740–749. 
 
5. Koehler AN. A complex task? Direct modulation of transcription factors with small 
molecules. Curr. Opin. Chem. Biol. 2010, 14: 331–340. 
 
6. Peixoto P, Liu Y, Depauw S, Hildebrand MP, Boykin DW, Bailly C, Wilson WD, David-
Cordonnier MH. Direct inhibition of the DNA-binding activity of POU transcription 
factors Pit-1 and Brn-3 by selective binding of a phenyl-furan-benzimidazole dication. 
Nucleic Acids Res. 2008, 36: 3341–3353. 
 
7. Mapp AK, Ansari AZ, Ptashne M, Dervan PB. Activation of gene expression by small 
molecule transcription factors. Proc. Natl. Acad. Sci. USA. 2000, 97: 3930–3935. 
 
  
 
 
61 
8. Dervan PB, Burli RW. Sequence specific DNA recognition by polyamides. Curr. Opin. 
Chem. Biol. 1999, 3: 688–693. 
 
9. Munde M, Poon GMK, Wilson WD. Probing the electrostatics and pharmacological 
modulation of sequence specific binding by the DNA-binding domain of the ETS family 
transcription factor PU.1: A binding affinity and kinetics investigation. J. Mol. Biol. 2013, 
425: 1655–1669. 
 
10. Abudaya A, Brown PM, Fox KR. DNA sequence preferences of several AT-selective 
minor groove binding ligands. Nucleic Acids Res. 1995, 23: 3385–3392. 
 
11. Liu Y, Kumar A, Boykin DW, Wilson WD. Sequence and length dependent 
thermodynamic differences in heterocyclic diamidine interactions at AT base pairs in the 
DNA minor groove. Biophys. Chem. 2007, 131: 1–14. 
 
12. Kielkopf CL, Baird EE, Dervan PD, Rees DC. Structural basis for G.C recognition in the 
DNA minor groove. Nat. Struct. Biol. 1998, 5: 104–109. 
 
13. Satam V, Patil P, Babu B, Gregory M, Bowerman M, Savagian M, Lee M, Tzou S, Olson 
K, Liu Y, Ramos J, Wilson WD, Bingham JP, Kiakos K, Hartley JA, Lee M. Hx-amides: 
DNA sequence recognition by the fluorescent Hx (p-anisylbenzimidazole)∙pyrrole and 
Hx∙imidazole pairings. Bioorg. Med. Chem. Lett. 2013, 23: 1699–1702. 
 
14. Wang L, Carrasco C, Kumar A, Stephens CE, Bailly C, Boykin DW, Wilson WD. 
Evaluation of the influence of compound structure on stacked-dimer formation in the DNA 
minor groove. Biochemistry 2001, 40: 2511–2521. 
 
15. Tanious F, Wilson WD, Wang L, Kumar A, Boykin DW, Marty C, Baldeyrou B, Bailly C. 
Cooperative dimerization of a heterocyclic diamidine determines sequence specific DNA 
recognition. Biochemistry 2003, 42: 13576–13586. 
 
16. Bailly C, Tardy C, Wang L, Armitage B, Hopkins K, Kumar A, Schuster GB, Boykin DW, 
Wilson WD. Recognition of ATGA sequences by the unfused aromatic dication DB293 
forming stacked dimers in the DNA minor groove. Biochemistry 2001, 40: 9770–9779. 
 
17. Laughton CA, Tanious F, Nunn CM, Boykin DW, Wilson WD, Neidle S. A 
crystallographic and spectroscopic study of the complex between d(CGCGAATTCGCG)2 
and 2,5-bis(4-guanylphenyl)furan, an analogues of berenil. Structural origins of enhanced 
DNA-binding affinity. Biochemistry 1996, 35: 5655–5661. 
 
18. Rosu F, De Pauw E, Gabelica V. Electrospray mass spectrometry to study drug-nucleic 
acids interactions. Biochimie 2008, 90: 1074–1087. 
 
19. Rosu F, Gabelica V, Houssier C, De Pauw E. Determination of affinity, stoichiometry and 
sequence selectivity of minor groove binder complexes with double-stranded 
  
 
 
62 
oligodeoxynucleotides by electrospray ionization mass spectrometry. Nucleic Acids Res. 
2002 30: e82. 
 
20. Brodbelt JS. Evaluation of DNA/ligand interactions by electrospray ionization mass 
spectrometry. Annu Rev Anal Chem. 2010, 3: 67–87. 
 
21. Buchmann W, Boutorine A, Halby L, Tortajada J, De Pauw E. A new method for the 
determination of the relative affinity of a ligand against various DNA sequences by 
electrospray ionization mass spectrometry. Application to a polyamide minor groove 
binder. J. Mass Spectrom. 2009, 44: 1171–1181. 
 
22. Dass, C. Fundamentals of Contemporary Mass Spectrometry. Wiley-Interscience; 
Hoboken, N.J.: 2007. 
 
23. Loo JA. Electrospray ionization mass spectrometry: A technology for studying 
noncovalent macromolecular complexes. Int. J. Mass Spectrom. 2000, 200: 175–186. 
 
24. Gale DC, Goodlett DR, Lightwahl KJ, Smith RD. Observation of duplex DNA-drug 
noncovalent complexes by electrospray ionization mass spectrometry. J. Am. Chem. Soc. 
1994, 116: 6027–6028. 
 
25. Gale DC, Smith RD. Characterization of noncovalent complexes formed between minor 
groove binding moleules and duplex DNA by electrospray ionization-mass spectrometry. 
J. Am. Soc. Mass. Spectr. 1995, 6: 1154–1164. 
 
26. Ganem B, Li YT, Henion JD. Detection of oligonucleotide duplex forms by ion-spray mass 
spectrometry. Tetrahedron Lett. 1993, 34: 1445–1448. 
 
27. Laughlin S, Wang S, Kumar A, Boykin DW, Wilson WD. A novel approach using 
electrospray ionization mass spectrometry to study competitive binding of small molecules 
with mixed DNA sequences. Anal. Bioanal. Chem. 2014, 406: 6441– 6445. 
 
28. Hopkins KT, Wilson WD, Bender BC, McCurdy DR, Hall JE, Tidwell RR, Kumar A, Bajic 
M, Boykin DW. Extended aromatic furan amidine derivatives as anti-Pneumocystis carinii 
agents. J. Med. Chem. 1998, 41: 3872–3878. 
 
29. Munde M, Kumar A, Nhili R, Depauw S, David-Cordonnier MH, Ismail MA, Stephens 
CE, Farahat AA, Batista-Parra A, Boykin DW, Wilson WD. DNA minor groove induced 
dimerization of heterocyclic cations: Compound structure, binding affinity, and specificity 
for a TTAA sites. J. Mol. Biol. 2010, 402: 847–864. 
 
30. Williamson DH, Fennell DJ. The use of fluorescent DNA-binding agent for detecting and 
separating yeast mitochondrial DNA. Methods Cell Biol. 1975, 12: 335–351. 
 
  
 
 
63 
31. Wang L, Bailly C, Kumar A, Ding D, Bajic M, Boykin DW, Wilson WD. Specific 
molecular recognition of mixed nucleic acid sequences: An aromatic dication that binds in 
the DNA minor groove as a dimer. Proc. Natl. Acad. Sci. USA. 2000, 97: 12–16. 
 
32. Kwok Y, Zhang WT, Schroth GP, Liang CH, Alexi N, Bruice TW. Allosteric interaction 
of minor groove binding ligands with UL9-DNA complexes. Biochemistry 2001, 40: 
12628– 12638. 
 
33. Fox KR. Probing the conformations of eight cloned DNA dodecamers; 
CGCGAATTCGCG, CGCGTTAACGCG, CGCGTATACGCG, CGCGATATCGCG, 
CGCAAATTTGCG, CGCTTTAAAGCG, CGCGGATCCGCG and CGCGGTACCGCG.  
Nucleic Acids Res. 1992, 20: 6487–6493. 
 
34. Ren J, Chaires JB. Sequence and structural selectivity of nucleic acid binding ligands. 
Biochemistry 1999, 38: 16067–16075. 
 
35. Wang S, Munde M, Wang SM, Wilson WD. Minor groove to major groove, an unusual 
DNA sequence-dependent change in bend directionality by a distamycin dimer. 
Biochemistry 2011, 50: 7674–7683. 
 
36. Gabelica V, Galic N, Rosu F, Houssier C, De Pauw E. Influence of response factors on 
determining equilibrium association constants of non-covalent complexes by electrospray 
ionization mass spectrometry. J. Mass Spectrom. 2003, 38: 491–501. 
 
37. Gabelica V, De Pauw E, Rosu F. Interaction between antitumor drugs and a double-
stranded oligonucleotide studied by electrospray ionization mass spectrometry. J. Mass 
Spectrom. 1999, 34: 1328–1337. 
 
38. Sakakibara Y, Abeysirigunawardena SC, Duc AC, Dremann DN, Chow CS. Ligand- and 
pH-induced conformational changes of RNA domain helix 69 revealed by 2-aminopurine 
fluorescence. Angew. Chem. Int. Ed. Engl. 2012, 51: 12095–12098. 
 
39. Das BP, Boykin DW. Synthesis and antiprotozoal activity of 2,5-bis(4-
guanylphenyl)furans. J. Med. Chem. 1977, 20: 531–536. 
 
40. Batista-Parra, A. PhD thesis. Georgia State University (USA) 2003. 
 
41. Fasman, GD. Handbook of Biochemistry and Molecular Biology 1975, 3rd ed., CRC Press, 
Cleveland.  
  
  
 
 
64 
4 MIXED UP MINOR GROOVE BINDERS: CONVINCING A∙T SPECIFIC 
COMPOUNDS TO RECOGNIZE A G∙C BASE PAIR 
 
 
Ananya Paul, Rupesh Nanjunda, Arvind Kumar, Sarah Laughlin, Raja Nhili, Sabine Depauw, 
Shelby Sheldon Deuser, Yun Chai, Arpana S. Chaudhary, Marie-Helene David-Cordonnier, 
David W. Boykin, W. David Wilson 
 
 
Paul A, et al. Bioorg. Med. Chem. Lett. 2015, 25 (21): 4927-4932. 
 
 
Copyright © 2015 Bioorganic Medicinal Chemistry Letters 
 
 
My contribution to this chapter was in sample preparation, performance, and analysis of the 
results by electrospray ionization mass spectrometry, and portions of writing. 
 
 
4.1 Abstract 
DNA minor-groove-binding compounds have limited biological applications, in part due 
to problems with sequence specificity that cause off-target effects. A model to enhance specificity 
has been developed with the goal of preparing compounds that bind to two A·T sites separated by 
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G·C base pairs. Compounds of interest were probed using thermal melting, circular dichroism, 
mass spectrometry, biosensor-SPR, and molecular modeling methods. A new minor groove binder 
that can strongly and specifically recognize a single G·C base pair with flanking A·T sequences 
has been prepared. This multi-site DNA recognition mode offers novel design principles to 
recognize entirely new DNA motifs. 
4.2 Key words 
Biophysical analysis; Heterocyclic diamidines; Mixed DNA recognition; Rational design; 
Sequence specificity 
4.3 Introduction 
The systematic design and preparation of compounds that can recognize mixed base pair 
(bp) nucleic acid sequences is a very important goal in DNA small-molecule applications. Such 
specific recognition would allow new diagnostic applications in vitro while in vivo they could 
provide new therapeutics and gene-specific probes. This goal has been difficult to reach, however, 
and to date only polyamides have had significant success in design of compounds for mixed-
sequence DNA recognition.[1-4] Unfortunately, polyamides can be limited by synthetic costs, 
aggregation and cell-uptake problems.[5, 6] In an interesting contrast, relatively simple A·T 
sequence selective minor-groove binders have had good success in therapeutic targeting of DNA 
in cells ranging from various types of cancers [7-13] to bacterial [4-16] and parasitic 
microorganisms [17-22]. DNA minor-groove binding heterocyclic diamidines, such as 
pentamidine and berenil, are examples with a long history of therapeutic use.[20, 23-25] DAPI is 
another heterocyclic diamidine that readily enters cells and is frequently used to stain nuclear DNA 
in imaging.[26] Limited selectivity and off-target effects, however, have restricted the therapeutic 
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applications of these types of compounds, and methods to increase their binding selectivity and 
affinity are essential for development of improved agents. 
The starting points for our development of new sequence specific agents are synthetic 
compounds known to recognize A·T sequences as well as the extensive literature on A·T specific 
minor-groove binders. The heterocyclic diamidines described above are all A·T site specific. For 
recognizing sequences containing G·C bp, new functional groups must be incorporated into the 
A·T specific agents. Such compounds would be helpful in a number of areas such as targeting the 
kinetoplast DNA (kDNA) of parasitic microorganisms, where a large number of A·T bp sites are 
frequently separated by a G·C bp [27-29], as well as transcription factor (TF) inhibition in gene 
control applications [30]. Targeting transcription factors has been recognized as a promising but 
difficult direction for therapeutic development.[31, 32] In our initial efforts in this area, 
compounds with alkyl or alkyl-aromatic linked amidine-benzimidazole-phenyl (ABP) motifs were 
designed, synthesized and evaluated for binding to A·T sites separated by one or two G·C base 
pairs.[33] The goal of these studies was to determine how linker length and rigidity affect the 
ability of ABP modules to recognize two A·T sites. 
In the progress to our next generation sequence specific minor groove binders, we have 
prepared a series of potential mixed-sequence DNA binding molecules from the existing pure A·T 
sequence binders. In the design path to G·C bp recognition by rationally designed small molecules, 
we have incorporated groups that can act as H-bond accepting units in the minor groove of DNA 
(Figure 4.1A). Some very encouraging initial success in targeting mixed bp DNA sequences was 
found with a relatively small, dissymmetric, diamidine compound, DB2277 (Figure 4.1A), which 
recognizes a single G in sequences such as AAGTT through an aza-benzimidazole group.[34, 35] 
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Figure 4.1 Representative minor groove binding compounds and test sequences.  
(A) Chemical structures of mixed sequence targeting compounds. (B) Energy minimized structures 
of DB2120 and DB2370 at the 6-31G∗ (p,d) level of theory. In the electrostatic potential maps, 
red color indicates high electronegativity and blue indicates electron deficient/positively charged 
regions. (C) DNA hairpin oligomer duplexes used in this study. DNA sequences with 5′-biotin 
labels were used for SPR studies. 
 
In this report we describe a more general approach by connecting two A·T specific binding 
modules with H-bond accepting linking units. The results show critical effects of molecular 
flexibility, position of the linker and heteroatom for mixed sequence specific DNA recognition. 
Detailed biophysical studies of the compounds in Figure 4.1 showed very strong and 
selective recognition of a G·C bp separating two A·T sites with much weaker recognition of pure 
A·T sites by a pyridyl-linked compound, DB2120. The rational design and preparation of a non-
polyamide compound that can selectively recognize long, mixed bp sequences is a significant step 
forward in the design of minor-groove binders for potential diagnostic and therapeutic use. While 
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there is much to learn, the new results offer clear directions and leads for the development of a 
DNA minor groove-binding language. 
Compound design and preparation: The design platform for the compounds in Figure 4.1 
starts with the classical A·T-specific minor-groove binding compound, DB2119.[33] The ABP 
A·T recognition unit was held constant for binding to the flanking A·T sites while other molecular 
units of DB2119 were varied and the derivatives were evaluated for G·C bp recognition. DB2370 
is similar to DB2119 but without the -O-CH2- linker groups and with the central phenyl replaced 
with a pyridine. It is a direct derivative of a classical triphenyl A·T-specific minor-groove binder. 
Combinations of these two gives DB2120 with a central pyridine. The DB2120 and DB2370 pair 
tell us if the pyridine-N can serve as an H-bond acceptor for the minor groove G-NH and whether 
the interaction is better with or without the flexible -O-CH2-. DB2319 is the same as DB2120 but 
with the amidine cationic groups changed to methyl piperazinyl which is in Hoechst nuclear DNA 
staining compounds (Figure 4.1). This cationic group change will indicate the contribution of the 
cations to binding and in cell studies may affect the types of cells that can be targeted with this 
molecular platform.[30] The new bis-benzimidazoles DB2120, DB2319, and DB2370 were 
synthesized employing standard methodology for coupling the proper substituted 
phenylenediamine with the appropriate bis-aldehyde; Schemes and experimental details are 
provided in the Supplementary Material section of Paul A, et al. Bioorg. Med. Chem. Lett. 2015, 
25 (21): 4927-4932. 
4.4 Results 
4.4.1 Thermal melting 
The compounds in Figure 4.1 were selected based on Tm screening studies of a large 
number of synthetic compounds and they illustrate how to incorporate G·C bp recognition into an  
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Figure 4.2 UV melting profiles of DNA with minor groove binding compounds. 
UV melting profiles at 260nm of (A) A4GT4, (B) A4T4, and (C) A4GCT4, hairpin DNA sequences 
in the absence and presence of the heterocyclic cations. The experiments were conducted in Tris-
HCl buffer. The listed values are for 2:1 [ligand]/[DNA] ratio and an average of two independent 
experiments with a reproducibility of ± 0.5 ºC. 
 
 
 
Table 4.1 Thermal melting studies (ΔTm [a], ºC) of the designed heterocyclic amidine compounds 
with mixed DNA sequences. 
 
Compound A4T4 A4GT4 A4GCT4 
DB2119 21 17 < 1 
DB2120 15 22 8 
DB2319 14 19 6 
DB2370 24 19 5 
[a]Tm = Tm (the complex) - Tm (the free DNA). The listed values are for 2:1 [ligand]/[DNA] ratio and an 
average of two independent experiments with a reproducibility of ± 0.5 oC. 
 
A·T binding compound. The crucial breakthrough in developing strong and selective G·C 
bp recognition in this series was achieved with the pyridyl derivative of DB2119, compound 
DB2120. The phenyl to pyridyl change resulted in an increase in the thermal stability of the single 
G·C-containing A4GT4 motif (ΔTm = 22 ºC; Figure 4.2, Table 4.1) but a decrease in A·T binding 
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(ΔTm = 15 ºC). The piperazinyl, DB2319, had some selectivity for G·C bp but weaker binding 
while DB2370 did not show significant selectivity (ΔTm = 19 ºC and ΔTm = 24 ºC for A4GT4 and 
A4T4, respectively). These results clearly indicate that the pyridine nitrogen in DB2120 is serving 
as an H-bond acceptor for the exocyclic amino group of guanine to give a considerable increase in 
thermal stability of the complex. All compounds showed limited enhancement in thermal stabilities 
for two G·C-containing sequences such as A4GCT4 (Table 4.1).  
4.4.2 Biosensor-surface plasmon resonance 
Biosensor-surface plasmon resonance (SPR) is an effective technique to quantitatively 
monitor biomolecular interactions in real-time to obtain binding affinity, kinetics, and 
stoichiometry.[33-38] Biosensor experiments were conducted with DB2120 based on the Tm 
screening results and Figure 4.3 shows sensorgrams of DB2120 with A4GT4, A4IT4 (I = inosine, 
2-amino of guanine replaced with H), and A4T4 motifs. It is apparent from these results that the 
interactions of DB2120 with DNAs with and without a G·C bp are quite distinct. The most striking 
result is the interaction with the single G·C bp-containing A4GT4, and particularly noteworthy is 
the very slow dissociation of DB2120 from the DNA complex (Figure 4.3A). Even with a quite 
long experimental dissociation time (1 h), very little dissociation of DB2120 from the complex is 
observed under these conditions. Global kinetics fitting yielded a single binding site and an 
approximate KA = 6.6 x 10
10 M-1 (KD = 1.5 x 10
-11 M) for DB2120 at 0.1 M Na+. This is an 
impressive 2000-fold increase compared to the parent compound, DB2119. DB2120 binds to 
A4T4 in a monomer complex with a 200-fold lower affinity compared to A4GT4, indicating high 
specificity for the single GC bp sequence. The sensorgrams of A4T4 show an off-rate that is much 
faster, and complete dissociation from the complex occurs within the first few minutes of the 
dissociation phase (Figure 4.2C). With the A4GCT4 sequence, no binding is observed for DB2120 
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Figure 4.3 Surface plasmon resonance sensorgrams for DB2120. 
(A) A4GT4, (B) A4IT4, and (C) A4T4 sequences, respectively. The injected concentrations of 
DB2120 with A4GT4 are 2, 3, 5, 7, 10 and 15 nM whereas with A4IT4 and A4T4 sequences the 
injected concentrations are higher; 3, 5, 7, 10, 15, 20, 30 and 5, 7, 10,15, 20, 30, and 50 nM, 
respectively. The black lines for all three sequences represent global kinetic fitting using a 1:1 
interaction model. 
 
under this experimental condition, in agreement with Tm results. When G (A4GT4) is substituted 
by I (A4IT4) at the minor groove of the mixed-DNA sequence, although the groove width remains 
similar [39], the binding affinity of the A4IT4–DB2120 complex decreases by 80-fold (KD = 1.2 
x 10-9 M). This phenomenon is expected by the interruption of H-bonding between the pyridyl-N 
and G-NH2 (Figure 4.3B) in the A4IT4 complex and confirms the DB2120 to G-NH H-bond. 
In summary, SPR and Tm results converge to indicate very strong and selective monomer 
binding of DB2120 to A·T binding sites separated by a single G·C bp. No other compound from 
Figure 4.1 showed significant DNA sequence specific recognition. The SPR results clearly 
highlight the success and the difficulties (compare DB2120 and DB2370) in the development of 
G·C specific recognition. 
4.4.3 Competition electrospray ionization mass spectrometry 
Competition electrospray ionization mass spectrometry (ESI-MS) is a method that we have 
developed to provide comparative information on the stoichiometry, cooperativity, and relative 
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affinity for DNA complexes.[40, 41] The use of multiple DNA sequences simultaneously mixed 
with a small molecule creates a competitive binding environment for comparison of DNA–ligand 
interactions. Since the free ligand concentration for all of the DNAs is the same, peak intensities 
of the free, unbound DNA and the DNA-small molecule complexes offer insight into the binding 
mode and preferred binding site(s). Each titration series contains a pure G·C sequence used as an 
internal standard that does not bind ligand. This offers a simple comparison for peak intensities, 
since the DNA molecular weights are adjusted to be different. To help adjust molecular weights 
among this set of sequences, substitution of guanine by inosine in the bp(s) nearest the hairpin loop 
were incorporated (Figure 4.4A). 
The top spectrum in Figure 4.4B is an example of free DNA prior to titration. The bottom 
spectrum (Figure 4.4C) illustrates DNA interactions with DB2120 at a [4:1] added ratio. The free 
A4GT4 sequence is no longer visible and shows that the DNA has formed a 1:1, DB2120– A4GT4 
complex, as indicated by the tall peak at m/z 10,324. It is striking that there are only very weak 
complexes for A4GCT4 and A4T4 DNAs at this ratio and is in direct agreement with Tm and SPR 
experiments. The relative peak intensities for the titrations are compared for DB2120 and DB2370 
in Figure 4.4D and shown as compound ratio versus relative abundance. DB2119 showed 
relatively weak binding to A4T4 and a small signal for A4GT4 at the [4:1] ratio, in agreement with 
Tm and SPR results. For DB2370 at a [4:1] ratio, the majority of A4GT4 and A4T4 DNAs are 
bound with nominal amounts of free DNA, whereas most of the A4GCT4 is left unbound. B2370 
thus has no significant selectivity for A4GT4 over A4T4. All compounds show very poor binding 
to the two GC bps sequence (A4GCT4). 
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Figure 4.4 Competition mass spectrometry. 
(A) Sequences used for competition ESI mass spectrometry. Example spectra of (B) free DNA and 
(C) DNA and DB2120-DNA complexes. (D) Comparison of the peak intensities for DNA and 
ligand–DNA complexes for a series of titrations of [1:1], [2:1], and [4:1] and are expressed as a 
mole to mole ratio of ligand to DNAsingle sequence (e.g., [2:1] = 10 μM DB2120 to 5 μM A4T4). 
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Figure 4.5 Circular dichroism titration spectra of DB2120 with A4GT4. 
Ligand was titrated until no further increase in the induced CD signals were observed. The insets 
show the ligand:DNA ratio. The strong induced CD signal indicates a very strong complex 
formation in the DNA minor groove. 
 
4.4.4 Circular dichroism 
Circular dichroism (CD) is a powerful technique to detect conformational changes of 
biomolecules, as well as small molecule binding modes using pattern recognition.[42, 43] Figure 
4.5 shows the titration CD spectra of DB2120 with the A4GT4 sequence. The compound exhibits 
strong, positive induced CD signals between 300 and 400 nm that have been found to be indicative 
of minor-groove binding, as expected from the structure. Small and consistent changes in the CD 
spectral region of DNA (230-290 nm) are observed with incremental titration of ligands, indicating 
only minor conformational changes in DNA upon complex formation. 
4.4.5 DNase I footprinting 
Do these results on sequence specificity by DB2120 hold up with a much longer DNA? To 
answer this question, binding to a long DNA fragment was also assessed using DNase I 
footprinting experiments. A DNA fragment containing A4CT4A4GT4, A4GCT4A4GCT4, 
A4T4A4T4, AATTGCAATTAATTGCAATT, and AATTCAATTAATTG AATT sequences  
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Figure 4.6 DNase I footprinting densitometry analysis. 
Binding of the phenyl (DB2119) and pyridyl (DB2120) compounds to the 3′-end radio-labeled 208 
bp DNA fragment (Experimental details in Supplementary Material) containing the five different 
DNA sequences (A4CT4·A4GT4, A4T4·A4T4, A4GCT4·A4GCT4, AATTCAATT·AATTGAATT, and 
AATTGCAATT·AATTGCAATT, localized as black lines) was quantified relative to unbound DNA 
treated with DNase I in similar manner. The primary bound portions of DNA are localized as red 
boxes. The single G·C bp recognition by the pyridyl compound is visually apparent. 
 
(black lines, Figure 4.6) was prepared (Experimental Section, Supplementary Material) and 
incubated with increasing concentrations of DB2120 and DB2119 prior to mild DNase I treatment 
(Figure 4.6, experimental gel electrophoresis results shown in Figure 4.7). The corresponding 
densitometric analyses for DB2120 and DB2119 (Figure 4.6) show very different results for the 
two compounds that structurally differ in only by replacing a CH by N. Strong and selective 
binding of DB2120 to the AATTCAATTAATTGAATT site contrasts with the absence of binding 
to AATTGCAATTAATTGCAATT. Binding is also seen for DB2120 with A4CT4A4GT4 but no 
significant binding to a similar A·T sequence without a G·C base pair (A4T4A4T4). In contrast, 
DB2119 shows weaker binding to all of the binding sites under the gel conditions, in agreement 
with the biophysical methods discussed above. 
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Figure 4.7 DNase I footprinting experiments. 
The 208bp DNA fragment containing the 5 sequences of interest (AATTGCAATT•AATTGCAATT, 
AATTCAATT•AATTGAATT, A4GCT4•A4GCT4, A4CT4•A4GT4 and A4T4•A4T4) was incubated 
with increasing concentrations of DB2119 and DB2120,  as indicated on the top of the lanes (µM) 
prior to being subjected to DNase I mild digestion. The digested products were separated on an 
8% polyacrylamide gel containing 8 M urea. The sequence was numbered and identified relative 
to classic DMS-piperidine treated DNA samples identifying guanines as strong, cleaved bands and 
adenines as much weaker bands (G-track lanes). 
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4.4.6 Molecular modeling 
For molecular insights into the structural parameters dictating G·C bp recognition by 
DB2120, molecular modeling studies were conducted with the A4GT4 sequence using 
experimentally derived information. Docking analysis reveals that DB2120 complements the DNA 
minor-groove shape and makes excellent van der Waals interactions with the walls of the minor 
groove (Figure 4.8A). The two terminal ABP modules are oriented parallel to the groove walls, 
while the central pyridine ring is deeply embedded in the minor groove. As expected, the inner- 
facing pyridine nitrogen is involved in H-bonding to the central G-NH that extends into the minor-
groove (Figure 4.8B, middle). Additional H-bonds are formed between the benzimidazole and 
amidine groups with AT bp (Figure 4.8B, left and right). This orientation provides excellent 
minor-groove recognition units for both G·C and A·T bp. In addition, the linker flexibility allows 
molecular twist along the groove that orients the two ABP units in such a way that the individual 
units on either side of the pyridine ring form strong interactions with both strands of the duplex. 
The specific interactions observed between DB2120 and the minor groove of A4GT4 dictate the 
sequence selectivity observed for this compound and provide a rational explanation for the 
observed mixed-sequence DNA recognition. 
4.5 Discussion 
In summary, new ideas for the design of a variety of cell-permeable compounds for 
sequence specific recognition of DNA are needed to take advantage of the wealth of new and 
expanding genomic information. The variety is required because of the different uptake 
characteristic of different cells and the different pharmacokinetics or ADME properties of 
compounds of different structure.[30, 44] In this project, A·T bp recognition groups were linked 
by test modules for potential G·C bp recognition with the long-term objective of developing a new  
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Figure 4.8 Molecular docking model of DB2120 with the A4GT4 sequence. 
(A) The model represents the minor (left) and major (right) groove views of DB2120 with A4GT4 
sequence. The A·T DNA bases are represented as stick models in red and the central G·C bp is 
green. The DNA backbone is represented as a tube in gray color. DB2120 is represented in a 
space-filling model with the carbons light blue, nitrogen dark blue, hydrogens orange and oxygen 
red. (B) Important interactions between different sections of DB2120 and DNA are illustrated. The 
central G·C bp is used as the reference for base numbering of the leading and complementary 
strands. The benzimidazole ring NH and the amidine unit at the top of DB2120 in this orientation 
forms strong interactions with the carbonyl groups of T+2 and T+3 bases in the minor groove of 
the leading strand (left). The pyridine nitrogen makes strong interactions with the G-NH2 (ball 
and stick) in the minor groove (middle). The benzimidazole NH at the bottom end forms bifurcated 
interactions with A-2 N3 on the 5′-AAACTTT-3′ strand and T+3 carbonyl groups of the 5′-
AAAGTTT-3′ strand, respectively. The amidine unit forms strong interactions with the carbonyl 
group of T+4 of the AAACTTT strand (right). All the interactions contribute to the overall stability 
of complex formation with the pyridine ring conferring G·C recognition as it was designed to do. 
 
paradigm for sequence specific DNA minor groove recognition using biologically-compatible 
heterocyclic cations. 
The pyridyl analogue of DB2119, DB2120, is a significant advance in the design of 
compounds that are highly selective for single G·C bp recognition with flanking A·T sequences. 
As noted above, such sequences appear often in the kDNA of parasitic microorganisms as well as 
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TF promoter sites. SPR results clearly show that the slow dissociation rate of DB2120 from the 
A4GT4 sequence is the primary factor in the strong and selective binding observed. The compound 
binds rapidly and forms numerous van der Waals and H-bond interactions (Figure 4.8) that must 
be disrupted to dissociate the complex. The absence of the intervening G·C bp in the A4T4 and 
inosine motifs clearly eliminates the H-bonding interaction between the G-NH2 group and DB2120 
and gives faster dissociation and weaker binding. The DNA interactions of DB2120 offer insights 
that can be integrated into future compound design schemes. The significant loss in binding 
selectivity by DB2370, due to the absence of the -O-CH2- linker, also indicates that not only the 
molecular geometry but also the flexibility of DB2120 play very critical roles for the selective 
recognition of the G-NH2 group. The sequence composition, which primarily governs the local 
microstructure of the minor groove, also strongly dictates the strength and stoichiometry of 
binding. While the narrower minor groove of pure A-tract motifs with enhanced negative 
electrostatic potential offer a more conducive environment for a highly favorable monomer 
complex formation, the somewhat wider grooves of other A·T or more G·C bp-containing 
sequences [33] may promote strong dimeric complex formation. 
The SPR, mass spectrometry, and DNase I footprinting results strongly support mixed bp 
DNA recognition by DB2120 but not the phenyl derivative, DB2119. This is particularly important 
since the DNase I cleavage experiments are done with long DNA sequences that are quite different 
from the shorter segments used in our other biophysical studies. An example densitometry trace 
of a DNase I footprinting gel that compares DB2119 to results with DB2120 (Figure 4.6) shows 
that AAAACTTTTAAAAGTTTT and AATTCAATTAATTGAATT sequences are the strongest 
binding sites for DB2120 with much weaker binding to two GC and pure AT sequences. 
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The molecular model in Figure 4.8 provides information to explain the strong and specific 
binding of DB2120 to the A4GT4 site. The pyridyl-N forms a strong and direct H-bond to the G-
amino-NH that projects into the minor groove. The two -O-CH2- flexible linking groups of 
DB2120 allow rotations of the terminal phenyl-benzimidazole–amidine units such that they are 
able to fit snuggly into the minor groove in the flanking A-tract sequences. Without these groups, 
DB2370 has poor GC selectivity. Both benzimidazole-NH and amidine-NH groups form strong, 
direct H-bonds with C=O groups of thymines in the minor groove (Figure 4.8). The amidine 
cationic charges are well-placed to form ionic interactions with the anionic DNA backbone. The 
entire DB2120 molecule is involved in optimizing the complex with the DNA minor groove. An 
electron density calculation (Figure 4.1) shows the positive electron density on the amidines and 
benzimidazole-NH groups, and the negative charge density on the pyridyl-N help account for 
strong binding between DB2120 and the DNA minor groove. 
4.6 Conclusion 
The combined biophysical results reveal that effective recognition of A·T-rich sequences 
with intervening G·C bps can be achieved with heterocyclic cations that have appropriately placed 
H-bond acceptors flanked by A·T bp recognition modules and appropriate flexibility. This 
information should assist significantly in the rational design of further potent heterocyclic cations 
to target larger mixed DNA sequences with more G·C base pairs. 
4.7 Materials and methods 
4.7.1 DNA oligonucleotides 
For the thermal melting and circular dichroism spectroscopy experiments, hairpin DNA 
oligomers used were A4GT4 [5’-CCAAAAGTTTTGCTCTCAAAACTTTTGG-3’], A4IT4 [5’-
CCAAAAITTTTGCTCTCAAAACTTTTGG-3’], A4T4 [5’-
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CCAAAATTTTGCTCTCAAAATTTTGG-3’], and with A4GCT4 [5’-
CCAAAAGCTTTTGCTCTCAAAAGCTTTTGG-3’], with the hairpin loop underlined (Figure 
4.1). Lyophilized DNA oligomers were purchased from Integrated DNA Technologies, Inc. (IDT, 
Coralville, IA) via HPLC purification. Doubly distilled water was added to the solid DNAs to 
bring the concentration to approximately 1.0 mM, based on the reported amount of DNA from 
IDT. The molar concentrations of these hairpin DNAs were then determined using a Cary 300 Bio 
UV−Vis spectrophotometer (Varian, Walnut Creek, CA) at 260 nm based on the molar extinction 
coefficients (ε = 260 nm) calculated by the nearest-neighbor method.[45] 
4.7.2 Thermal melting (Tm) 
Thermal melting experiments were performed on a Cary 300 Bio UV-Vis 
spectrophotometer (Varian). The concentration of each hairpin DNA sequence was 3 μM and 
experiments were in buffer (50 mM Tris-HCl, 100 mM NaCl, 1 mM EDTA, pH 7.4) in 1 cm quartz 
cuvettes at 2:1 ligand-DNA ratio. The DNA solutions were annealed prior to being tested. The 
spectrophotometer was set at 260 nm, 0.5 °C/min increase beginning at 25 °C, well below the 
DNA melting temperature and ending well above it or at 95 °C. The absorbance of the buffer was 
subtracted, and a graph of normalized absorbance vs. temperature was created using KaleidaGraph 
software. The ΔTm values were calculated using a combination of the derivative function and 
estimation from the normalized graphs.  
4.7.3 Biosensor surface plasmon resonance (SPR) 
SPR measurements were performed with a four-channel BIAcore T200 optical biosensor 
system (GE Healthcare, Inc., Piscataway, NJ).  A streptavidin-derivatized (SA) sensor chip was 
prepared for use by conditioning with a series of 60 s injections of 1 M NaCl in 50 mM NaOH 
(activation buffer) followed by extensive washing with HBS buffer (10 mM HEPES, 150 mM 
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NaCl, 3 mM EDTA, and 0.05% P20, pH 7.4).  Biotinylated-DNA samples (A4T4, A4GT4, A4IT4, 
and A4GCT4 hairpins) of 25-30 nM were prepared in HBS buffer and immobilized on the flow 
cell surface by noncovalent capture as previously described.[36, 37] Flow cell 1 was left blank as 
a reference, while flow cells 2-4 were immobilized with DNA by manual injection of DNA stock 
solutions (flow rate of 1 μL/min) until the desired amount of DNA response units (RU) was 
obtained (320 - 330 RU). Ligand solutions were prepared with degassed and filtered 50 mM Tris-
HCl buffer (pH 7.42) by serial dilutions from a concentrated stock solution.  Typically, a series of 
different ligand concentrations (1 nM to 1 μM) were injected over the DNA sensor chip at a flow 
rate of 100 μL/min until a constant steady-state response was obtained (3 min), followed by buffer 
flow for ligand dissociation (10 - 60 min). After each cycle, the sensor chip surface was regenerated 
with a 10 mM glycine solution (pH 2.5) for 30 s followed by multiple buffer injections to yield a 
stable baseline for the following cycles. RUobs was plotted as a function of free ligand 
concentration (Cfree), and the equilibrium binding constants (KA) were determined either with a 
one-site binding model (K2 = 0) or with a two-site model, where r represents the moles of bound 
compound/mol of DNA hairpin duplex and K1 and K2 are macroscopic binding constants.  
 
𝑟 =  
[(𝐾1∙𝐶𝑓)+(2𝐾1∙𝐾2∙𝐶𝑓
2)]
1+(𝐾1∙𝐶𝑓)+(𝐾1∙𝐾2∙𝐶𝑓
2)
   (1) 
 
RUmax in the equation was used as a fitting parameter, and the obtained value was compared 
to the predicted maximal response per bound ligand to independently evaluate the 
stoichiometry.[37]  Kinetic analyses were performed by globally fitting the binding results for the 
entire concentration series using a standard 1:1 kinetic model with integrated mass transport-
limited binding parameters as described previously.[37] 
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4.7.4 Mass spectrometry (ESI-MS) 
Electrospray ionization mass spectrometry experiments were performed using a Waters 
Micromass Q-ToF (Milford, MA) in negative ion mode and MassLynx 4.1 software for data 
analysis. Hairpin DNA sequences (Integrated DNA Technologies) were designed to maintain 
flanking base pairs in the duplex stem while altering only the target binding site with A4T4: [5'-
GCGAAAATTTTGCGTTTTCGCAAAATTTTCG-3'], A4GT4: [5'-
CGAAAAGTTTTCIICCCCCCGAAAACTTTTCG-3'], A4GCT4: [5'-
CGAAAAGCTTTTCICCCCCGAAAAGCTTTTCG-3'], and GC internal standard: [5'-
CGCGCGCGCTTTTGCGCGCGCG-3'] with the hairpin loop underlined. Guanine base pairs not 
in the target site nor adjacent to the target site were substituted with an inosine to create sequences 
with distinguishable molecular weights. Buffer solution of 0.15 M ammonium acetate buffer (pH 
6.7) was prepared in doubly distilled water and filtered using a 0.22 µm hydrophilic cellulose filter 
(Millipore, Darmstadt, Germany). DNAs were dissolved in 0.15 M ammonium acetate buffer to a 
concentration near 1.0 mM and dialyzed in a 1000 Da MWCO dialysis membrane tubing 
(Spectrum Laboratories, Rancho Dominguez, CA) at 4 ºC with 3x buffer exchange. Following 
dialysis, DNA concentrations were spectroscopically determined using extinction coefficients 
provided by IDT based on the nearest neighbor method.[45] DNA sequences were heated to 95 ºC 
and quenched on ice to initiate hairpin formation. DNAs were prepared in 0.15 M ammonium 
acetate buffer to concentrations of 5 µM. Titrated amounts of compound were added based on a 
mole to mole ratio of compound to a single DNA sequence (e.g. 10 µM compound to 5 µM A4GT4 
to create a [2:1] concentration ratio) and 5% methanol (v/v) to increase sample volatility. Capillary, 
sample cone, and extraction voltages were set to 2100 V, 25 V, and 1.5 V, respectively. Source 
block and desolvation temperatures were respectively set to 80 ºC and 110 ºC. Collision energy 
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was set to 2 V. Cone gas and desolvation gas flows were at 50 L/h and 350 L/h. Samples were 
injected at a flow rate of 5 µL/min and run for ≈ 10 min until the MassLynx chromatogram reached 
stabilization. Scanned peaks were analyzed over m/z 300 – 3,000 range and the final 2 min 
averaged. The most abundant peak intensities observed belonged to charge states of -3 to -6. 
Spectra were deconvoluted using the ‘Maximum Entropy 1’ function (MassLynx) which multiplies 
each peak (m/z) by its respective charge (z) to produce a single-charge peak for each DNA and/or 
complex and allow for a simplified comparison. Between each set of titrations, the instrument was 
thoroughly cleaned using HPLC-grade methanol, acetonitrile, methanol/acetonitrile mixture (1:1) 
and finally flushed with 0.15 M ammonium acetate buffer. Estimated peak intensities for the 
titration comparisons are within ± 3% of peak values.  
4.7.5 Circular dichroism spectroscopy (CD) 
Circular dichroism experiments were performed on a Jasco J-810 CD spectrometer in 1 cm 
quartz cell at 25 ºC. The hairpin DNA (5 µM) sequence in buffer (50 mM Tris-HCl, 100 mM NaCl, 
1 mM EDTA, pH 7.4) was added to the cell prior to the experiment and then the compound was 
added to the hairpin DNA solution and incubated for 10 min to achieve equilibrium binding for 
the DNA complex. For each titration point, four spectra were averaged from 500 to 220 nm with 
scan speed 50 nm/min, and a response time of 1 s. Buffer subtracted graphs were created using the 
KaleidaGraph software. 
4.7.6 DNase I footprinting experiments 
[5'-
gatcgtgcAAAATTTTgcgtccAAAAGTTTTggtgcgAAAAGCTTTTcccgggcAATTGAATTg 
gcgccAATTGCAATTcggc-3'] and [5'- gatcgccgAATTGCAATTggcgccAATTCAATTgcccg 
ggAAAAGCTTTTcgcaccAAAACTTTTggacgcAAAATTTTgcac-3'] oligonucleotides 
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(Eurogentec, Belgium) were annealed and cloned in BamH I site of the pBSIISK vector 
(Stratagene, La Jolla, CA). The DNA fragment encompassing this sub-cloned sequence was 
obtained from ClaI-NotI, double digestion and 3'-end-labeled using γ-[32P]-dCTP (Perkin-Elmer, 
France) and Klenow enzyme. The resulting 208-bp radio-labeled DNA fragment was then purified 
and the DNase I footprinting experiments performed as previously described.[48] 
4.7.7 Structural model calculation methods 
Molecular modeling studies were initiated with conformational analysis of the tested 
compounds with a molecular mechanics MMFF approximation level with the Spartan’10 software 
package (Wavefunction Inc. Irvine, CA). The Spartan’10 software package was employed to 
optimize the final geometry by using ab initio calculations with density functional theory (DFT), 
B3LYP at the 6-31G* approximation level. The alignment of compounds was done using the 
‘Align Database’ option of the QSAR module in SYBYL-X1.2 software package on a Windows 
workstation.[47] 
Molecular docking and visualization studies were performed with the SYBYL-X1.2 
software. The initial DNA duplex [5'- d(GCAAAAGTTTTCC)-3'·5'-d(GGAAAACTTTTGC)-3'] 
was constructed in the ‘Biopolymer-Build DNA Double Helix’ module employing regular B-DNA 
parameters. The DNA was next energy minimized for a maximum of 100 iterations using the 
conjugate gradient algorithm and Tripos force field, with a termination gradient of 0.1 kcal/mol Å. 
The three-dimensional structure of DB2120 was built, assigned Gasteiger-Hückel charges and 
minimized using the Tripos force field until a terminating conjugate gradient of 0.01 kcal/mol Å 
or the maximum 1000 iterations was reached.[47] 
During the docking process, DB2120 and the DNA were in separate molecular areas within 
the SYBYL graphical user interface. DB2120 was manually inserted into the DNA minor groove 
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and the ‘Flexidock’ module was then employed. Ten different random numbers were designed and 
employed by the genetic algorithm, one at a time, for a total of 10 docking trials. 456,000 
generations were calculated and assigned for docking DB2120 into the DNA minor groove.[47-
49] A large amount of generations ensured that the lowest-energy conformations were obtained. 
Both the ligand and the bound DNA were permitted torsional flexibility in the docking process. 
Atomic charges were computed using Kollman all-atom for DNA and Gasteiger-Hückel for the 
ligand. All possible H-bond sites were selected for the DNA-ligand complex. From each docking, 
the 20 lowest-energy structures were selected. 
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5.1 Abstract 
Specific targeting of protein-nucleic acid interactions is an area of current interest, for 
example, in the regulation of gene-expression. Most transcription factor proteins bind in the DNA 
major groove; however, we are interested in an approach using small molecules to target the minor 
groove to control expression by an allosteric mechanism. In an effort to broaden sequence 
recognition of DNA-targeted-small-molecules to include both A∙T and G∙C base pairs, we recently 
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discovered that the heterocyclic diamidine, DB2277, forms a strong monomer complex with a 
DNA sequence containing 5’-AAAGTTT-3’. Competition mass spectrometry and surface plasmon 
resonance identified new monomer complexes, as well as unexpected binding of two DB2277 with 
certain sequences. Inherent microstructural differences within the experimental DNAs were 
identified through computational analyses to understand the molecular basis for recognition. These 
findings emphasize the critical nature of the DNA minor groove microstructure for sequence-
specific recognition and offer new avenues to design synthetic small molecules for effective 
regulation of gene-expression. 
5.2 Key words 
Competition ESI mass spectrometry; Competition SPR; DNA shape; Microstructure; 
Mixed site; Molecular dynamics; Sequence specificity 
5.3 Abbreviations 
Base pair (bp); Deoxyribonucleic acid (DNA); Electrospray ionization mass spectrometry 
(ESI-MS); Molecular dynamics (MD); Surface plasmon resonance (SPR); Transcription factor 
(TF) 
5.4 Introduction 
Regulation of the binding affinity in protein-nucleic acid complexes is an attractive concept 
for development of novel therapeutics and agents for control of gene expression.[1-4]. Several 
innovative approaches have used small molecules to target disease-associated DNA binding 
transcription factors or TFs.[5-15] Most TFs of interest bind in the major groove [16] and an 
alternative approach to control expression is to use small molecules to modulate TF activities by 
interacting directly with the minor groove of DNA where most of these agents bind.[17-19] There 
are two possible mechanisms whereby a minor groove binding compound could disrupt protein-
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nucleic acid interactions in the major groove to modulate TF association. First, when bound to the 
minor groove, the small molecule could distort DNA so that the structure of the TF no longer 
complements its target recognition site, such as an allosteric inhibition mechanism.[20, 21] 
Alternatively, direct competition is another possible mechanism which may be significant for TFs 
that position side chains into or near the DNA minor groove. By knowing how small molecule 
inhibitors recognize DNA, it is possible to preemptively block TF binding to DNA. Our main goal 
is to understand, in detail, the minor groove binding variations of synthetic small molecules with 
different DNA sequences and how they vary with sequence-dependent DNA structure.  
Small molecules that bind in the minor groove of DNA have been validated for this 
approach from studies using synthetic polyamides.[22-24] However, polyamides have limitations 
such as aggregation and cell uptake and a wider variety of agents is needed for diverse biological 
systems.[25, 26] We are approaching this problem with a class of sequence-specific, DNA-targeted 
minor groove binders based on a heterocyclic cation design since these compounds have shown 
good cell uptake and biological properties through human clinical studies.[27, 28] Few non-
polyamide minor groove agents, including heterocyclic diamidines, have been identified to 
selectively recognize mixed, A∙T and G∙C base pair-containing DNA sequences.[29, 30] This 
constitutes a significant barrier to progress in the area of designed synthetic agents for the 
disruption of TF-DNA complexes. To interact with the edges of A∙T base pairs in the minor 
groove, compounds must have hydrogen bond donor groups for the thymidine carbonyl and an N3 
of adenine acceptor. To recognize a G∙C base pair, the compound must have an acceptor to 
hydrogen bond to the guanine NH2 group. It is also critical that a successful small molecule have 
the appropriate shape and charge to complement the DNA minor groove.[31, 32]  
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Figure 5.1 Test compound and sequences for ESI-MS. 
(A, B) Structures of DB2277 and (C) DNA sequences used to screen for binding with the DB2277 
using ESI-MS. 
 
A synthetic effort has led to cationic diamidines that strongly and selectively recognize the 
minor groove in mixed-site DNA sequences.[33] The lead compound in this development is 
DB2277, which contains a nitrogen hydrogen bond acceptor in an aza-benzimidazole (Figure 5.1). 
Strong binding of DB2277 requires the 2-amino group of guanine and suggests an aza-N∙G-NH2 
hydrogen bond. These observations show that DB2277 binds best to mixed-site sequences with a 
single G∙C base pair flanked by A∙T base pair sites.[34] Key questions in the design effort for new 
mixed-sequence minor groove compounds that recognize G∙C base pairs with flanking A∙T base 
pairs: In addition to monomer binding to recognize a single G∙C base pair, can the compound form 
dimers to recognize two G∙C base pair sequences? What is the effect of the flanking A∙T base 
pairs? How could this influence binding affinity? 
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  To address these questions, a systematic set of DNAs were tested with DB2277 and their 
interactions, affinities and stoichiometries were investigated. The composition of A∙T base pairs 
was maintained (i.e. number of A∙T base pairs per binding site) to see how interactions vary due 
to A∙T base pair order with one and two, central G∙C base pairs. Electrospray ionization mass 
spectrometry (ESI-MS) and surface plasmon resonance (SPR) were used to examine stoichiometry 
and binding behavior for the DNA-DB2277 complexes. Significant variations in affinity and 
stoichiometry for binding of DB2277 to the different, closely related sequences were observed. To 
help understand these sequence-dependent variations, extensive molecular dynamics (MD) 
simulations were conducted to provide specific details regarding the structural properties intrinsic 
to each DNA sequence that govern small molecule recognition. Large differences in the local DNA 
structure were observed with these closely related sequences and the differences correlate with 
observed differences in DB2277 binding affinity and stoichiometry. The results described here 
provide new and fundamental information in design research for DNA sequence-specific 
recognition and structural complementarity between a small molecule and its target site. 
5.5 Results and discussion 
5.5.1 Competition electrospray ionization mass spectrometry identifies new 
interactions 
Competition electrospray ionization mass spectrometry (ESI-MS) can simultaneously identify 
affinity, stoichiometry and cooperativity in multiple DNA-small molecule interactions.[35] The 
molecular weights of all possible DNA species are controlled through sequence modifications, 
making each sequence distinguishable (Figure 5.1C). The target binding sites of the tested DNA 
sequences are listed as DNA 1-9 in Figure 5.2. DNA 2, which contains the AAAAGTTTT target 
site, was used as a reference to compare binding due to the extensive data available for DB2277
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Figure 5.2 Representative ESI-MS spectra of DB2277 binding with DNA.  
(A) DNA sequences in the absence of DB2277 with m/z 1,580-1,780 signifying -6 charged species. 
Molar concentration ratio of [DB2277] to [DNA] expressed as: (B) [0.5 to 1], (C) [1 to 1], (D) 
[1.5 to 1], (E) [2 to 1], (F) [2.5 to 1], and (G) [3 to 1]. Concentrations of DNA were fixed at 5 
µM. Unbound DNA, 1 to 1, and 2 to 1 complexes labelled above respective boxes. 
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Figure 5.3 Comparison of deconvoluted peak intensities from titrated DB2277 with DNA.  
Comparison of relative peak intensities for AAAATTTT, AAAAGTTTT, AAAACTTTT, 
AAAAGCTTTT, AAAAGCAATT, AATTGCAATT, AATTGGAATT, AATTCGAATT, ATATGCATAT, 
and their DB2277 complexes. Molar ratios are expressed as [DB2277] to [DNA]. Concentrations 
of DB2277 increased from [0.5 to 1] to [3 to 1] with a fixed DNA concentration of 5 µM. 
Complexes are expressed as unbound DNA (empty), 1:1 (checkered), and 2:1 (solid) complexes. 
 
with that and similar sequences. Target binding sites were designed to test the interactions of the 
compound with a range of closely related DNA sequences. Each sequence has two set of A∙T base 
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pairs as AAAA, AATT or ATAT. Only DNA 1 lacks a central G∙C base pair. Two categories of 
mixed sequences are grouped with either one or two G∙C base pairs. 
Figure 5.2 illustrates the changes in relative peak intensity for DB2277-DNA complexes. 
Changes in the relative intensities are based on the binding of DB2277 to DNA and compared to 
a reference sequence present in the sample. In the presence of DB2277, peak intensities for free 
DNA disappear while intensities for DB2277-DNA complexes emerge. For instance, in Figure 
5.2B, half of the unbound AAAAGTTTT (DNA 2) is present at a concentration molar ratio of [0.5 
to 1] as well as ≈ 50% of 1:1 complex. As the concentration of DB2277 is increased, unbound 
AAAAGTTTT decreases with a concurrent increase in 1:1 binding. Based on these results, 
sequences which contain A-tracts (DNA 1-3, 9) prefer 1:1 binding. The -6 charged species were 
used for illustrative purposes in Figure 2 since they were the most abundant of the multiply charged 
species. Relative binding affinities were measured using deconvoluted spectra which takes into 
account all multiply charged species (Figure 5.3). 
Sequences in the AATT subcategory (DNA 5-8) allow us to examine the transition from 
A-tracts to sites with an ApT base pair step. Surprisingly, for this closely related sequence, the 
ESI-MS results show that 2:1 binding is strongly preferred over 1:1 complex formation for AATT 
DNAs. Finding such preference was especially interesting since many minor groove binding 
compounds cannot differentiate among A∙T base pair sites.[36, 37] Based on the results from 
AATT sequences, one might expect to find strong 2:1 complexes formed between DB2277 and 
ATAT sequences since alternating A∙T sites have wide minor grooves similar to AATT. In another 
surprise, the compound preferentially formed a 1:1 complex with ATATGCATAT (Figure 5.2). 
DB2277 can bind tightly to sites with a single G base flanked by A-tract sites [31]; however, little 
is known regarding sequences with two G∙C base pairs. In summary, the ESI-MS results show that 
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monomer complexes are the preferred systems for AAAA and ATAT base pair sites that flank a 
core G∙C base pair whereas 2:1 complexes are preferred for sequences containing AATT sites. 
5.5.2 Surface plasmon resonance confirms sequence specific behavior identified by 
ESI-MS 
Surface plasmon resonance (SPR) is a powerful method to define the thermodynamic and 
kinetic properties of biomolecular interactions.[38, 39]. In our experiments, increasing 
concentrations of DB2277 were injected over a set of immobilized DNA sequences. Binding 
curves for DB2277 are shown in Figure 5.4. Binding affinities for steady-state equilibrium and 
kinetics-fitted analyses are compared in Table 5.1 as well as the binding on and off-rates. The 
unexpected 2:1 binding of AATTGCAATT was of considerable interest, especially since it 
contains two central G·C base pairs. To directly compare flanking base pair sequence and its role 
in small molecule recognition, binding of DB2277 was measured with AATTGCAATT, as well 
as with AAAAGCTTTT and ATATGCATAT since all three sequences contain the same G·C base 
pair core. A representative sensorgram of DB2277 binding to AATTGCAATT is shown in Figure 
5.4A. Results of AATTGCAATT binding from SPR are in direct agreement with those obtained 
from ESI-MS with two binding sites, KD1 and KD2, near 15 nM and 30 nM, respectively. Also in 
agreement, a strong 1:1 complex for DB2277 and AAAAGCTTTT was observed (KD ≈ 50 nM). 
With the ATATGCATAT sequence, a weaker 1:1 complex was formed (KD ≈ 100 nM) and a 
second, much weaker 2:1 complex was detected at high compound concentrations, which were 
well above the first KD. These results are in agreement with those obtained by ESI-MS for preferred 
1:1 binding. 
Competition SPR [40] was used to measure the binding of three single G∙C base pair 
sequences against the original immobilized DNA. Similar to direct-binding SPR experiments, the 
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Figure 5.4 SPR sensorgram and binding curves of DB2277 and DNA.  
(A) SPR sensorgram of AATTGCAATT binding DB2277. Injected concentrations of DB2277 
shown are 5, 10, 30, 70 and 200 nM. (B) Steady-state fits for binding with AAAAGCTTTT, 
AATTGCAATT and ATATGCATAT fit using a two site binding model. (C) Competition SPR 
steady-state fits of competitor DNA sequences AAAAGTTTT, AATTGAATT and ATATGATAT fit 
using a one-site binding model. 
 
DB2277 was added to the sample solution and the observed response at steady-state is plotted to 
determine the binding constant. In the competition SPR experiments, the compound was held at a 
fixed concentration while the competing DNA was added to the sample solution. The observed 
response, however, decreased as concentrations of competing DNA were increased, which resulted 
in less available free compound in solution. Calculated dissociation constants of AAAAGTTTT, 
AATTGAATT and ATATGATAT were determined from Figure 5.4C and are listed in Table 5.1.  
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Table 5.1 Comparison of kinetics-fitted and steady-state equilibrium binding constants (KD 
x 10-9 M). 
Kinetic rates and fits were determined using direct-binding SPR. Steady-state fits were compared 
using both direct-binding and competition binding SPR. Sequences with multiple binding 
constants are listed as KD1 and KD2. 
 
 Kinetic Rates Dissociation Constants 
 
ka 
(10+6·M-1 s-1) 
 
kd 
(10-1·s-1) 
 
Kinetics-Fit 
(10-9 M) 
 
Steady-State  
(10-9 M) 
 
AAAAGCTTTT 5.3 ± 0.7 2.4 ± 0.5 44.8 ± 4.7 49.6 ± 1.1 
ATATGCATAT 1.6 ± 0.2 1.4 ± 0.2 87.8 ± 3.8 120.3 ± 5.0 
AATTGCAATT 
KD1 
KD2 
 
1.0 ± 0.2 
0.5 ± 0.08 
 
0.1 ± 0.01 
0.2 ± 0.02 
 
14.1 ± 3.1 
35.5 ± 3.0 
 
12.5 ± 1.3 
33.3 ± 3.8 
AAAAGTTTT ND ND ND a 4.4 ± 0.7 
ATATGATAT ND ND ND a 50.8 ± 16.1 
AATTGAATT 
KD12 
KD1 
KD2
 
b KD12 
 
4.4 ± 1.0 
3.1 ± 1.2 
1.3 ± 0.4 
1.6 ± 0.7 
28.7 ± 1.6 
51.1 ± 2.6 
a 41.7 ± 6.1 
b, c 44.6 ± 2.6 
d 25.0 ± 2.3 
d 57.0 ± 5.9 
b, d √25.0 ∙ 57.0  
≈ 39.2 
 
ND Not determined 
a Determined using competition SPR 
b KD12 value determined by √𝐾𝐷1 ∙ 𝐾𝐷2 with KD1 and KD2 values obtained through direct-
binding SPR 
c Value determined by direct-binding SPR and fit with one-site binding model 
d Value determined by direct-binding SPR and fit with two-site binding model 
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The observed response (RUobs) was plotted as a function of competitor DNA concentration [38, 
39] and fit to a 1:1 binding model using Equation 5.2. 
Using competition SPR, the strongest 1:1 complex formed within this DNA series was 
AAAAGTTTT (KD ≈ 4 nM) as expected from ESI-MS and literature.[33, 34] A 10-fold weaker 
complex was formed with the compound and AAAAGCTTTT. Results by competition SPR for 
AATTGAATT show it formed a strong 1:1 complex with a binding constant of 40 nM. Since its 
two G∙C counterpart (i.e. AATTGCAATT) forms both 1:1 and 2:1 complexes, a direct-binding 
SPR approach was also used to compare the binding affinities and determine if multiple binding 
modes occur. In this experiment, AATTGAATT forms both 1:1 and 2:1 complexes with KD values 
near 25 nM and 60 nM, respectively. Competition SPR results were fit using a one-site binding 
model; however, when more than one compound binds (e.g. AATTGAATT) the calculated value 
for two binding constants is KD12 or√𝐾𝐷1 ∙ 𝐾𝐷2). Various forms of analyzing DB2277 with 
AATTGAATT were compared, such as direct-binding SPR, competition SPR, and using one and 
two-site binding models. Likewise, a comparison of kinetics-fitted and steady-state binding 
constants, determined by the two SPR methods, are in excellent agreement for AATTGAATT 
(Table 5.1). 
Interestingly, association rate constants for 1:1 binding of DB2277 to DNA are similar for 
all sequences (ka ≈ 106 M-1s-1) whereas association rate constants are comparatively slower for the 
second DB2277 molecule binding with AATTGCAATT or AATTGAATT. On the other hand, the 
second off-rate for DB2277 is faster than the first off-rate. The calculated binding constants of 
AATTGAATT are similar to those for AATTGCAATT (Table 5.1) and further suggest a binding 
mechanism for the compound unique to the AATT sequences. Results obtained by ESI-MS and 
SPR are in excellent agreement and indicate binding of DB2277 differs when the order of flanking 
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A∙T base pairs is varied. Clearly, the exact order of the flanking bases influences binding of the 
test compound since both global and local structure of the DNA are contingent on base pair 
sequence. In order to probe the basis of these binding differences in molecular detail, we turned to 
molecular dynamics simulations. 
5.5.3 Molecular dynamics identifies microstructural differences in the experimental 
DNAs 
Honig, Rohs and others have shown that the local structure within the DNA minor groove 
can depend on base pair sequence.[41-44] Such microstructural variations may explain why 
binding of DB2277 varies greatly even though base pair composition is maintained. To elucidate 
how DNA microstructure may influence small molecule binding, extensive molecular dynamics 
(MD) simulations of a systematic set of closely related experimental DNA sequences with central 
G∙C base pairs flanked by A∙T base pairs of different sequence were carried out. Variations of the 
resulting structures in the MD trajectories were analyzed with Curves+ [45] to predict their roles 
in DB2277-DNA recognition. We measured helical parameters with specific emphasis on minor 
groove width and depth (Figures 5.5-5.7). Additionally, simulations for select sequences were 
repeated and analyzed over 100 ns intervals to validate structure and flexibility convergences 
(Figures 5.8, 5.9). This is the first highly detailed structural analysis on the effects of systematic 
changes in DNA sequence focused on one and two core G∙C base pairs flanked by varying 
sequences of A∙T-rich sites over long trajectories for 200 ns.[46, 47] 
Varying the A∙T flanking sequence around the core G∙C produced a surprisingly large 
deviation in minor groove widths and depths. Comparison of the flanking sequences reveals unique 
groove width variations. For example, the 2D contour histogram for the minor groove width of 
AAAAGTTTT (Figure 5.5C) indicates a high probability of adopting a narrow (4.5 Å) and deep 
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Figure 5.5 2D contour histograms for minor groove widths of unbound DNA. 
Representative manta plots for (A) 13 and (B) 14 base pair sequences. Number of points along the 
spline of the backbone was increased from 10 to 50 to produce 601 points for 13 base pair 
sequences and 651 points for 14 base pair sequences. Using these two dimensional distance 
matrices, a smooth line was interpolated along the global minimum (red arrow) to construct 
contoured histograms of the minor groove width. Contour 2D histograms of minor groove widths 
vs. base pair sequence. (C) AAAAGTTTT, (D) AAAAGCTTTT, (E) AATTGAATT, (F) 
ATTGCAATT, G) AATTGGAATT, (H) ATATGATAT, and (I) ATATGCATAT. The color gradient 
indicates increasing probability (navy to red) of observing a minor groove width (in Å). 
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(5.0 Å) minor groove with little variation along the target binding. This sequence has the highest 
binding affinity of all the DNA sequences investigated and is explained by the inherently narrow 
and deep groove pre-formed for energetically favorable binding of the compound. DB2277 and 
similar compounds thus bind and fit well into A-tract flanking sequences in strong 1:1 complexes. 
In contrast, AATTGAATT has a strong preference toward maintaining a narrow and deep 
groove at the terminal AA∙TT regions. The groove width increases to 8.0 Å, becoming much wider 
than AAAAGTTTT, at the central G·C base pair of the sequence (Figure 5.5E). The depth of the 
sequence at the central G·C is also less than the AAAAGTTTT sequence. Due to the change in 
groove width and depth, the central G∙C therefore provides a less favorable binding site for 
DB2277 monomer binding. The competition SPR results have, thus, revealed sequence-specific 
variations in both stoichiometry and affinity. We speculate that a single DB2277 binds first with 
AATTGAATT and because of the wider groove and variable depth, it is possible that two 
molecules of DB2277 can fit the optimum groove structure by staggered stacking at the central 
G∙C base pair. 
Finally, within the single G∙C base pair series, the widest and most shallow measurable 
groove occurs in the ATATGATAT sequence throughout the course of the trajectory. Unlike the 
previous two sequences, it is energetically unfavorable for ATATGATAT to exist in a deep and 
narrow groove conformation. Instead, there is a strong preference for the groove to remain wide 
(8.0 Å) and shallow (4.0 Å). The MD described combination of an intrinsically wide groove and 
shallow depth would be expected to bind two DB2277 molecules. Our findings, however, suggest 
the DNA is ill-suited for binding a curved, planar small molecule such as DB2277. Instead, the 
wide and shallow groove must undergo an induced fit to bind DB2277 with a high deformation 
energy penalty. 
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Figure 5.6 2D histograms of most probable minor groove widths for unbound DNA.  
Most probable groove widths per base pair for (A) one G∙C and (B) two G∙C base pair sequences. 
2D histograms of minor groove widths vs. base pair sequence. (C) AAAAGTTTT, (D) 
AAAAGCTTTT, (E) AATTGAATT, (F) AATTGCAATT, (G) AATTGGAATT, (H) ATATGATAT, and 
(I) ATATGCATAT. The color gradient indicates increasing probability (blue to red) of observing 
a minor groove width (in Å). 
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Sequences with two G∙C base pairs were next simulated to better understand the structural 
(dis)similarities among sequences with one or two central G∙C base pairs in the target binding site. 
Altering the core from G to GC increases the overall probability of adopting a wide and shallow 
groove. For instance, a contour 2D histogram of AAAAGCTTTT in Figure 5.5D indicates a higher 
probability of the groove width expanding to 12.0 Å compared to AAAAGTTTT. It is also less 
probable for AAAAGCTTTT to maintain a deep groove, but rather becomes shallowest with the 
additional G∙C base pair in its core. This observed decrease in probability of a narrow and deep 
minor groove may help to explain the weaker binding found by DB2277 with AAAAGCTTTT 
compared to binding with AAAAGTTTT (KD = 49.6 ± 1.1 nM and KD = 4.4 ± 0.7 nM, 
respectively). 
A wide groove also exists at the GC region in AATTGCAATT (Figures 5.5F, 5.6F), and 
is more probable than its AATTGAATT counterpart. In addition to the widened groove, a 
correlated decrease in groove depth also occurs at this region (Figure 5.7D). Comparing both 
histograms, it is evident that the shallowest region occurs at the GpC step and is much more 
pronounced in the AATTGCAATT sequence over AATTGAATT. Interestingly, altering the 
central G∙C base pairs in the sequence to create AATTGGAATT reveals little change in width or 
depth of the minor groove (Figures 5.5-5.7). Little change in groove width and depth between 
AATTGCAATT and AATTGGAATT explains why little detectable difference occurred for 
binding of DB2277 to these two sequences. The MD results therefore provide a rationale for why 
the AATT sequences are favorable for a 2:1 complex in both ESI-MS and SPR. 
Like AATTGCAATT, the ATATGCATAT sequence also has a higher probability of 
existing in a wider state than its counterpart ATATGATAT (Figure 5.6B). Changing G to GC in 
the core of the alternating A∙T base pair flanking sequences stabilizes a wider minor groove. This 
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Figure 5.7 2D histograms of DNA minor groove depths for unbound DNA.  
2D histograms of minor groove depths vs. base pair sequence. (A) AAAAGTTTT, (B) 
AAAAGCTTTT, (C) AATTGAATT, (D) AATTGCAATT, (E) AATTGGAATT, (F) ATATGATAT, and 
(G) ATATGCATAT. The color gradient indicates increasing probability (blue to red) of observing 
a minor groove depth (in Å). 
 
stability is even more evident when looking at the minor groove depth histograms (Figure 5.7). 
For the sequence ATATGCATAT, there is a clear preference for shallow groove depth throughout 
the entire sequence and unlike ATATGATAT, does not break at its core G∙C region. This would, 
therefore, indicate that a wide and stable minor groove within the two GC sequence is consistent 
for ATATGCATAT in having the lowest binding affinity for DB2277. Upon binding a single 
DB2277 molecule, the flexibility of the ATAT sequence allows it to favorably constrict to a narrow 
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Figure 5.8 2D histograms of minor groove width for AAAAGTTTT. 
(A) 100 ns original simulation (B) 200 ns original simulation (C) 100 ns for repeated simulation 
(D) 200 ns repeated simulation. The color gradient indicates increasing probability (navy to red) 
of distance in Angstroms (in Å) for each base pair. 
 
 
groove, rather than binding two molecules in an unfavorable wider groove conformation. These 
MD simulations complement ESI-MS and SPR studies and indicate that DB2277 binding should 
be more favorable where the minor groove is intrinsically narrow and deep and is related to the 
pre-organized groove width prior to binding the compound. These local structural differences also 
influence how and where the molecule will bind in the minor groove. It is somewhat surprising 
that the large diversity of microstructural characteristics, such as groove width, observed for the 
minor groove are not found in the major groove, which has a much more constant structure 
(Figures 5.10, 5.11). 
 
  
 
 
108 
 
Figure 5.9 2D histograms of minor groove width for AATTGCAATT 
(A) 100 ns original simulation (B) 200 ns original simulation (C) 100 ns for repeated simulation 
(D) 200 ns repeated simulation. The color gradient indicates increasing probability (navy to red) 
of distance in Angstroms (in Å) for each base pair. 
 
A comparison of the sequences with matched flanking sites (AAAAGTTTT vs. 
AAAAGCTTTT) shows little variation in local DNA structure (Figure 5.5). On the other hand, a 
comparison of unmatched flanking sequences, for example AAAA to AATT, indicates a larger 
variation in microstructure which in turn governs binding stoichiometry. For sequences with 
AAAA sites, there are similar distributions of a well-maintained narrow groove (4.5-5.0 Å) along 
the target site in the region of AAAAGTTTT and AAAAGCTTTT. Likewise, there is a 
consistently wide groove for both ATATGATAT and ATATGCATAT. With a range of 7.0-8.5 
Å, the narrowest regions occur along the ends of the target site while the widest portions are at the 
T to G/C transitions (i.e. TpG and TpC of the complementary strand). Alternatively, large groove
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Figure 5.10 2D histograms of major groove widths for DNA sequences.  
2D histograms of major groove widths. A) AAAAGTTTT B) AAAAGCTTTT; C) AATTGAATT D) 
AATTGCAATT E) AATTGGAATT F) ATATGATAT G) ATATGCATAT. The color gradient 
indicates increasing probability (blue to red) of observing a minor groove width (in Å). 
 
width variations within the target site occur for both AATTGAATT and AATTGCAATT. 
Specifically in AATT regions at the ApT base steps, there exist large differences in minor groove 
width (Δwidth ≈ 3.5 Å) compared to variations of Δwidth < 2 Å among AAAA and ATAT flanks 
width. This type of intra-target-site variation is significant to the AATT sequences resulting in two 
bound DB2277 molecules. Current observations of a monomeric DB2277-AATT system would 
suggest that a wide minor groove at the core G or G·C base pair region, adjacent to a narrow AATT 
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Figure 5.11 2D histograms of major groove depths for DNA sequences.  
2D histograms of major groove depths vs. base pair sequence. (A) AAAAGTTTT, (B) 
AAAAGCTTTT, (C) AATTGAATT, (D) AATTGCAATT, (E) AATTGGAATT, (F) ATATGATAT and 
(G) ATATGCATAT. The color gradient indicates increasing probability (blue to red) of observing 
a minor groove depth (Å). 
  
site, may support staggered stacking of two DB2277 molecules at the G/C core with the unstacked 
ends of DB2277 in the AATT sites.
The sequence-dependency of other helical parameters for the DNA was also compared. 
Differences in propeller twist were very informative and the averages for each sequence are shown 
in Figure 5.12 (see also Tables 5.2, 5.3). For all sequences there is a characteristic “W” shape to 
each curves but the range varies. For instance, the degree of propeller twist for AAAAGTTTT is
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Figure 5.12 Most probable propeller twist per base pair. 
(A) One G∙C and (B) two G∙C base pair sequences. When the DNA sequences experience a high 
propeller twist the groove width is narrow. When the propeller twist is relieved, the groove is 
broadened. The terminal base pair caps were removed. 
 
large and quite constant along the target site. On the other hand, AATTGAATT has a much wider 
range of propeller twist along the target binding site. Interestingly, the AATTGAATT sequence is 
closely related to the AATTGCAATT sequence, which may partially explain the similar binding 
measured for both sequences by SPR (Table 5.1). In general, sequences with consecutive A or T 
bases (e.g. AAAA) have steric clash due to CH3 groups of thymidine.[48] Propeller twists in A∙T 
base pairs form bifurcated hydrogen bonds between the NH2 of adenosine to O4 of the adjacent 
thymidine on the complementary strand (Figure 5.12A) which reduces the amount of fluctuation. 
Likewise, sequences with AATT have two consecutive A∙T base pairs and are also likely to form 
bifurcated hydrogen bonds; however, two fewer possible hydrogen bonds likely increases the 
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Table 5.2 Mean (M), standard deviation (SD), and 99.9% confidence interval (CI) of the propeller twist over 50,000 frames for the 
13 base pair sequences. 
Central G∙C base pair is shaded in gray. 
  CGAAAAGTTTTCG  CGAATTGAATTCG  CGATATGATATCG 
Base Pair  M (SD) 99.9% CI  M (SD) 99.9% CI  M (SD) 99.9% CI 
1  -6.80 (28.31) [-7.22,  -6.38]  -6.71 (24.85) [-7.08, -6.35]  -10.28 (19.28) [-10.57, -10.00] 
2  -4.72 (10.13) [-4.87, -4.58]  -7.57 (10.07) [-7.72, -7.42]  -10.21 (9.71) [-10.36, -10.07] 
3  -14.95 (8.18) [-15.08,  -14.83]  -18.01 (8.12) [-18.13, -17.89]  -16.08 (7.97) [-16.20, -15.96] 
4  -17.84 (8.08) [-17.96, -17.72]  -22.19 (7.38) [-22.30, -22.08]  -15.78 (8.15) [-15.90, -15.66] 
5  -19.17 (7.52) [-19.28, -19.06]  -20.52 (7.51) [-20.63, -20.41]  -13.53 (8.50) [-13.66, -13.41] 
6  -19.20 (7.47) [-19.31, -19.09]  -9.30 (8.36) [-9.42, -9.18]  -11.32 (8.24) [-11.44, -11.19] 
7  -16.85 (7.66) [-16.96, -16.73]  -4.98 (8.58) [-5.11, -4.86]  -9.41 (9.43) [-9.55, -9.27] 
8  -17.60 (7.41) [-17.70, -17.49]  -18.00 (7.65) [-18.11, -17.89]  -14.94 (7.92) [-15.05, -14.82] 
9  -19.59 (7.94) [-19.71, -19.48]  -21.47 (7.11) [-21.57, -21.36]  -15.25 (8.52) [-15.38, -15.13] 
10  -17.54 (8.07) [-17.66, -17.43]  -21.52 (7.21) [-21.63, -21.42]  -15.57 (8.50) [-15.69, -15.44] 
11  -14.61 (8.30) [-14.98, -14.74]  -16.91 (8.49) [-17.03, -16.78]  -15.83 (8.19) [-15.95, -15.71] 
12  -3.61 (10.36) [-3.46, -3.76]  -5.87 (10.99) [-6.04, -5.72]  -10.13 (10.82) [-10.29, -9.97] 
13  -6.76 (23.21) [-6.42, -7.10]  -7.43 (27.72) [-7.84, -7.03]  -20.33 (45.85) [-21.01, -19.66] 
 
  
  
 
 
113 
Table 5.3 Mean (M), standard deviation (SD), and 99.9% confidence interval (CI) of the propeller twist over 50000 frames for the 
14 base pair sequences. 
Central G∙C base pairs are shaded in gray. 
  CGAAAAGCTTTTCG  CGAATTGCAATTCG  CGATATGCATATCG CGAATTGGAATTCG 
Base Pair  M (SD) 99.9% CI  M (SD) 99.9% CI  M (SD) 99.9% CI M (SD) 99.9% CI 
1  -16.58 (39.12) [-17.15, -16.00]  -34.27 (55.20) [-35.08, -33.46]  -47.48 (59.25) [-48.35, -46.61] -8.27 (20.76) [-8.58, -7.97] 
2  -3.27 (11.00) [-3.43, -3.11]  -3.47 (12.06) [-3.65, -3.30]  -2.37 (12.67) [-2.55, -2.18] -8.44 (9.33) [-8.58, -8.30] 
3  -14.11 (8.60) [-14.24, -13.99]  -16.09 (8.35) [-16.21, -15.97]  -16.04 (8.71) [-16.17, -15.92] -18.30 (7.82) [-18.42, -18.19] 
4  -17.58 (8.26) [-17.71, -17.46]  -21.11 (7.51) [-21.22, -21.00]  -20.06 (8.24) [-20.18, -19.94] -22.28 (7.29) [-22.39, -22.17] 
5  -18.53 (7.63) [-18.65, -18.42]  -20.17 (7.58) [-20.28, -20.06]  -18.54 (8.00) [-18.66, -18.42] -20.70 (7.30) [-20.81, -20.59] 
6  -17.01 (7.90) [-17.13, -16.90]  -12.95 (8.55) [-13.07, -12.82]  -12.69 (8.52) [-12.81, -12.56] -9.64 (8.23) [-9.76, -9.52] 
7  -12.19 (8.11) [-12.31, -12.07]  -4.60 (9.15) [-4.73, -4.46]  -4.13 (9.22) [-4.26, -3.99] -2.75 (8.20) [-2.87, -2.63] 
8  -12.90 (8.03) [-13.02, -12.79]  -4.50 (9.19) [-4.63, -4.36]  -5.21 (9.03) [-5.34, -5.08] -11.80 (8.34) [-11.92, -11.68] 
9  -17.50 (7.88) [-17.62, -17.39]  -12.61 (8.69) [-12.73, -12.48]  -13.02 (8.75) [-13.15, -12.89] -17.79 (7.77) [-17.91, -17.68] 
10  -18.68 (7.65) [-18.79, -18.57]  -19.84 (7.50) [-19.95, -19.73]  -18.30 (7.92) [-18.42, -18.18] -19.90 (7.38) [-20.01, -19.79] 
11  -18.001 (8.12) [-18.13, -17.89]  -21.09 (7.61) [-21.20, -20.98]  -20.20 (8.02) [-20.32, -20.09] -20.44 (7.28) [-20.54, -20.33] 
12  -14.55 (8.85) [-14.68, -14.42]  -18.15 (7.72) [-18.26, -18.03]  -17.00 (8.13) [-17.11, -16.87] -17.87 (7.73) [-17.97, -17.76] 
13  -4.65 (11.12) [-4.81, -4.48]  -8.18 (9.53) [-8.32, -8.04]  -3.70 (11.75) [-3.87, -3.53] -8.19 (9.41) [-8.33, -8.05] 
14  -12.55 (34.08) [-13.05, -12.05]  -7.93 (17.12) [-8.18, -7.67]  -38.99 (52.32) [-39.76, -38.22] -7.84 (18.02) [-8.10, -7.57] 
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structural flexibility as shown by the break at the G or GC core in the minor groove width 
comparisons. Alternatively, sequences with alternating A∙T base pairs do not experience steric 
clash of the CH3 groups and are therefore more flexible with lower propeller twist. 
In addition to propeller twist of our sequences, other base step parameters were evaluated 
for influence on DNA structure. Comparing the single G-containing sequences, only nominal 
differences occur in all of the parameters except for roll (Figure 5.13). Roll increases after 
thymidine-purine steps in AATTGAATT and ATATGATAT. On the other hand, comparison of 
the two central GC sequences shows interesting results within helical parameters. Significant 
increases are seen at TpA steps for slide, rise and twist while other sequences are constant. With 
shift, both up and down changes are seen in ATATGCATAT (Figure 5.13) while no consistent 
patterns occur within the set of sequences. Increases also occur in slide at TpA steps for 
ATATGCATAT. Additionally, tilt and roll decrease as AATTGAATT transitions to 
AATTGCAATT at the CpA step. It is interesting to note how the addition of the second core G∙C 
base pair causes ATATGCATAT to become an outlier compared to the other sequences. 
Specifically, the marked deviations that occur at the pyrimidine-purine steps exhibit the most 
dramatic changes in helical parameters. Propeller twists, rolls, and tilts likely compensate for each 
other in AAAA∙TTTT and AATT sites due to the bifurcated hydrogen bonding networks. 
The observable changes in ATATGCATAT for every measurable parameter is likely from 
an inherent flexibility due to the alternating 5’ to 3’ purine-pyrimidine steps that can perturb 
canonical B-DNA conformations.[49] The ATATGCATAT sequence is the only consistently 
alternating purine-pyrimidine sequence within this series and is the sequence with the lowest 
binding affinity for DB2277. There is a high degree of dynamic helical bending in ATATGCATAT 
compared to AAAAGTTTT. Early reports by Charney and co-workers demonstrated alternating 
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Figure 5.13 Average helical base pair step parameters for one and two G·C base pair 
sequences.  
(A, G) Shift, (B, H) slide, and (C, I) rise (i.e. translational parameters) are reported in Å. (D, J) 
Tilt, (E, K) roll, (F, L) twist (i.e. rotational parameters) are reported in degrees. The terminal 
base pair caps were removed. 
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poly (dA∙dT) sequences are nearly twice as flexible as “random” DNA.[50] Therefore, the 
apparent increased flexibility and dynamic bending of our alternating purine-pyrimidine sequences 
can explain the relatively poor binding of DB2277 with ATATGCATAT and ATATGATAT. 
These findings suggest that for ATATGCATAT, no single base pair parameter contributes 
substantially to minor groove width or depth. Instead, minor groove characteristics are a collective 
contribution of intra and inter-base pair parameters. 
Simulations of the 1:1, monomeric complexes were next performed for DB2277 binding 
with single G·C sequences. Because the DNA sequences are asymmetric about the DB2277 
binding site (i.e. 5’-AAAAGTTTT-3’ vs. 5’-AAAACTTTT-3’) and because of asymmetry in the 
small molecule, DB2277 was oriented in both the 5' to 3' and the 3' to 5' directions, totalling six 
simulations. For all orientations (six total), two-dimensional contour histograms of the simulated 
complexes are shown in Figure 5.14. To our surprise, the minor groove width distributions for the 
1:1 complexes changed markedly and were nearly identical for all the simulated orientations. Upon 
binding DB2277, the preferred sequence, AAAAGTTTT, undergoes very small change in minor 
groove width. In both AATTGAATT and ATATGATAT simulations, the minor groove becomes 
constricted at the central G·C base pair, indicative of an induced fit recognition mechanism. This 
phenomenon is especially prevalent in ATATGATAT, yielding a Δwidth ≈ 3.5 Å. The comparison 
of effects for AAAAGTTTT and ATATGATAT is interesting since the intrinsic minor groove 
structure of AAAAGTTTT did not change much upon binding DB2277, in contrast to 
ATATGATAT. This phenomenon is worth noting since AAAAGTTTT showed the highest 
affinity for DB2277 while ATATGATAT had the lowest affinity within this series. Regardless of 
sequence, in the presence of DB2277, minor groove width conforms to the same pattern at its target 
binding site. Therefore, sequences that the start (free) and end (bound) most similarly have the 
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Figure 5.14 2D contour histograms of minor groove width for 1:1, DB2277-DNA complexes.  
(A) AAAAGTTTT, (B) AATTGAATT and (C) ATATGATAT. The color gradient indicates increasing 
probability (navy to red) of distance in Angstroms (in Å) for each base pair. 
 
most favorable binding as a result of lower deformation energy of the DNA.  This implies that the 
sequence with the highest binding affinity for our test compound already has a shape 
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complementary to the small molecule and further suggests that inherent microstructure of the DNA 
strongly influences binding affinity. 
5.6 Conclusion 
In this study, the molecular basis for sequence-specific binding by a synthetic minor groove 
binder is explained by inherent differences in the local DNA structure for an investigated set of 
sequences. This is the first reported use of competition mass spectrometry to identify unique DNA-
ligand interactions that are explained by highly detailed, long time-scale molecular dynamics 
simulations. Our current understanding suggests that planar, synthetic small molecules, such as 
our test compound, bind best to sequences with a narrow and deep minor groove. Increased 
flexibility in specific sequences contributes to a wide and shallow groove that is unfavorable for 
strong 1:1 binding, while unexpected 2:1 binding of the compound for certain sequences further 
illustrates the sequence-dependent, microstructural variations within DNA. These findings 
emphasize the need for structural complementarity between the shape of a designed small molecule 
binder and the local structure of the DNA minor groove, and is therefore critical for understanding 
small molecule, sequence-specific recognition of DNA. Such site-specific recognition would 
prove useful for selectively targeting and modulating transcription factor activity and can become 
a powerful therapeutic tool for treating genetic-related diseases. 
5.7 Materials and methods 
5.7.1 Compound and dsDNA 
Synthesis of compound DB2277 can be found in Chai et al.[33] Stock solution of 1.5 mM 
DB2277 was prepared by dissolving solid in doubly distilled water and storing at 4 ºC until use. 
DNA sequences were bought from Integrated DNA Technologies (Coralville, IA, USA). 
Sequences were dissolved in the appropriate experimental buffer and spectroscopically determined 
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with extinction coefficients at 260 nm provided by IDT calculated using the nearest-neighbor 
method.[51] All buffers were filtered and degassed using a 0.22 µm hydrophilic cellulose filter 
(Millipore, Darmstadt, Germany). 
5.7.2 Electrospray ionization mass spectrometry 
Every sequence was designed to have a unique molecular weight so that all DNAs could 
be combined into a single sample vial for mass spectrometry experiments. Distinguishability was 
possible by substitution of guanine for inosine (/ideoxyI/) which removes NH2 from the N3 
position of G, addition of a phosphate group (p) at the 3’ terminus, or modification of the hairpin 
loop with pyrimidine bases (i.e. thymidine and/or cytidine). Stock solutions of 1 mM DNA were 
prepared by dissolving DNA in 150 mM NH4OAc (pH 6.8) and dialyzed using a 1000 Da MWCO 
(Spectrum Labs, Rancho Dominguez, CA, USA) in 150 mM NH4OAc buffer with 3x buffer 
exchange. Reference DNA: 5’-CGCGCGCGCTTTTGCGCGCGCG-3’; DNA 1: 5’-
GCGAAAATTTTGCGTTTTCGCAAAATTTTCGC-3’; DNA 2: 5’-
CGAAAAGTTTTC/ideoxyI//ideoxyI/CCCCCCGAAAACTTTTCG-3’; DNA 3: 5’-
CGAAAAGCTTTTC/ideoxyI/CCCCCGAAAAGCTTTTCG-3’; DNA 4: 5’-
CGATATGCATATCGCCCCCGATATGCATATCG-3’; DNA 5: 5’-
CGAATTGGAATTCGCTCCCGAATTCCAATTCG-3’; DNA 6: 5’-
CGAATTGCAATTCGTCTCCGAATTGCAATTCG-3’; DNA 7: 5’-
CGAATTCGAATTCGTCTTCGAATTCGAATTCG-3’; DNA 8: 5’-
CGAAAAGCAATTCGTTTTCGAATTGCAATTCpG-3’; DNA 9: 5’-
CGAAAACTTTTGCGCCCCCGCAAAAGTTTTGpC-3’. 
Samples were prepared by combining 10 µM of each DNA sequence into a single vial. A 
G∙C base pair sequence (i.e. no AT base pairs present) of equimolar concentration was used as a 
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reference sequence for which complex peak intensities were compared. In the same vial, DB2277 
was added so that the total concentration of compound was equivalent to the desired molar 
concentration ratio of the total DNA concentration. For example, a [3 to 1] concentration ratio of 
DB2277 to DNA = [DNA 1] 10 µM + [DNA 2] 10 µM + … + [DNA 9] 10 µM = 90 µM total 
concentration DNA in sample (9 x 10 µM = 90 µM) and, therefore, 270 µM of DB2277 in the 
sample gives [270 to 90] or [3 to 1]. An additional 5% MeOH (v/v) was added to the sample prior 
to injection to help facilitate gas-phase transition and give a total sample volume of 75 µL. 
Samples for ESI-MS were e using a Waters Micromass ESI-Q-ToF spectrometer (Waters 
Corporation, Milford, MA, USA) and analyzed with MassLynx 4.1 software. Samples were 
scanned from m/z 500-3,000 in negative ion mode at a flow rate of 5 µL∙min-1 with the final two 
minutes of the chromatogram (≈ 200 scans) averaged. Spectral peaks were deconvoluted. Capillary 
2000 V, sample cone 20 V, extraction cone 1.8 V, source 70 ºC, desolvation 100 ºC, cone gas flow 
30 L∙hr-1, desolvation gas flow 450 L∙hr-1, ion energy 2.5 V, collision energy 2 V, RF1 lens -125 
V, RF2 lens -103 V, and acceleration lens 88 V. A comparison of deconvoluted peak intensities is 
shown in Figure 5.2. Some variations exist in peak intensity for free DNA since the ionization 
efficiencies and response sensitivities are different among the sequences and so samples of free 
DNA are analyzed as a reference. Upon complex formation, however, response sensitivities even 
out, as indicated by the excellent agreement in stoichiometry and relative binding affinities for 
ESI-MS with other biophysical and bioanalytical methods. 
5.7.3 Molecular dynamics simulations 
The sequence dependent major and minor groove widths and depths were analyzed using 
molecular dynamics trajectories.[52-55] Seven double-stranded sequences used in the 
computational simulations mirrored the hairpin sequences used in the competition mass 
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spectrometry studies: 5’-CGAAAAGTTTTCG-3’, 5’-CGAATTGAATTCG-3’, 5’-
CGATATGATATCG-3’, 5’-CGAAAAGCTTTTCG-3’, 5’-CGAATTGCAATTCG-3’, 5’-
CGATATGCATATCG-3’, including a comparative sequence with two GG bases in the core as 
5’-CGAATTGGAATTCG-3’. Nucleic Acid Builder (NAB) was used to construct canonical B-
form dsDNA models for the above sequences.[56] Optimization and electrostatic potential 
calculations for DB2277 were performed using the DFT/B3LYP [57-60] method with the 6-31+G* 
basis set [61-63] in Gaussian09 (Gaussian, Inc., 2009, Wallingford, CT). Atom charges were 
calculated using the Merz-Singh-Kollman (MK) Scheme.[64, 65] Force field parameter and 
AMBER preparation files were generated using ANTECHAMBER [66] with the GAFF force 
field.[67] The angle and dihedral parameters of DB2277 that were not defined by the GAFF force 
field were modified in the force field modification (frcmod) file to fit ab initio calculations from 
potential energy scans performed in Guassian09. Three of the seven sequences, 5’-
CGAAAAGTTTTCG-3’, 5’-CGAATTGAATTCG-3’, 5’-CGATATGATATCG-3’, were 
simulated with DB2277 bound in the minor groove. Because these sequences are non-palindromic 
about the DB2277 binding site (i.e. 5’-AAAAGTTTT-3’ vs. 5’-AAAACTTTT-3’) and because of 
the asymmetry in DB2277, it was oriented in both 5' to 3' and 3' to 5' directions. The small molecule 
was manually docked at the central G of the Watson strand of the canonical B-form dsDNA 
modelsproduced by NAB using the visualization software, VMD.[68] All systems were solvated 
with TIP3P water [69] in a truncated octahedral water box extending 10.0 Å from the dsDNA in 
each dimension and neutralized with Na+ ions in TLeap (AMBER 2015, University of California, 
San Francisco). Additional Na+ and Cl- ions were added to reach a salt concentration of 150 mM 
for each dsDNA system.
  
 
 
122 
 
Figure 5.15 Cartoon representations of groove widths. 
Cartoon representation of minor groove width (cyan) and depth (dashed line) and major groove 
width (green). Groove depths are defined as the distance between the center of the width vector 
(cyan or green) and the mid-point of the vector constructed using the C6 of pyrimidines and the 
C8 of purines (orange), which defines the corresponding base pair. 
 
All systems were relaxed over 5,000 steps of steepest-descent minimization with positional 
restraints imposed on the nucleic acid residues. Heating 0 K to 310 K was carried out over 10 ps 
in the canonical ensemble with 5 kcal∙ Å-2∙mol-1 harmonic restraints enforced on the heavy atoms 
of the nucleic acid residues.  For the DB2277-DNA complex systems, 5 kcal∙ Å-2∙mol-1 distance 
restraints were applied between hydrogen bond donor and acceptor pairs in the capping base pairs, 
and between the nitrogen of the DB2277 aza-benzimidiazole ring and the guanine NH2 group. The 
harmonic restraints were released over eight stages of equilibration in the isothermal-isobaric 
ensemble (T = 310 K, P = 1 atm) with a 2 fs time step for a total of 500 ps using the Berendsen 
algorithm [70] to control temperature and Monte Carlo barostat as implemented in AMBER14. 
SHAKE was imposed on bonds involving hydrogen atoms [71] and electrostatic interactions were 
treated using the smooth Particle Mesh Ewald method [72] with a 10.0 Å cutoff. Distance restraints 
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were monotonically released to 1 kcal∙Å-2∙mol-1 for the capping base pairs and 0 kcal∙Å2∙mol-1 for 
the aza-N∙G-NH2 hydrogen bond over 50 ns after positional restraints were fully released. The 1 
kcal∙ Å-2∙mol-1 distance restraints on the capping base pairs were maintained during the production 
simulations to prevent fraying which could skew the dynamics of the DB2277-DNA complex. 
Production level simulations were extended to 200 ns and trajectory snapshots were saved every 
1 ps. All simulations were performed using the PMEMD CUDA [73] module of AMBER14 with 
the parm99 force field and the parmbsc0 + ε/ζOL1+χOL4 force field modifications for DNA [74-
76]. 
 Trajectories were preprocessed using CPPTRAJ module of AMBERTOOLS 15 to produce 
50,000 snapshots for analysis and visualization in VMD. Major and minor groove width and depth, 
and propeller twist for each base pair were calculated as well as base pair step translational and 
rotational helical parameters using Curves+ and Canal programs for the unbound complexes.[77] 
Minor groove width of the bound complexes was also calculated using the Curves+ and Canal 
programs. Contoured histograms were produced by increasing the number of points per base pair 
that define the backbone spline from 10 to 50 and collecting the resultant minor groove widths 
from the two-dimensional distance matrix produced by Curves+ (Figure S2). A smooth line was 
interpolated along the entire groove for each frame analyzed. Width and depth data generated from 
Curves+ was then binned into 100 evenly spaced bins and represented as histograms using 
MATLAB (The MathWorks, 2016, Natick, MA, USA). To establish the convergence of our 
simulations, repeats of the 200 ns simulations for two sequences with randomized initial velocities. 
For both Simulation 1 and Simulation 2, the minor groove width was analyzed in 100 ns sections. 
It can be seen clearly that for both sequences, the minor groove width is nearly identical in all 
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cases (Figures 5.8, 5.9).  Additionally, PDB coordinates of DB2277 bound to AAAAGTTTT can 
be found as Supplementary Data. 
5.7.4 Biosensor surface plasmon resonance 
SPR experiments were performed using a four-channel Biacore T200 (GE Healthcare, Inc., 
Piscataway, NJ, USA) and the Biacore T200 Evaluation Software. A streptavidin-coated sensor 
chip was prepared by series injections of 1 M NaCl in 50 mM NaOH at 60 s intervals. Washing of 
the chip surface followed using HBS buffer (10 mM HEPES, 150 mM NaCl, 3 mM EDTA, 0.05% 
P20, pH 7.4). Following chip washing, biotin-5’-end labelled hairpin DNA sequences (5’-
/5Biosg/CCAAAAGCTTTTGCTCTCAAAAGCTTTTGG-3’, 5’-
/5Biosg/GGAATTGCAATTCGTCTCCGAATTGCAATTCC-3’, 5’-
/5Biosg/GGATATGCATATCGCTCTCGATATGCATATCC-3’) were dissolved to 25 nM 
concentrations in HBS buffer and immobilized to the flow cell surface via non-covalent capture 
using previously described methods.[78, 79] The first flow cell (FC1) was intentionally left blank 
as a reference cell while FC2, FC3 and FC4 were immobilized with 50 nM stock solutions of 
AAAAGCTTTT, AATTGCAATT and ATATGCATAT sequences, respectively. Immobilization 
was achieved by manual injection of the DNAs at a flow rate of 1 µL∙min-1 until response units 
(RU) of 310-330 were reached. Compound solution concentrations of DB2277 were prepared in 
50 mM Tris-HCl buffer (pH 7.4) ranging 10 nM – 1 µM and were injected over the sensor chip at 
a flow rate of 100 µL∙min-1 until steady-state responses were reached. Buffer was then flowed over 
the chip surface to dissociate bound DB2277 from DNA. Following each cycle, the surface of the 
sensor chip was regenerated with 10 mM glycine (pH 2.5) for 30 s and rinsed with three injections 
of experimental buffer to produce a stable baseline for the following cycles. The observed response 
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(RUobs) was plotted as a function of free compound concentration (Cf) and dissociation binding 
constants (KD) determined using the following equations:  
 
(5.1𝑎) 𝑅𝑈𝑜𝑏𝑠 =  
𝑀𝑊 𝑜𝑓 𝑙𝑖𝑔𝑎𝑛𝑑
𝑀𝑊 𝑜𝑓 𝐷𝑁𝐴
=  
𝑅𝑈 𝑜𝑓 𝑙𝑖𝑔𝑎𝑛𝑑
𝑅𝑈 𝑜𝑓 𝐷𝑁𝐴
  
(5.1𝑏) 𝑅𝑈𝑜𝑏𝑠 =  
[(𝐾1∙𝐶𝑓)+(2𝐾1∙𝐾2∙𝐶𝑓
2)] ×𝑅𝑈𝑚𝑎𝑥
1+(𝐾1∙𝐶𝑓)+(𝐾1∙𝐾2∙𝐶𝑓
2)
  
(5.1𝑐) 𝑅𝑈𝑜𝑏𝑠 =  
[(𝐾1∙𝐶𝑓)+(2𝐾1∙𝐾2∙𝐶𝑓
2)+(3𝐾1∙𝐾2∙𝐾3𝐶𝑓
3)] ×𝑅𝑈𝑚𝑎𝑥
1+(𝐾1∙𝐶𝑓)+(𝐾1∙𝐾2∙𝐶𝑓
2)+(3𝐾1∙𝐾2∙𝐾3𝐶𝑓
3)
  
 
Binding plots were fit using a binding model of “n+1”, where n equals the number of binding sites 
determined for a sequence from ESI-MS. An “n+1” model was used to confirm the binding 
constants were not averaged (i.e. K12) thus providing an additional, low affinity binding constant 
well above the measured concentration range (i.e. KD > 10
-6 M). Data were fit using Equations 
5.1b and 5.1c in KalediaGraph (Synergy Software, Reading, PA, USA). RUmax represents the 
maximum measured response for bound DB2277 to DNA from the equation and K1, K2 and K3 are 
macroscopic association constants in units M-1. Equilibrium binding constants were converted to 
dissociation constants (KD) and reported in units of concentration, M. The microscopic association 
and dissociation rates, ka and kd, (i.e. on and off-rates) were calculated at low concentrations of 
DB2277 using Biacore T200 Evaluation Software and kinetics fit binding constants were 
compared to values obtained by steady-state models. 
5.7.5 Competition biosensor-surface plasmon resonance 
The same streptavidin-coated sensor chip previously described was also used for 
competition SPR analyses. Samples containing unlabeled hairpin DNA sequences (5’-
CGAAAAGTTTTCGGCTCTCCGAAAACTTTTCG-3’, 5’-
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CGAATTGAATTCGGCTCTCCGAATTCAATTCG-3’, and 5’-
CGATATGATATCGGCTCTCCGATATCATATCG-3’) were added to a constant concentration 
of DB2277 and flowed over the chip surface. The added DNA sequences in solution compete for 
binding to DB2277, which results in the decrease of RUobs. Solutions were prepared in 50 mM 
Tris-HCl buffer with constant 100 nM DB2277 compound. Competing DNA concentrations 
ranging 0 nM – 2.5 µM were injected over the sensor chip at a flow rate of 100 µL∙min-1 until 
steady-state responses were reached. Experimental buffer (i.e. no DB2277) was flowed over the 
chip surface to dissociate bound DB2277 from DNA and competing DNA. The sensor chip surface 
was regenerated with 0.5 M NaCl for 30 s and rinsed with three injections of experimental buffer 
to produce a stable baseline for the next cycle. For chip regeneration, no detectable differences 
were observed in the baseline stabilization among 10 mM glycine, 1 M NaCl, and 0.5 M NaCl 
solutions. A lower salt concentration of 0.5 M NaCl was used for competition SPR analyses to 
ensure a constant RU of immobilized 5’-end labeled biotinylated DNA was maintained, meaning 
none of the immobilized DNA dissociated during regeneration. 
To determine the solution dissociation constant (KS) of the competing DNA, a one-site 
binding model was used to determine KS of the competing DNA with DB2277 in solution by the 
following equation:  
(5.2) 𝑅𝑈𝑜𝑏𝑠 =
{([𝐿]𝑇)−0.5(𝐾𝑆+[𝐿]𝑇+[𝐷]𝑇)−√(𝐾𝑆+[𝐿]𝑇+[𝐷]𝑇
2
)−4([𝐿]𝑇∙[𝐷]𝑇)}×𝑅𝑈𝑚𝑎𝑥
{([𝐿]𝑇)−0.5(𝐾𝑆+[𝐿]𝑇+[𝐷]𝑇)−√(𝐾𝑆+[𝐿]𝑇+[𝐷]𝑇
2
)−4([𝐿]𝑇∙[𝐷]𝑇)}+𝐾𝐷
  
 
The RUobs was plotted against total competing DNA concentration to determine dissociation 
constants of the competitor DNA (KS) in solution. Equation 5.2 was derived specifically for 
competition SPR analyses since the concentration of DNA-ligand complex in solution cannot be 
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determined. It substitutes a conventional one-site binding model with a quadratic formula [40] 
which includes total concentrations of DB2277 ligand and competing DNA in solution as [L]T and 
[D]T, respectively. The KD in Equation 5.2 is an averaged equilibrium dissociation constant of K1 
and K2 values (i.e. K12) for DB2277 binding with AAAAGCTTTT, AATTGCAATT or 
ATATGCATAT previously determined by Equations 5.1b or 5.1c. Here, [L]T, [D]T , RUmax and 
KD are used as fitting parameters to determine KS using KalediaGraph. Dissociation constants for 
AATTGAATT using competition SPR are compared to values obtained direct-binding SPR and 
are reported in Table 5.1. 
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6 CONCLUSIONS 
In this dissertation, recognition of the DNA minor groove by small molecules was 
investigated. The use of electrospray ionization mass spectrometry was the primary tool used to 
identify ligand-DNA interactions. In addition to the findings by electrospray ionization mass 
spectrometry (ESI-MS), other biophysical methods were used to validate our findings. 
We first introduced the development of a novel technique using ESI-MS to observe 
competitive binding of well-characterized compounds with various DNA sequences. We 
highlighted the many advantages competition ESI-MS has to offer such as the rapid and convenient 
sample analysis, as well as the small amounts of sample required. More importantly, competition 
ESI-MS allowed easy identification of stoichiometry, cooperativity, and a direct comparison of 
relative binding affinities. In theory, any number of sequences and ligands can be simultaneously 
analyzed as long as the moleculer weights of each species and their potential complexes are 
discernable. With one sample, lots of information can be gathered all the while reducing reagents 
used and time spent cleaning between sample runs. More importantly, it is not limited to DNA and 
can be applied to other biomacromoleculear interactions. 
Our competition ESI-MS method was next applied to investigations of mixed DNA 
sequences with small molecules. Many important features were discovered using systematic 
variations of a test compound and its target binding site. Specificity and cooperativity of the test 
compound against several analogues determined the parent compound was optimum for binding 
with the target sequence. One such analogues showed unexpected binding with both target and 
mixed-site reference sequences. Several mutant sequences displayed unusual binding patterns 
strictly based on sequence such that a simple reversal of two bases would result in complete loss 
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of binding of the parent compound. Overall, the consensus binding site remained the preferred 
sequence and further illustrated the importance of base pair sequence in minor groove recognition. 
In the next project, several diamidines were test for selectivity among a set mixed-site 
sequences. Recognition groups within the compounds, such as hydrogen bond acceptors and 
donors, and flexibility of the compound were strategically modified to determine the effects on 
minor groove binding. Competition ESI-MS, in combination with other biophysical methods, 
confirmed the strong and selective recognition of a diamidine for a single G-containing sequence. 
The information gathered provided additional information for the rational design of more specific 
compounds to target longer mixed-site sequences. 
 Finally, ESI-MS was used to identify additional binding interactions of a well-
characterized compound with new mixed-site sequences. Competition ESI-MS initially provided 
information such as stoichiometry and cooperativity. More detailed studies using SPR showed 
direct correlation for binding with results obtained by ESI-MS. MD simulations unveiled a distinct 
pattern in the DNA microstructure for several sequences which later explained the intrinsic binding 
behavior of our test compound. Complementary evidence from both experimental and computional 
methods provided a rationale for the sequence-dependent behavior of the compound binding in the 
minor groove. 
The common denominator in each of these projects is the application of competition ESI-
MS to identify interactions of minor groove binding compounds with DNA. This method is 
versatile in its ability to provide quick and accurate information regarding stoichiometry, 
cooperativity, and relative binding affinity. ESI-MS, in conjunction with other analytical and 
biophysical techniques, is capable of identifying patterns in minor groove recognition which are 
based on structural features found (1) in the compound and (2) within the minor groove itself. This 
  
 
 
136 
wealth of information is useful in developing a new paradigm for sequence specific recognition of 
the DNA minor groove by synthetic small molecules which will ultimately lead to desired 
regulation of genetic expression. 
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APPENDIX A. MODULATION OF TOPOISOMERASE IIα EXPRESSION AND 
CHEMOSENSITIVITY THROUGH TARGETED INHIBITION OF NF-γ: DNA BY A 
DIAMINO p-ANISYL-BENZIMIDAZOLE (Hx) POLYAMIDE 
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A.1 Abstract 
A.1.1 Background 
Sequence specific polyamide HxIP 1, targeted to the inverted CCAAT Box 2 (ICB2) on 
the topoisomerase IIα (topo IIα) promoter can inhibit NF-Y binding, re-induce gene expression 
and increase sensitivity to etoposide. To enhance biological activity, diamino-containing 
derivatives (HxI*P 2 and HxIP* 3) were synthesised incorporating an alkyl amino group at the 
N1-heterocyclic position of the imidazole/pyrrole. 
A.1.2 Methods 
DNase I footprinting was used to evaluate DNA binding of the diamino Hx-polyamides, 
and their ability to disrupt the NF-Y:ICB2 interaction assessed using EMSAs. Topo IIα mRNA 
(RT-PCR) and protein (Immunoblotting) levels were measured following 18 h polyamide 
treatment of confluent A549 cells. γH2AX was used as a marker for etoposide-induced DNA 
damage after pre-treatment with HxIP* 3 and cell viability was measured using Cell-Titer Glo®. 
A.1.3  Results 
Introduction of the N1-alkyl amino group reduced selectivity for the target sequence 5′-
TACGAT-3′ on the topo IIα promoter, but increased DNA binding affinity. Confocal microscopy 
revealed both fluorescent diamino polyamides localised in the nucleus, yet HxI*P 2 was unable to 
disrupt the NF-Y:ICB2 interaction and showed no effect against the downregulation of topo IIα. 
In contrast, inhibition of NF-Y binding by HxIP* 3stimulated dose-dependent (0.1–2 μM) re-
induction of topo IIα and potentiated cytotoxicity of topo II poisons by enhancing DNA damage. 
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A.1.4  Conclusions 
Polyamide functionalisation at the N1-position offers a design strategy to improve drug-
like properties. Dicationic HxIP* 3 increased topo IIα expression and chemosensitivity to topo II-
targeting agents. 
A.1.5  General significance 
Pharmacological modulation of topo IIα expression has the potential to enhance cellular 
sensitivity to clinically-used anticancer therapeutics. This article is part of a Special Issue entitled: 
Nuclear Factor Y in Development and Disease, edited by Prof. Roberto Mantovani. 
A.2  Key words 
DNA-binding polyamides; Sequence selectivity; Transcription factor-DNA interactions; 
Gene modulation; NF-Y; Topoisomerase II (Topo II); Chemosensitisation 
A.3 Introduction 
Gene expression is precisely regulated by the binding of the transcription machinery to 
specific DNA sequences. Dysregulation of transcriptional activity leading to aberrant gene 
expression is a fundamental driver of a diverse array of human diseases. Sequence selective (P) 
pyrrole-(I) imidazole polyamides are able to modulate gene expression through binding non-
covalently to specific DNA sequences and disrupting the DNA interactions of transcription factors. 
These reversible DNA minor groove binders can arrange in a stacked, antiparallel 2:1 
(ligand:DNA) orientation and afford programmable sequence recognition, governed by the side-
by-side heterocyclic ring pairing rules.[1-4] A P/P pairing degenerately targets A·T or T·A, 
whereas P/I recognises C·G and I/P preferentially binds to G·C. The reported anti-cancer 
biological activity of these cell permeable small molecules in both cellular and in vivo studies has 
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highlighted the potential of therapeutic strategies that directly target transcription factor-DNA 
interfaces known to be implicated in certain malignant phenotypes.[5-8]  
Nuclear Factor Y (NF-Y) is a heterotrimeric CCAAT-binding transcription factor involved 
in cell differentiation, proliferation and implicated in cancer progression.[9-13] NF-Y has been 
shown to bind to the promoter of the essential DNA processing enzyme, topoisomerase IIα (topo 
IIα) and regulates its transcription through interactions with the inverted CCAAT box (ICB) 
sequences located within the promoter.[14-16] Topo IIα plays a critical role in DNA metabolism, 
maintaining genomic stability [17], and is the target of clinically-used chemotherapeutic agents 
etoposide and doxorubicin [18], with low levels of topo IIα conferring cellular resistance to these  
 
  
 
Figure A.1. Schematic representation of topoIIα. 
Schematic representation of the confluence-induced downregulation of topo IIα, mediated by the 
repressive binding of NF-Y to the ICB2. The ICB sequence ATTGG is highlighted in blue and the 
5′-flanking sequence of the ICB2 is outlined with a dashed box. 
 
anticancer agents.[19-22] NF-Y acts as both an activator and repressor of topo IIα transcription 
with increased association of NF-Y to the promoter exerting a negative effect at confluence.[15, 
16] The ICB2 has been identified as the crucial DNA regulatory element and its interaction with 
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NF-Y (Figure A.1) mediates the confluence-induced downregulation of topo IIα and reduced 
chemosensitivity to topo II targeting therapeutics. 
Chemical approaches that re-induce topo IIα expression have the potential to increase 
cellular sensitivity to topo II poisons and to this end, our group has used various DNA binding 
small molecules and polyamides to inhibit the repressive activity of NF-Y on the topo 
IIα promoter.[16, 23-27] Most recently, we reported the synthesis and biological activity of a novel 
polyamide incorporating the p-anisylbenzimidazole (Hx) DNA recognition element.[28, 29] 
Designed to enhance polyamide-DNA binding and cellular uptake, the Hx moiety exhibits intrinsic 
fluorescence upon binding DNA enabling the direct visualisation of polyamide nuclear 
localisation. Hx-polyamide HxIP (1) (Figure A.2A) designed to target the 5′-flanking sequence 
5′-TACGAT-3′ of the ICB2 (Figure A.1), binds to DNA with high affinity and sequence 
selectivity, and disrupts the NF-Y:ICB2 interaction resulting in the upregulation of topo IIα 
expression at confluence. HxIP pre-treatment enhanced etoposide-induced DNA damage, 
providing further evidence that sequence specific polyamides can re-sensitise confluence-arrested 
cancer cells to topo IIα poisons.[28]
 The development of HxIP provides a new framework for the design of fluorescent 
sequence selective DNA binding molecules, distinct in configuration from the prototypical hairpin 
polyamide, yet capable of efficient nuclear localisation and in vitro gene regulation. In parallel, 
we have continued to explore an alternative strategy for further optimisation of polyamide 
physicochemical and DNA binding properties, through the introduction of an additional alkyl 
amino group at the N1 position of the heterocyclic rings.[30-33] DNA binding studies by our 
groups revealed the small diamino polyamide containing an orthogonal positioned propyl amino 
group, f-IP*I (*denotes modified heterocycle) to have greater binding affinity than its monoamino 
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Figure A.2. Design of the diamino Hx-polyamides 2 and 3. 
(A) Structures of the monoamino Hx-polyamide, HxIP 1 and the orthogonally positioned diamino-
containing derivatives, HxI*P 2 and HxIP* 3. The asterisk (*) denotes position of the N-alkyl 
amino group. (B) Schematic models of polyamides 2 and 3 binding to the 5′-TACGAT-3′ sequence 
on the 5′-flank of the ICB2 in an antiparallel 2:1 fashion as an overlapped stacked dimer.. 
 
counterpart and analogous sequence selectivity. Importantly, the inclusion of an extra amino 
group, which is cationic at physiological pH, also increases water solubility and may afford greater 
polyamide nuclear uptake. We aim to exploit this potential combination of improved DNA binding 
and solubility properties to engineer a potentially more potent generation of dicationic polyamides. 
This study presents the DNA binding and biological activities of the diamino Hx-
polyamides HxI*P 2 and HxIP* 3, which incorporate the N1-alkyl amino group modification 
  
 
 
143 
(Figure A.2A). Polyamides 2 and 3 are functionalised derivatives of HxIP 1 and like their 
monoamino predecessor are designed to target the ICB2 5′-flanking sequence 5′-TACGAT-3′ on 
the topo IIα promoter (Figure A.2B) and disrupt NF-Y binding, inducing topo IIα expression at 
confluence. Comparison with the monoamino HxIP 1 will reveal the effect the inclusion of an N1-
alkyl amino group in the Hx-framework has on DNA binding and the feasibility of using 
functionalisation of the N1 position to enhance polyamide cellular uptake and biological activity. 
Additionally, we shall assess the potential chemosensitising effects of the diamino generation of 
polyamide inhibitors of NF-Y:DNA binding and the effectiveness of pharmacological modulation 
of topo IIα expression as a strategy for overcoming the drug resistance exhibited by confluence-
arrested cells. 
A.4 Methods and materials 
A.4.1  Synthesis of polyamides 
Details of the synthesis and characterisation of diamino Hx-polyamides 2 and 3 are 
provided in the Supplemental Materials and Methods (Scheme S1). 
A.4.2  Thermal denaturation studies 
Thermal denaturation (ΔTM) studies were performed using a Cary Bio 100 
spectrophotometer UV–Vis instrument (Palo Alto, CA) as previously described by Chavda et 
al.[29] DNA oligomers were purchased from Operon and the sequences are provided in the 
Supplemental materials. Experiments for diamino Hx-polyamides 2 and 3 were performed at a 
concentration of 3 μM ligand and 1 μM DNA. All melts were performed in 10-mm path length 
quartz cells. TM values were determined as the maximum of the first derivative, and ΔTM values 
are the difference between the melting temperatures of ligand bound DNA and free DNA. 
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A.4.3 Circular dichroism 
Circular dichroism (CD) studies were carried out as previously reported,[30] using an OLIS 
(Bogart, GA, USA) DSM20 spectropolarimeter. Experiments were conducted at ambient 
temperature in a 1-mm path length quartz cell using phosphate A PO40 buffer (10 mM sodium 
phosphate, 1 mM EDTA, pH 6.2). Buffer and stock DNA were added to the cuvette to give a final 
DNA concentration of 9 μM. Each diamino Hx-polyamide (in 500 μL in ddH2O) was titrated in 
increments of 1 M equivalent into the relevant DNA (160 μL of 9 μM DNA). Each run was 
performed over 400–220 nm. The CD response at the λmax of the induced peak was plotted against 
the mole ratio of ligand to DNA. 
A.4.4  Surface plasmon resonance 
Surface plasmon resonance (SPR) measurements were performed with a four-channel 
BIAcore T100 optical biosensor system (Biacore, GE Healthcare Inc.). A streptavidin-coated 
sensor chip was prepared by a series injections of 1 M NaCl in 50 mM NaOH for periods of 60 s 
followed by washing of the chip surface with HBS buffer (10 mM HEPES, 150 mM NaCl, 3 mM 
EDTA, 0.05% P20, pH 7.4). Biotin-5′-end labelled DNA hairpin oligomers dissolved to 25 nM 
concentrations in HBS buffer were immobilized to the flow cell surface via non-covalent capture 
using previously described methods.[34, 35] The sequences of the three hairpin oligomers are 
detailed in the Supplemental Materials. Three flow cells were used to immobilise the DNA, while 
a fourth was left blank as a control. Immobilization was achieved by manual injection of the DNAs 
at a flow rate of 1 μL/min until response units (RU) of 350–400 were reached. Diamino 
polyamide 3 was dissolved in 500 μL MeOH and 0.9 mol eq. of HCl was added to form a salt. 
Methanol was removed using N2 at 25 °C leaving a yellow salt. The compound was then re-
dissolved in ddH2O to a concentration near 1 mM and spectroscopically determined by UV–Vis 
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using the extinction coefficient (ε322 nm = 29,129 L/(mol·cm) and stored at 4 °C until use (within 
2 weeks). Compound solution concentrations of 3 were prepared in 10 mM cacodylic acid (CCL), 
1 mM EDTA, and 200 mM NaCl buffer (pH 6.5) ranging 2 nM to 1 μM and were injected over 
the sensor chip at a flow rate of 100 μL/min for 180 s. Buffer was then flowed over the chip surface 
for 600 s to dissociate bound HxIP* 3 from DNA. Following each cycle, the surface of the sensor 
chip was regenerated with 1 M NaCl for 30 s and rinsed with three injections of experimental 
buffer to produce a stable baseline for the following cycles. The relative response units (RUs) were 
plotted as a function of free compound concentration (Cf) and equilibrium binding constants (Keq) 
were determined using a two-site cooperative binding model with Equation 1. 
 
𝑟 =  
𝑅𝑈
𝑅𝑈𝑚𝑎𝑥
=  
[(𝐾1∙𝐶𝑓)+(2𝐾1∙𝐾2∙𝐶𝑓
2)] ×𝑅𝑈𝑚𝑎𝑥
1+(𝐾1∙𝐶𝑓)+(𝐾1∙𝐾2∙𝐶𝑓
2)
   (1) 
   
Here, K1 and K2 are macroscopic binding constants in units per concentration (M
− 1). The 
maximum obtainable response (RUmax) in Equation 1 was calculated from the product of 
immobilized DNA response units, HxIP* molecular weight, refractive index of HxIP*, and the 
inverse DNA molecular weight. The obtained maximum value was compared to predict RUmax of 
bound HxIP* to determine the stoichiometry. Equilibrium binding constants (Keq) were determined 
using both global kinetics fits and/or steady-state binding models. Two equilibrium binding 
constants, K1 and K2, were determined, multiplied by each other, and the square root of the 
resulting calculated value gave an averaged equilibrium binding constant (Keq) to compare with 
previous results.[29]  
 
𝐾𝑒𝑞 =  √𝐾𝐷1 ∙ 𝐾𝐷2       (2) 
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A.4.5  DNase I footprinting 
The 5′ radiolabelled DNA substrate corresponding to the topo IIα promoter was prepared 
by PCR amplification and then isolated and purified as previously reported.[16] The DNase I 
footprinting reactions were performed as described by Kiakos et al. [28] and resolved on a 10% 
denaturing polyacrylamide-urea gel (National Diagnostics) by electrophoresis for 3 h at 1650 V 
(55 °C) in 1 × TBE buffer. The gel was then transferred onto Whatman 3MM paper, dried and 
exposed overnight to Fuji medical X-ray film to visualise the radioactive signal. 
A.4.6  Cell lines and culture conditions  
NIH3T3 mouse fibroblast cells were obtained from CR-UK London Research Institute, 
and the A549 cell line was purchased from the European Collection of Cell Cultures. All cell lines 
were maintained in DMEM (Sigma-Aldrich) supplemented with 2 mM l-glutamine (Sigma-
Aldrich) and 10% foetal bovine serum (Gibco, Life Technologies). 
A.4.7  Electrophoretic mobility shift assays 
Electrophoretic mobility shift assay (EMSA) experiments were conducted as outlined by 
Kiakos et al. [28] using nuclear protein extracts from NIH3T3 fibroblast cells and the ICB2-
containing oligonucleotide; 5′-GGCAAGCTACGATTGGTTCTTCTGGACG-3′ (sense); 5′-
CGTCCAGAAGAACCAATCGTAGCTTGCC-3′ (antisense). Oligonucleotides containing a 
mutated ICB2 were used as specific competitors, with the wild-type ICB motif replaced by 
AAACC and GGTTT in sense and antisense oligonucleotides, respectively. For supershift 
experiments the nuclear extract and radiolabelled oligonucleotide were incubated with anti-NF-
YA antibody (Abcam) for 1 h. 
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A.4.8  Immunofluorescence staining and confocal microscopy 
To assess polyamide nuclear uptake, A549 and NIH3T3 cells grown on 13-mm glass cover 
slips were treated with different concentrations of polyamides 2 and 3 for various incubation 
times. Cells were fixed (2% PFA), washed with PBS and then permeabilised to allow nuclear DNA 
staining with PI (2 μg/mL). Alternatively, MitoTracker® Red was used to stain the mitochondria, 
without fixation or permabilisation. The blue fluorescence of the Hx-polyamides was excited with 
a UV-laser (364 nm) and detected using the DAPI filter. PI/MitoTracker® Red was excited with 
an argon-ion laser (488 nm) and detected at 642 nm. The fluorescence of the polyamide was 
detected and imaged by z-stack acquisition using the Zeiss 510 UV–VIS microscope and the 
LSM510 software. Immunofluorescence was used to assay for H2AX foci induction after 
polyamide-etoposide combination treatment. A549 cells were washed with PBS, fixed with 2% 
PFA and permeabilised with PBS containing 0.5% Triton X-100. Cells were subsequently blocked 
in PBS 5% BSA for 1 h and incubated with anti-phospho-histone H2A. X mouse monoclonal 
antibody (1:100; Millipore) diluted in PBS 1% BSA for 1 h. After three washes, cells were 
incubated with the goat anti-mouse secondary antibody Alexa Fluor 488 (1:100; Life 
Technologies) for another hour. Following further three washes in PBS 0.1% Triton X-100, nuclei 
were stained using a PI solution (2 μg/mL; Sigma-Aldrich). γH2AX levels were then visualised 
using confocal microscopy and the number of foci per nuclei was quantified using the CellProfiler 
software.[36, 37] 
A.4.9  Quantitative real time PCR 
RNA was isolated using the RNeasy Plus Mini Kit (Qiagen) and cDNA was generated with 
the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems). Real time PCR was 
carried out using the ABI PRISM 7000 Sequence Detection System (Applied Biosystems) and 
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Taqman assay probes (Life Technologies) for the target gene, topo IIα(Hs01032137_m1) and the 
internal control, GAPDH (Hs03929097_g1). The relative quantification of topo IIα mRNA levels 
from untreated and polyamide treated confluent A549 cells was determined using the 2^(− ΔΔCt) 
method and normalised to the internal control.. 
A.4.10  Immunoblotting 
Nuclear extracts from A549 cell lines were prepared using a Nuclear Extraction Kit (Active 
Motif) following the manufacturer's protocol. Protein concentration was quantified using the Bio-
Rad DC protein assay. Nuclear proteins were separated on a NuPAGE 7% Tris-acetate gel (Life 
Technologies), transferred to PVDF membranes and blocked (5% w/v non-fat dry milk in 1 × TBS, 
0.1% Tween-20) for 1 h at ambient temperature. Topo IIα was identified by overnight incubation 
with topo IIα rabbit polyclonal antibody (1:5000, kindly provided by Dr. I.D. Hickson, Weatherall 
Institute of Molecular Medicine, Oxford, UK) and subsequent incubation for 1 h with anti-rabbit 
secondary antibody. Chemiluminescent visualisation was performed using ECL reagent 
(Amersham) and exposure onto autoradiography film (Kodak-X-Omat). Protein levels of γH2AX 
were also assessed after polyamide-etoposide combination treatment. For the detection of 
phosphorylated histone H2AX (Ser139), proteins were separated using a NuPAGE 4–12% Bis-tris 
gel and probed using the anti-phospho-histone H2AX monoclonal antibody (1:500, Millipore). 
Lamin (Cell Signalling) was used as a loading control for the nuclear protein extracts. 
A.4.11  Cell viability 
The CellTiter-Glo luminescent assay (Promega) was used as per manufacturer's 
instructions to assess viability of A549 cancer cells after combination treatment with 
polyamide 3 and etoposide (400 μM) or doxorubicin (75 μM). 
 
  
 
 
149 
A.4.12  Statistical analysis 
For statistical analysis of significance, data were analysed using either the unpaired, two-
tailed Student's t-test or one-way analysis of variance (ANOVA) as appropriate. Results were 
considered statistically significant at a p value < 0.05 and were calculated using GraphPad Prism 
6. 
A.5 Results 
A.5.1  DNA binding affinity and sequence selectivity of diamino Hx-polyamides 2 & 3 
The DNA binding properties of the diamino Hx-polyamides 2 and 3 were investigated to 
assess the effect of introducing an alkyl amino group at the heterocyclic N1 position. Thermal 
denaturation analysis probed the binding affinity and selectivity of polyamides 2 and 3 by 
 
Table A.1 Thermal denaturation values and SPR equilibrium binding constants for polyamides 
HxIP 1, HxI*P 2 and HxIP* 3. 
 
ATCGAT ACGCGT ATGCAT AAATTT 
ΔTM (ºC); [Keq M −1] 
HxIP (1)a 15; [3 × 106] 0; [< 105] - 5; [4 × 106] 
HxI*P (2) 30 13 - 15 
HxIP* (3) 32; [3 × 106] 13; [< 105] [2 × 106] 18 
a Values presented for HxIP (1) were previously reported.[29] 
 
measuring their ability to stabilise duplex DNA. The Hx recognition element behaves similarly to 
two consecutive pyrrole units and as a result, polyamides 1, 2 and 3 can degenerately bind 
sequences 5′-ATCGAT-3′ and 5′-TACGAT-3′, with the latter found on the 5′-flank of the ICB2. 
The ΔTM data presented in Table A.1 indicate that polyamides 2 (ΔTM = 30 °C) 
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and 3 (ΔTM = 32 °C) bind to the target sequence (5′-ATCGAT-3′) with greater affinity than their 
monoamino counterpart 1 (ΔTM = 15 °C), displaying a 2-fold increase in ΔTM relative to 
HxIP 1.[29] These results show that the additional positively charged alkyl amino group 
contributes favourably to DNA stabilisation. However, polyamides 2 and 3 also showed increased 
ΔTM values for the non-cognate sequences 5′-ACGCGT-3′ and 5′-AAATTT-3′, suggesting an 
overall decrease in sequence selectivity relative to 1, which has previously been shown to have 
little effect on the stabilisation of non-cognate sequences.[29] The increased stabilisation of the 
oligonucleotides by dicationic Hx-polyamides 2 and 3 demonstrated by thermal denaturation is 
consistent with previously published of comparable N1-derivaitized dicationic polyamides.[32, 
33] 
Circular dichroism (CD) studies confirmed that both diamino Hx-polyamides 2 and 3 bind 
effectively to the 5′-ATCGAT-3′ target sequence in the minor groove (Figure A.3A), as shown by 
the emergence of a strong DNA-induced ligand band at ≈ 330 nm. The observation of a clear 
isodichroic point at 305 nm suggests that 2 and 3 bind through a single mechanism, in a presumed 
side-by-side, antiparallel, stacked orientation. However, HxIP* 3 induced a strong CD band and 
clear isodichroic point when titrated to the non-cognate sequences, demonstrating that DNA 
sequence selectivity is reduced by the presence of the second alkyl amino group and corroborating 
the findings from the DNA denaturation experiments. HxI*P 2 also bound to the non-cognate 
sequences, but overlaid CD spectra showed that the CD bands were weaker and the isodichroic 
points less distinct than those observed for 3, confirming the overall lower binding affinity of 
polyamide 2 and highlighting that the position of the N1 modification affects DNA binding 
affinity. 
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To further investigate the effect of the N1-alkyl amino group, the binding constants (Keq) 
of the diamino Hx-polyamide 3 were determined using the surface plasmon resonance (SPR) 
biosensor assay. The sensorgrams and steady-state plots shown in Figures A.3B & A.3C, revealed 
that HxIP* 3 binds to the consensus 5′-ATCGAT-3′ site with high affinity (Keq ≈ 3 × 106 M− 1 or 
a KD of approximately 0.3 μM). Interestingly, diamino Hx-polyamide 3 also binds to the non-
cognate sequence 5′-ATGCAT-3′ (Keq ≈ 2 × 106 M− 1) almost as strongly as to the consensus 
sequence, but showed little affinity for 5′-ACGCGT-3′ (Keq < 105 M− 1). The favourable binding 
of Hx-polyamide 3 to the non-cognate sequence 5′-ATGCAT-3′ could be due to strong 
electrostatic interactions between the protonated alkyl amino groups and the negatively charged 
phosphodiester backbone of DNA, which could compromise the weaker forces, such as hydrogen 
bonding and hydrophobic interactions that govern sequence selectivity. Alternatively, we cannot 
rule out the possibility that a stacked, anti-parallel dimer of Hx-polyamide 3 could interact with 
5′-ATCGAT-3′ in a reversed alignment of 3′–to-5′, rather than the typical 5′-to-3′ manner. 
A.5.2  Binding of diamino HxI*P and HxIP* on the topoIIα promoter  
DNase I footprinting studies on the biologically relevant topo IIα promoter (Figure A.4) 
reveal that HxI*P 2 binds to the 5′-TACGAT-3′ target sequence of the 5′-flank of the ICB2 with 
weaker affinity (3 μM) than the monoamino HxIP 1 (1 μM, [28]) despite showing greater affinity 
in the biophysical studies. HxIP* 3 displayed a 2-fold enhancement of binding affinity relative to 
polyamide 1, generating a footprint evident at 0.5 μM, which is in strong agreement with the SPR 
results. Incorporating an additional alkyl amino group had a detrimental effect on the sequence 
selectivity, with both polyamides 2 and 3 showing off-target binding at a sequence (5′-TTGGTT-
3′) overlapping the ICB3. 
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Figure A.3. Biophysical comparison of the diamino Hx-polyamide DNA binding characteristics. 
(A) CD spectra for HxIP* 3 (top panel) and HxI*P 2 (bottom) binding with the target sequence 
5′-ATCGAT-3′ and non-consensus sequences 5′-AAATTT′-3 and 5′-ACGCGT-3′. (B) SPR 
sensorgram of HxIP* 3 with the target 5′-ATCGAT-3′ sequence at 100, 200 and 300 nM 
concentrations of compound. Thick grey lines represent true association and dissociation and thin 
black lines represent global kinetics fits. (C) Steady-state analyses of HxIP* 3 with 5′-ATGCAT-
3′ (●, solid line), 5′-ATCGAT-3′ (▲, dashed line), and 5′-ACGCGT-3′ (◆, dotted line) sequences. 
SPR experiments were run in 10 mM CCL, 1 mM EDTA, 200 mM NaCl, 0.05% P20 (pH 6.5) at 
25 °C. 
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A.5.3  Disruption of the NF-γ:ICB2 interaction by diamino Hx-polyamides 
The diamino polyamides inhibit the NF-Y binding to the ICB2 in a cell-free system with 
contrasting effectiveness as shown by electrophoretic mobility shift assay (EMSA) experiments 
(Figure A.5). A radiolabelled oligonucleotide containing the ICB2 and target flanking sequence 
5′-TACGAT-3′ was incubated with nuclear protein extract from NIH3T3 cells after pre-treatment 
with HxI*P 2 or HxIP* 3. Supershift studies using an antibody specific for NF-YA confirmed the 
presence of NF-Y within the ICB2-bound protein complex (Figure A.5C). HxI*P 2 only affected 
NF-Y binding at higher concentrations of 10–20 μM, whereas HxIP* 3 displayed a dose-
dependent inhibition of the NF-Y:ICB2 interaction, evident at doses ≥ 3 μM. In addition, diamino 
HxIP* 3 was able to displace NF-Y already bound to the ICB2 (Figure A.5B), when the 
radiolabelled oligonucleotide was incubated with the nuclear extract prior to the addition of the 
polyamide. The comparative EMSA study of polyamides 2 and 3 emphasises the importance of 
optimising the DNA binding affinity and sequence selectivity to deliver polyamide-directed 
interference of specific protein-DNA interactions. 
A.5.4  Nuclear uptake of diamino Hx-polyamides 
Emission studies confirmed that the diamino-containing HxI*P 2 and HxIP* 3 retain the 
characteristic fluorescent output exhibited by Hx-polyamides upon binding DNA and UV 
excitation (322 nm), with emission bands detected at 370 and 375 nm for compounds 2 and 3, 
respectively (data not shown). Previously reported cellular uptake studies of HxIP 1 utilised the 
intrinsic fluorescence of the Hx fluorophore to visualise the rapid polyamide localisation in the 
nucleus.[28] Confocal microscopy and flow cytometry experiments were also used in this study to 
assess the nuclear uptake of polyamides 2 and 3. A549 and NIH3T3 cells were treated with  
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Figure A.4. Binding of diamino Hx-polyamides 2 and 3 to the topo IIα promoter.  
Autoradiograms of DNase I footprinting gels, HxI*P 2 (left) and HxIP* 3 (right). The 
concentrations (μM) used are shown at the top of the gel. G + A represents a formic acid-
piperidine marker specific for purines. The positions of the ICB1, ICB2, ICB3 and the target 
sequence are indicated. 
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Figure A.5. Inhibition of NF-Y binding to ICB2 by the diamino Hx-polyamides.  
Electrophoretic mobility shift assays (EMSAs) using a radiolabelled oligonucleotide containing 
the ICB2 and target sequence 5′-TACGAT-3′ were pre-incubated with increasing concentrations 
of polyamide 2 or 3 for 1 h at room temperature prior to addition of the NIH3T3 nuclear extract. 
0, control reaction containing the oligonucleotide and nuclear extract without polyamide; C, 
reaction in the presence of an excess of unlabelled competitor oligonucleotide of the same 
sequence as the control reaction; M, reaction in the presence of an excess of unlabelled 
oligonucleotide with a mutation to the ICB2 motif. (A) Comparative analysis of the inhibitory 
effects of HxI*P 2 and HxIP* 3 on the binding of NF-Y containing protein complexes to the ICB2. 
(B) EMSA showing HxIP* 3 is able to displace NF-Y already bound to the ICB2 when the 
radiolabelled oligonucleotide is pre-incubated with the nuclear extract prior to the addition of the 
polyamide. (C) Supershift analysis using an anti-NF-YA antibody confirmed the presence of NF-
Y in the protein complex bound to the radiolabelled oligonucleotide. 
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increasing concentrations of polyamides for 24 h and representative confocal microscopy images 
are shown in Figure A.6. Nuclear uptake of 2 and 3 was confirmed by co-localisation of the 
polyamide fluorescence signal (blue) and propidium iodide (PI) signal (red). HxI*P 2 and 
HxIP* 3 nuclear staining increased in a dose-dependent manner, most prominent after exposure to 
20 μM of each polyamide. Flow cytometry analysis (Figure S2, Supplementary Material) 
confirmed the confocal microscopy findings, with a 24 h exposure to each diamino polyamide 
resulting in a concentration-dependent increase in the median fluorescence intensity of the 
distribution of the treated cell populations when compared to the DMSO-treated controls. A 41-
fold and a 26-fold increase were observed after treatment with HxI*P 2 and HxIP* 3, respectively. 
It is not clear whether this difference in fluorescent output is due to the enhanced nuclear uptake 
of 2 or because of lower sequence selectivity, leading to promiscuous nuclear DNA binding and 
therefore greater fluorescence signal. 
To examine polyamide uptake in live, unfixed NIH3T3 cells, the MitoTracker® Red dye, 
which stains the mitochondria, was used to define the cytoplasm without cell fixation or 
permeabilisation. The preferential accumulation of the polyamides in the nucleus was observed in 
NIH3T3 cells, with no overlap between the diamino polyamides and the MitoTracker fluorescence 
signals (Figure S3A, Supplementary Material). A time course experiment revealed the rapid 
nuclear uptake and sustained localisation of both diamino analogues following exposure to 20 μM, 
with blue fluorescence signal visible after just 1 h and still evident after 48 h (Figures S3B & C). 
These results highlight the advantage of incorporating the fluorogenic Hx moiety to monitor 
cellular uptake. 
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Figure A.6. Visualisation of HxI*P 2 and HxIP* 3 nuclear localisation.  
A549 (top panels) and NIH3T3 (bottom panels) cells were treated with the indicated 
concentrations of HxI*P (left) or HxIP* (right) for 24 h, washed with PBS, and fixed with 2% 
paraformaldehyde (PFA). They were subsequently permeabilised and the nuclei were stained with 
propidium iodide (PI) before confocal microscopy imaging. The composite image presents the 
superimposed overlay of diamino Hx-polyamide fluorescence and the PI fluorescence. No 
polyamide fluorescent signal was detected in the control, untreated cells under the same 
observation settings. 
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A.5.5  Biological activity of diamino Hx-polyamides in A549 cells 
To explore whether the introduction of a second alkyl amino group enhanced polyamide biological 
activity, topo IIα expression in confluent A549 cancer cells was evaluated by measuring topo IIα 
mRNA and protein levels after polyamide treatment (Figure A.7). HxIP* 3 induced a dose-
dependent increase in topo IIα mRNA levels as shown by Quantitative RT-PCR, with expression 
upregulated by 2.1-fold after 18 h treatment with 2 μM polyamide. In contrast, HxI*P 2 had no 
effect on topo IIα mRNA expression at the same concentration. Immunoblot analysis confirmed 
the differing biological activities of the diamino HxIP analogues. Treatment with 
HxIP* 3 mediated a concentration-dependent (0.1–2 μM) enhancement of topo IIα protein levels 
relative to the untreated cells, with a stimulatory effect exerted at 0.1 μM, whereas, HxI*P 2 had 
no effect on the nuclear topo IIα content (Figure A.7B). With both diamino polyamides confirmed 
to localise in the nucleus via confocal microscopy, these findings indicate that the strikingly 
different in vitro biological activities displayed by 2 and 3 are dictated by the position of the 
additional alkyl amino group and its effect on DNA binding. Importantly, topo IIα expression in 
A549 cells is upregulated by the dicationic polyamide 3 at a lower concentration than reported for 
the monocationic polyamide 1.[28] The enhanced polyamide efficacy may be a consequence of 
increased DNA binding affinity and water solubility arising from the inclusion of a second 
positively charged amino group. 
A.5.6  HxIP*-mediated chemosensitisation to topo II poisons 
The NF-Y-induced transcriptional downregulation of topo IIα at confluence results in 
cellular resistance to anti-cancer therapeutics targeting the activity of the enzyme. Previously, we 
reported that the re-induction of topo IIα expression after treatment with HxIP 1 re-sensitised 
confluent A549 cells to the DNA damaging effects of etoposide, as shown by the increased levels 
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Figure A.7. Effect of the diamino HxIP derivatives on topo IIα expression in confluent A549 
cells.  
(A) Quantification of topo IIα mRNA levels via RT-PCR analysis. Cells were maintained at 
confluency before 18 h treatment with increasing concentrations of HxI*P 2 or HxIP* 3. mRNA 
levels are compared relative to untreated confluent A549 cells (CON). Error bars represent the 
SEM from three biological replicates. Statistical significance was calculated using one-way 
ANOVA analysis (*p < 0.05). (B) Immunoblot analysis of confluent A549 nuclear extracts probed 
with topo IIα antibody following 18 h treatment with HxI*P 2 or HxIP* 3. Lamin is shown as a 
loading control. 
 
of DNA damage marker, γH2AX.[28] Here, we show the effects of combining topo II poisons with 
the more biologically active polyamide, HxIP* 3 (Figure A.8). Following pre-treatment of 
confluent A549 cells with increasing concentrations of HxIP* for 24 h, cells were exposed to 
50 μM etoposide for 2 h and allowed to recover in drug-free medium for a further 24 h before 
visualisation of γH2AX. Representative immunofluorescence confocal microscopy images shown 
in Figure A.8A. A revealed that HxIP*-etoposide combination treatment regimes initiated a 
polyamide dose-dependent increase in the number of γH2AX foci, relative to the etoposide 
treatment alone. The mean number of foci per nuclei was quantified (Figure A.8B) using 
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CellProfiler Software.[36, 37] Compared to etoposide alone (~ 0.46 γH2AX foci), combination 
treatments with 1 μM (~ 1.6 γH2AX foci) and 2 μM HxIP* (~ 2.5 γH2AX foci) induced 
statistically significant 3.5-fold and 5.4-fold increases in γH2AX foci, respectively (Figure A.8B). 
HxIP* treatment resulted in negligible levels of γH2AX as it does not induce DNA damage due to 
the non-covalent binding nature of polyamides. Immunoblot analysis (Figure A.8C) corroborated 
these findings and after pre-treatment with HxIP* there was a concentration-dependent increase in 
the phosphorylation of H2AX relative to etoposide alone, with the most significant increase 
observed after pre-treatment with 5 μM HxIP*. A sustained, dose-dependent upregulation of 
nuclear topo IIα expression by HxIP* was observed in parallel and correlated with the enhanced 
levels of γH2AX. 
HxIP* can mediate the chemosensitisation of confluent A549 cells to the cytotoxic effects of 
etoposide and doxorubicin. Cell viability was assessed following single agent HxIP* or etoposide 
treatment, and after HxIP*-etoposide combinations, where 6 h etoposide exposure followed 24 h 
pre-treatment with HxIP*. Combination of etoposide with increasing concentrations of HxIP* 
caused a synergistic dose-dependent decrease in cell viability relative to the untreated control. The 
combination of etoposide (400 μM) with 5 μM HxIP* reduced cell viability by an additional 50% 
compared to cells treated with etoposide alone (Figure A.8D). HxIP* alone had little effect on 
viability and displayed no cytotoxic effects below 100 μM in exponential or confluent A549 cells 
following 24 h treatment (Figure S4A, Supplementary Materials). Whereas, etoposide induced-
cytotoxicity following 6 h exposure was attenuated in confluent-arrested cells (Figure S4B, 
Supplementary Materials), further demonstrating the confluence-mediated resistance to topo II 
poisons. Finally, polyamide induced cellular sensitisation was also observed in combination with  
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Figure A.8. Potentiation of topo II poison induced-cytotoxicity by HxIP*. 
A549 cells were pre-treated with the indicated concentrations of HxIP* 3 for 24 h and exposed to 
etoposide (50 μM) for 2 h. After 24 h in drug free medium, they were analysed for γH2AX levels 
by confocal microscopy and immunoblotting. (A) Representative images of A549 cells. (B) Number 
of H2AX foci per nuclei for the indicated treatment combinations, as quantified by CellProfiler 
Software. (C) Immunoblot analysis of the nuclear levels of γH2AX and topo IIα, 24 h after pre-
treatment with HxIP* for 24 h, treatment with etoposide for 2 h and their combination. (D) 
Confluent A549 cells were treated with HxIP* (2 and 5 μM) or etoposide (400 μM) and HxIP*-
etoposide combination, where 6 h etoposide exposure followed 24 h pre-treatment with HxIP*. 
Cell viability (%) was measured using the CellTiter-Glo® assay. Luminescence values are 
normalised to those of the untreated control. (E) Viability was also assessed after 6 h treatment 
with doxorubicin (75 μM) and HxIP*-doxorubicin combinations, where 6 h exposure followed 
24 h HxIP* pre-treatment. All data are represented as mean ± SEM (n = 3). Statistical 
significance was calculated using one-way ANOVA analysis (*p < 0.05, **p < 0.01, 
***p < 0.001). 
 
 
doxorubicin (Figure A.8E). Pre-treatment with 5 μM HxIP* enhanced doxorubicin induced-
cytotoxicity causing an additional 22% decrease in viability relative to cells treated with 
doxorubicin (75 μM) alone. These results confirm the potential application of NF-Y modulating 
polyamides as chemosensitising agents to increase the cytotoxic potency of topo II poisons and 
reverse the resistance of confluence-arrested cancer cells. 
A.6  Discussion 
DNA binding polyamides with programmed sequence recognition are able to chemically 
control transcription and their gene regulatory activities have been confirmed in various biological 
contexts, targeting a range of transcription factors such as nuclear hormone receptors [6, 8], 
hypoxia-inducible factor 1 (HIF-1) [38], nuclear factor κβ (NF-κβ),[7] and c-Myc [39]. 
Nevertheless, design strategies that further enhance polyamide activity are still required in order 
to realise the therapeutic potential of this class of small molecules. Recent advances within the 
field have centred on improving the often-modest nuclear uptake properties, which is essential for 
polyamide activity as gene control agents.[40-43] We reported that the incorporation of the p-
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anisylbenzimidazole (Hx) DNA recognition element into a simple triamide structure increases 
nuclear uptake and the subsequent biological activity of the polyamide HxIP 1, targeting the 
repressive DNA binding of transcription factor NF-Y to the ICB2 of the topo IIα promoter.[28] 
Here, we present the continued evolution of NF-Y targeting polyamides, and explore the 
modification of the Hx-polyamide framework through the introduction of an alkyl amino group at 
the N1 position of either the imidazole (HxI*P 2) or pyrrole (HxIP* 3).  
This approach to polyamide functionalization was driven by the higher binding affinity and 
more effective inhibition of transcription factor-DNA interactions by polyamides integrating 
pyrrole N1-alkyl spermine/spermidine groups.[44, 45] The results of ΔTM and CD studies confirm 
that the presence of the N1-alkyl amino group increases binding affinity of the diamino Hx-
polyamides 2 and 3 to the cognate sequence, because of electrostatic interactions between the 
additional positively charged amino group and the negatively charged phosphodiester groups of 
the DNA backbone. However, the position of the N1 modification also affected the binding affinity 
of isomers 2 and 3. The inclusion of the propyl amino group at the C-terminal heterocycle of the 
HxIP design (HxIP* 3) caused a greater enhancement of binding affinity than derivatisation of the 
central heterocycle (HxI*P 2). The difference in affinities between the two diamino analogues 
became more apparent following footprinting studies to assess their binding to the biologically 
relevant 5′-TACGAT-3′ sequence on the topo IIα promoter. Diamino HxIP* 3 displayed greater 
binding affinity (0.5 μM) than the monoamino HxIP 1 (1 μM),[28] whereas HxI*P 2 binds to the 
target sequence with reduced affinity (3 μM). The weaker binding affinity of polyamide 2 relative 
to 3 may be due to the closer proximity of the cationic N1-alkyl amino groups of the stacked 
HxI*P 2 dimers when bound in a 2:1 configuration. Electrostatic repulsions between the positively 
charged groups and steric effects between the alkyl chains could cause non-optimal polyamide-
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DNA binding orientations and compromise DNA binding affinity. N1 modification to C-terminal 
pyrrole on the other hand, limits the electrostatic and steric clash as the propyl amino groups of 
the stacked HxIP* 3 dimers are positioned at the maximum possible distance apart.  
The importance of the position of the orthogonal propyl amino group in the polyamide 
design was previously revealed when the binding affinities of 5′-ACGCGT-3′ targeting diamino 
triamides were shown to be dependent upon the position of the modified heterocycle, without 
significantly affecting DNA sequence selectivity.[30-33] In contrast, the diamino Hx-
polyamides 2 and 3 both display reduced DNA sequence selectivity relative to monoamino 1, with 
the integration of the N1-alkyl amino group at the imidazole (HxI*P 2) further compromising 
selectivity compared to attachment to the pyrrole ring (HxIP* 3). This reduced selectivity is 
attributed to the increased positive electrostatic potential of the diamino polyamides, due to the 
presence of a second cationic moiety, resulting in greater attraction to the negative potential in the 
minor groove of A·T-rich sequences. These findings demonstrate how modifications can 
dramatically influence polyamide-DNA binding characteristics, and underline the importance of 
functionalities which can enhance DNA binding affinity without affecting sequence selectivity to 
deliver optimised binding properties.  
Engineered to derepress the NF-Y-mediated downregulation of topo IIα, the diamino Hx-
polyamides displayed markedly different in vitro biological activities, seemingly dictated by the 
position of the N1-alkyl amino group and its effect on the polyamide's ability to disrupt the 
repressive NF-Y:ICB2 interaction. HxI*P 2 had no effect on topo IIα expression at mRNA or 
protein levels in A549 cancer cells, whereas HxIP* 3 induced upregulation in a dose-dependent 
manner. Previously, polyamides that displayed no biological effect were assumed to be incapable 
of penetrating into the nucleus.[27] Here, confocal microscopy and flow cytometry studies 
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exploiting the inherent fluorescence of the diamino Hx-polyamides confirmed the rapid and 
sustained nuclear accumulation of both analogues. Therefore, the inability of HxI*P 2 to control 
topo IIα transcription can be attributed to the polyamide's attenuated DNA binding properties and 
the resulting moderate inhibition of the NF-Y:DNA interaction. In contrast, diamino 
polyamide 3 not only exhibited a greater biological effect than 2, but also stimulated upregulation 
of topo IIα at a lower concentration than the monoamino HxIP 1.[28] EMSA studies revealed that 
HxIP* 3 and HxIP 1 inhibited the NF-Y:ICB2 interaction with comparable efficiency despite 
footprinting studies showing diamino polyamide 3 to bind to the target sequence 5′-TACGAT-3′ 
with higher affinity.[28] This suggests that the greater induction of topo IIα expression by 
HxIP* 3 is not solely a result of superior DNA binding. The presence of an additional cationic 
functionality also increases the aqueous solubility of diamino Hx-polyamides. Taken together, 
these results indicate that the improved biological effects of diamino HxIP* 3 derive from 
improved physicochemical properties including enhanced water solubility arising from the 
inclusion of a second positively charged alkyl amino group. 
The introduction of a N1-alkyl amino group and its position influenced the DNA binding 
and biological activities of diamino Hx-polyamides 2 and 3, and highlights why polyamide 
functionalisation has been widely explored as a strategy to advance their therapeutic potential 
(reviewed in [46]). Dervan and co-workers have reported on the effect of altering the composition 
of the C-terminal tail group of non-fluorescent polyamides.[40, 41, 47] The introduction of an 
isophthalic acid (IPA) group at the C-terminus preserved DNA binding affinity and selectivity, 
and increased potency in cell culture.[41] The attached IPA group enhanced nuclear localisation 
and enabled non-conjugated polyamides to replicate the efficient uptake of fluorophore-conjugated 
derivatives to deliver greater biological effects. An additional adjustment to the C-terminus group 
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via the substitution of the amide linkage with an oxime linkage between the aliphatic linker and 
the aromatic tail group further enhanced the potency of polyamides targeting the androgen 
response element.[42] In a different approach, Sugiyama's group tested the introduction of a 
hydrophilic methoxypolyethylene glycol (PEG) 750 group as a strategy to address the poor 
aqueous solubility of their hairpin polyamide seco-CBI conjugates.[48] Conjugates modified by 
PEGylation at the hydroxyl group of the seco-CBI moiety showed moderately higher solubility 
and caused greater cytotoxic effects in A549 and DU145 cell lines due to improved cell 
permeability. Furthermore, work in Dervan's group showed that variation of the hairpin polyamide 
γ-aminobutyric acid turn (γ-turn) significantly affected the biological efficacy, pharmacokinetics 
and toxicity.[43, 49, 50] The integration of an aryl group at the β-position of the γ-turn enhanced 
biological activity against nuclear receptor mediated transcription by two orders of magnitude.[43] 
However, further studies confirmed that modifications to the α- and β-positions of the γ-turn 
dramatically altered systemic toxicity of polyamides in mice.[49, 50] 
The inclusion of a second alkyl amino group did not change the inherently non-cytotoxic 
properties of the Hx-polyamides and no evidence of polyamide-induced DNA damage was 
detected after exposure to diamino polyamide 3. However, when used in combination with 
etoposide and doxorubicin, HxIP* 3 stimulated the chemosensitisation of confluence-arrested 
cancer cells to the DNA damaging effects of these topo II targeting agents. Enhancing cellular 
sensitivity to the cytotoxic effects of topo II poisons through abrogation of the repressive NF-Y 
binding to the ICB2 was first demonstrated using bis-benzimidazole minor groove binder Hoechst 
33342.[16] Upregulation of topo IIα expression in confluent mouse fibroblast NIH3T3 cells 
significantly lowered the IC50value of etoposide in combination treatments and inspired the 
development of sequence specific DNA interacting agents with greater selectivity for the critical 
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ICB2 sequence. Hairpin polyamide JH-37 bound to the 5′-TTGGT-3′ sequence overlapping the 
ICB2 and ICB3, and increased formation of DNA strand breaks when NIH3T3 cells were exposed 
to polyamide-etoposide treatments, resulting in a synergistic reduction in cell viability.[25] 
Recently, HxIP 1 was the first ICB2-targeting polyamide to sensitise confluent cancer cells to 
etoposide.[28] Here, diamino HxIP* 3, our most potent NF-Y inhibiting polyamide to date, re-
activated topo IIα expression and the subsequent increase of etoposide-generated DNA damage 
significantly reduced cell viability in combination treatments. The enhancement of etoposide and 
doxorubicin induced-cytotoxicity by diamino Hx-polyamide 3 reaffirmed the feasibility of direct 
modulation of transcription factor NF-Y activity as an approach to chemosensitisation within the 
context of cellular confluency. 
A.7  Conclusion 
Polyamide functionalisation via the N1 position of the pyrrole and imidazole rings in the 
Hx-framework presents a promising approach to improving the drug-like properties of these small 
molecules. The introduction of an additional cationic alkyl amino functionality enhances water 
solubility and facilitates the nuclear uptake of the diamino polyamides 2and 3. However, the N1-
alkyl amino group had a detrimental effect on DNA sequence selectivity, and binding affinity for 
the target sequence 5′-TACGAT-3′ on the topo IIα promoter was dependent upon the position of 
the modified heterocycle. The diamino polyamides displayed strikingly different in vitro biological 
activities. HxI*P 2 showed no effect against the downregulation of topo IIα at confluence, while 
HxIP* 3 stimulated a dose-dependent upregulation of topo IIα expression. This discrepancy is 
seemingly dictated by their contrasting abilities to disrupt the NF-Y:ICB2 interface. Overall, the 
correct positioning of a second alkyl amino group in the HxIP structure generated a more potent 
dicationic polyamide, benefiting from superior solubility relative to its monocationic counterpart. 
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Targeted inhibition of NF-Y binding by HxIP* 3 and the subsequent re-induction of topo IIα levels 
potentiated the cytotoxicity of topo II poisons. These results further highlight the need for in vivo 
investigation of the efficacy of drug combination strategies that employ polyamides to overcome 
resistance to clinically-used anticancer therapeutics. 
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B.1  Abstract 
Telomeres are the ends of chromosomes which help protect the chromosome from 
degradation during the cell life cycle. The ends are made up of guanine-rich repeats with areas that 
form structures known as G-quadruplexes. These structures are important in cellular processes and 
have been identified specifically in relation to certain cancers and neurodegenerative diseases. G-
quadruplex topologies are contingent on solution conditions and can occur for both DNA and RNA 
nucleotide forms. Several RNA quadruplexes have been identified in individuals having dementia 
with correlations of large quadruplex repeats of 5’-GGGGCC-3’. Little is known regarding RNA 
G-quadruplexes so their structure and function are of great interest. We have investigated the 
interactions of four quadruplex-binding compounds for selectivity of RNA quadruplexes over 
DNA quadruplexes. Additionally, the compounds were also tested with both DNA and RNA forms 
of the human telomeric sequence 5’-TTAGGG-3’ and 5’-UUAGGG-3’, respectively. Here, we 
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found morpholine-containing compound, CM03, showed the highest affinity of the compounds 
tested. Furthermore, CM03 showed very good selectivity for RNA quadruplexes with multiple 
binding stoichiometries. These results are an exciting step towards the targeting of selectivity for 
specific quadruplex structures, particularly RNA quadruplexes, with the potential to treat 
neurodegenerative diseases. 
B.2  Key words 
Anisotropy; G-quadruplex; Mass spectrometry; Neurodegenerative; RNA; Telomere 
B.3  Abbreviations 
Deoxyribonucleic acid (DNA); Electrospray ionization mass spectrometry (ESI-MS); 
Fluorescence polarization (FP); Guanine (G); Human telomere DNA 21mer (HTel21); 
Ribonucleic acid (RNA); Human telomere RNA 21mer (rHTel21); telomeric RNA (TERRA) 
B.4  Introduction 
Telomeres are the end regions of chromosomes and contain repeats of nucleotide 
sequences.[1] These end caps protect the termini of the chromosome from degradation and/or 
merging with nearby chromosomes. During replication, DNA polymerases are restricted from 
copying the DNA towards the end cap resulting in a shortened chromosome. Telomeres can, 
therefore, be considered barriers to protect the chromosome and gene during cell division. In 
addition to acting as a protector, telomeres also act as regulators for the cell life cycle and signal 
senescence or cell death. In humans, it is common to find tandem repeats of the nucleotide 
sequence, 5’-TTAGGG-3’. Often times, the guanine or G-rich regions of these repeats form a 
unique planar quartet structure called G-quadruplexes (Figure B.1A). These planar regions, or 
tetrads, are coordinated with four guanine bases that are hydrogen bonded through Hoogsteen base 
interactions with a core cation.[2] 
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Figure B.1. Cartoon representation of G-quadruplex formation. 
(A) G-quadruplex tetrad formed by Hoogsteen hydrogen bonded guanines coordinated by a core 
monovalent metal cation. (B) Cartoon representation of stacked tetrads which form the G-
quadruplex. (C) Parallel and (D) antiparallel topologies of G-quadruplexes, indicated by 5’ to 3’ 
arrows as representative nucleotide backbone. 
 
The stability and topology of a G-quadruplex is often influenced by the internal cation 
bound within the core. In general, monovalent cations including as K+ and Na+ are the dominant 
cations.[3] G-quadruplexes can take on several specific topologies in which the sequence can be 
intramolecular or intermolecular.[4] The intramolecular topology consists of a single strand 
whereas an intermolecular topology can be made up of two or four strands. Within these 
topologies, the backbone can run parallel or antiparallel (Figures B.1C & B.1D). Little is known 
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regarding the topology of RNA quadruplexes except that they are usually limited to forming the 
parallel topology due to steric interactions by the hydroxyl groups of the RNA ribose sugar. On 
the other hand, much more is known DNA G-quadruplexes which can adopt any type of structure.  
RNA G-quadruplexes have been identified as markers for neurodegenerative diseases, such 
amyotrophic lateral sclerosis (ALS) and other types of dementia, associated with the C9orf72 gene. 
Healthy individuals were identified to contain an average 2-8 repeats of 5’-rGrGrGrGrCrC-3’.[5, 
6] Unfortunately, individuals with a mutation were found to have repeats ranging from several 
hundred to thousands. Alternatively, the human RNA telomeric sequence, or TERRA, has also 
been identified with 5’-rUrUrArGrGrG-3’ repeats in vertebrates. Less is known regarding its 
function compared to the DNA form but is involved in telomerase regulation processes.[7-9] ESI-
MS[10] studies by Collie and co-workers revealed a dimer system of two TERRA while later NMR 
solution studies showing binding of an acridine ligand bound to two parallel TERRA strands 
associated at their 5’ ends.[11] It therefore comes as no surprise that targeting G-quadruplexes 
with small molecules has become a hot topic in the potential treatment of certain cancers and other 
genetically-related diseases due to the inherent relevance of quadruplexes. If a stacked dimer 
system can be selectively targeted, RNA quadruplexes may be able to offer an attractive target for 
potential drug candidates. 
 
B.5  Materials and methods 
B.5.1  DNA and compounds 
DNA and RNA quadruplexes were purchased from Integrated DNA Technologies (IDT, 
Coralville, IA, USA). DB1246 and DB1247 were synthesized by Mohamed A. Ismail in Prof. 
David W. Boykin’s group at GSU. Two sets of sequences were studied by ESI-MS. The first series, 
5-GGG GCC GGG GCC GGG GCC GGG G-3 (G4-ALS) and 5-rGrGrG rGrCrC rGrGrG rGrCrC  
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Figure B.2 Morpholine-containing compounds. 
(A) MM41 and (B) CM03 tested with DNA and RNA quadruplexes. 
 
 
rGrGrG rGrCrC rGrGrG rG-3 (rG4-ALS) was designed to mimic ALS-related sequences. The 
second set of sequences were designed based on the human telomere, 5’-GGG TTA GGG TTA 
GGG TTA GGG-3’ (HTel21) and 5’-rGrGrG rUrUrA rGrGrG rUrUrArGrGrG rUrUrA rGrGrG-
3’ (rHTel21). Stock solutions of 0.5 mM of the ALS-related sequences were dissolved in 150 mM 
NH4OAc (pH 6.8) prepared in nuclease-free water. Stock solution of 1 mM of the HTel21-related 
sequences were dissolved in 150 mM NH4OAc (pH 6.8) prepared in nuclease-free water. All 
samples were aliquot into 25 µL volumes into 200 µL PCR tubes and heated to 98 ºC for 10 min 
in a thermocycler. The heating block was powered off and the samples were slowly cooled for 
additional 15 min while remaining within the thermocycler. Samples were transferred to a plastic, 
autoclaved rack, slowly cooled an additional 30 min at 25 ºC, and stored at 4 ºC until use (within 
2 days). Concentrations were spectroscopically determined using extinction coefficients provided 
by IDT using the nearest-neighbor method.[12] 
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Figure B.3 Dicationic diamidines. 
(A) DB1246 and (B) DB1247 tested with ALS-related DNA and RNA quadruplexes with 5’-
GGGGCC-3’ repeats. 
 
B.5.2  Electrospray ionization mass spectrometry 
 Samples were prepared to quadruplex concentrations of 20 µM using 150 mM NH4OAc 
(pH 6.8) prepared in nuclease-free water. In separate vials, molar concentrations of compound to 
quadruplex were prepared to create ratios of [1:1], [2:1], and [4:1]. Compound was added so that 
the total concentration of compound was equivalent to the desired molar concentration ratio of the 
total DNA concentration. For example, to prepare a [4:1] concentration ratio of CM03 and MM41 
to DNA would be the equivalent of [DNA] = 20 µM + [CM03] = 40 µM + [MM41] = 40 µM.  
Total concentration of DNA in the sample is 20 µM with a total compound concentration of 80 
µM (2 x 40 µM = 80 µM) and, therefore, 80 µM of total compound in the sample gives [80:20] or 
[4:1]. Likewise, a [4:1] ratio of a single DNA to compound would be the equivalent of DNA at 20 
µM with CM03 only at 80 µM. An additional 5% MeOH (v/v) was added to the sample seconds 
prior to injection to help facilitate gas-phase transition to give a total sample volume of 100 µL.  
 Samples for ESI-MS were run using a Waters Micromass ESI-Q-ToF spectrometer (Waters 
Corp., Milford, MA, USA) and analyzed with MassLynx 4.1 software. They were scanned from 
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m/z 500-3000 in negative ion mode for DNA. Negative ion mode was attempted for RNA but 
resulted in poor signal therefore positive ion mode was used. Flow rates for all samples were of 5 
µL/min and the final two minutes of the chromatogram (≈ 200 scans) was averaged. Spectral peaks 
were deconvoluted using the MaxEnt 1 function in MassLynx 4.1. A G4T4G4 dimer quadruplex 
was used as a standard to calibrate the instrument parameters. ESI source: capillary 2200 V, sample 
cone -130 V, extraction cone -115 V, source 40 ºC, desolvation 60 ºC, cone gas 30 L/hr, 
desolvation gas flow 450 L/hr. Quadrupole: ion energy, 2.5 V; collision energy, 2 V; RF1 lens, -
125; RF2 lens, -103 V. Time-of-flight: acceleration lens 88 V. 
B.5.3 Fluorescence polarization spectroscopy 
 Fluorescence polarization spectroscopic studies were performed using 1 mM stock 
solutions of quadruplex sequences in 150 mM NH4OAc (pH 6.8) in nuclease-free water using a 
Varian Cary Eclipse Fluorescence Spectrophotometer (Agilent Technologies, Santa Clara, CA) 
using a 3 mL volume, 4-sided quartz cuvette. Compounds were dissolved to 1 mM stock solutions 
in nuclease-free water and stored in the dark at 4 ºC. Samples were prepared by first diluting 
compound in the cuvette with 10 mM Tris-HCl (pH 7.4), 50 mM KCl in nuclease-free water, 
except for CM03 which was also tested using 200 mM KCl. Quadruplex was then titrated in with 
concentrations of both compound and quadruplex appropriately adjusted in calculations. 
Anisotropy titrations were used to measure the binding affinity of MM41 to RNA and DNA 
quadruplex sequences. Direct fluorescence titrations were used to measure the affinity of CM03 
to RNA and DNA quadruplexes. Data was fitted using a one-site binding model (1 to 1) to obtain 
the equilibrium dissociation binding constant (KD). 
  
 
 
180 
B.6  Results and discussion 
B.6.1  Sequence specific investigations of small molecule interaction with ALS-related 
quadruplexes 
There are many biophysical techniques which can be used to measure the binding of these 
compounds with DNA and RNA quadruplex systems; however, there is some difficulty in 
investigating RNA due to instability and/or decomposition of the nucleic acids by naturally-
occurring RNase enzymes which can easily break down the nucleic acid. One method which is 
useful for solution measurements of such systems is fluorescence polarization (FP) spectroscopy. 
Additionally, because of its native solution properties, low concentrations (picomolar to 
nanomolar) of sample can be used along with rapid analysis of the sample. Fortunately, both series 
of compounds, including DB1246 and DB1247 and CM03 and MM41, have inherent fluorescence 
properties. Figure B.4 shows the anisotropy of DB1246, DB1247 and MM41 with G4-ALS. 
Beginning with compound at 50 nM concentrations, G4-ALS was titrated in, resulting in 
increasing anisotropy values (r), indicative of ligand-G4 complex formation. Based on the FP 
results of G4-ALS, the quadruplex sequence showed weak binding with DB1246 (KD ≈ 240 nM). 
On the other hand, both DB1247 and MM41 showed 5-fold stronger binding for the same 
sequence. Values are listed in Table B.1. Interestingly, interaction between CM03 and the G4-
ALS quadruplex sequence was difficult to observe due to significant decreases in fluorescence 
intensity upon complex formation, therefore, in an effort to measure binding of CM03, direct 
fluorescence quenching was used instead. Figure B.5 illustrates quenching of 25 nM CM03 upon 
titrating in DNA. Based on the fluorescence quenching experiments, binding of CM03 with G4-
ALS showed the strongest interaction of within this series of compounds. 
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Figure B.4 Fluorescence anisotropy measurements for G4-ALS quadruplex DNA.  
(A) DB1246, (B) DB1247, and (C) MM41. Compound concentrations were held near 50 nM in 10 
mM Tris-HCl, 50 mM KCl in nuclease-free water (pH 7.4) with increasing concentrations of G4-
ALS. 
 
 
 
Figure B.5 Fluorescence titration assays of quadruplex DNA and CM03.  
Fluorescence intensity vs. DNA concentration (left) and fluorescence scans of CM03 upon 
increasing concentrations of DNA (right). Fluorescence intensities decrease with increasing 
concentrations of quadruplex species. [CM03] is 25 nM in 10 mM Tris-HCl (pH 7.4) and 50 mM 
KCl. Maximum λem = 570 nm for CM03. Data fit using a one-site binding model. 
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Table B.1 Equilibrium binding constants (KD) of G-4 binding compounds with DNA and RNA 
quadruplexes. 
 
 
To confirm the one-site binding model used FP analyses, compound and G4-ALS DNA 
quadruplex complexes were evaluated using electrospray ionization mass spectrometry (ESI-MS). 
Samples of quadruplex DNA were prepared with and without various ratios of compound. Figure 
B.6 shows an ESI-MS mass spectrum of G4-ALS with two internal NH4
+ cations within the tetrad 
core, in the absence of compound. A -5 species was chosen since it had the highest intensity of all 
observed charge states. Following addition of compound, the -5 remained the dominant charge 
state even after complex was formed. Binding of CM03 to DNA shows a preferred binding more 
of 1 to 1 stoichiometry, but some 2 to 1 binding is observed at high concentrations as illustrated in 
a [4:1] molar concentration ratio (Figure B.7A). Alternatively, DB1246 in Figure B.7B shows 
similar preferential binding to DNA at high compound concentrations with an additional peak 
corresponding to 2 to 1 binding stoichiometry. Results by FP indicate very strong binding of CM03 
(subnanomolar) to quadruplex DNA; however, the peak intensities in Figure B.7A suggest 
otherwise, meaning peak intensities for the CM03-G4 complex should be more intense. Likewise, 
peak intensities for DB1246-G4 complexes should be less in comparison to CM03 complexes since 
binding is nearly 500-fold weaker. It is believed that that much of the compound is lost during the 
injection due to the increased number of charges and size of the ligand for MM41 and DB1247, 
respectively. Regardless, results by ESI-MS agreement well with FP for a one-to-one binding 
mode. 
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Figure B.6 ESI-MS spectrum of DNA quadruplex.  
MW of DNA is 6,940.5. The -5 charge peak was the most abundant species and is shown here with 
m/z of 1,394. Tallest peak corresponds to quadruplex DNA with two internal NH4
+ ions. 
Quadruplex shown is in the absence of any quadruplex-binding compounds. DNA concentration 
is 20 µM and analyzed in negative ion mode. 
 
 
Figure B.7 ESI-MS spectra of quadruplex DNA (20 µM) in the presence of ligand. 
(A) CM03 and (B) CM03 each at [4 to 1] molar concentration ratios of [compound to DNA]. 
Spectra m/z ranges 1,250 – 1,700. Left peaks correspond to unbound DNA. Green labeled peaks 
shows CM03-DNA and DB1246-DNA complexes of 1 to 1 stoichiometry. The purple label in (A) 
is of a 2 to 1 stoichiometry of 2 CM03-DNA complex. 
 
  
 
 
184 
 
Figure B.8 Fluorescence anisotropy measurements for rG4-ALS quadruplex DNA. 
(A) DB1246, (B) DB1247, and (C) MM41. Compound concentrations were held near 50 nM in 10 
mM Tris-HCl, 50 mM KCl in nuclease-free water (pH 7.4) with increasing concentrations of rG4-
ALS. 
 
A second sequence was investigated with the same set of fluorescent small molecules using 
the ALS-related RNA quadruplex, rG4-ALS. Using the aforementioned polarization experiments 
for DB1246, DB1247 and MM41, Figure B.8 shows a similar increase in anisotropy values upon 
binding with the RNA quadruplex. Similarly, CM03 was again investigated using fluorescence 
quenching experiments. Unlike the DNA quadruplex sequence which showed a clear preference
for CM03 over the other compounds, the RNA quadruplex showed weak binding of DB1246 and 
DB1247 compounds over the morphonolino series. Table B.1 also lists the equilibrium 
dissociation binding constants. 
Analyses of rG4-ALS with DB1246, DB1247, CM03 and MM41 were expected to produce 
similar results using ESI-MS as were obtained by FP. The compound-RNA interactions were 
unfortunately not detectable in negative ion mode due to specific properties of the RNA 
quadruplex which cannot be explained at this time. While optimizing conditions for ESI-MS, it 
was found that RNA quadruplex was surprisingly better-detected using ESI positive ion mode. 
That being said, results by fluorescence polarization of DB1246 showed the weakest binding for  
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Figure B.9 Molecular mechamics energy minimized structures.  
(A) MM41 and (B) CM03, tested with DNA and RNA quadruplexes. 
 
 
 
 
Figure B.10 Fluorescence titration assays of quadruplex RNA with CM03. 
Fluorescence intensity vs. RNA concentrations (left) and fluorescence scans of CM03 upon 
addition of RNA (right). Fluorescence intensities decrease with increasing concentrations of 
quadruplex species. [CM03] is 25 nM in 10 mM Tris-HCl (pH 7.4) and 50 mM KCl. Maximum λem 
= 570 nm for CM03. Data fit using a one-site binding model. 
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both DNA and RNA quadruplex sequences while CM03 was the strongest binding compound. 
DB1246 and DB1247, dicationic diamidines, do not have the typical planar, conjugated structure 
found with many end-stacking compounds. Binding of these compounds with quadruplex can 
occur through end-stacking, groove-binding, or intercalation and may explain why binding is 
weak. On the other hand, both MM41 (Figure B.9A) and CM03 (Figure B.9B) share a similar 
planar structure found within many end-stacking compounds and are similar in RNA binding 
strength. The RNA quadruplex structure is not selective to either of these compounds unlike the 
DNA quadruplex which preferentially binds CM03 over MM41 based on the apparent binding 
constants. 
B.6.2  Sequence specific investigations of small molecule interaction with human 
telomere (HTel21) quadruplexes  
To better understand sequence selectivity of the CM03 and MM41 compounds, these 
compounds were investigated with additional biologically important quadruplex sequences. The 
human telomere sequences studied contain 21 nucleotide bases with both DNA (HTel21) and RNA 
(rHTel21) forms. Here, fluorescence polarization and mass spectrometry were again used to study 
the binding interactions of the DNA and RNA telomeric sequences with CM03 and MM41. Figure 
B.11 compares the binding of MM41 to DNA and RNA telomeric sequences. Based on the larger 
increase in anisotropy values (r) at the same quadruplex concentrations, these results indicate that 
rHTel21 binds MM41 nearly 15 times stronger than the DNA quadruplex. Additionally, the 
anisotropy value for rHTel21 at saturation is nearly twice as high as the DNA. This anomaly may 
be due simply to the structure of RNA compared to DNA and/or may suggest more than 1 to 1 
binding for MM41 with RNA.  
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Figure B.11 Fluorscence anisotropy titrations of DNA and RNA with MM41. 
Fluorescence anisotropy measurements of MM41 with (A) HTel21 DNA quadruplex (B) TERRA 
or rHTel21 RNA quadruplex. Compound concentrations were held near 50 nM in 10 mM Tris-
HCl, 50 mM KCl in nuclease-free water (pH 7.4) with increasing concentrations of quadruplex. 
 
 
Table B.2 Equilibrium binding constants (KD) of G4-binding compounds with TERRA and 
HTel21 quadruplexes. 
 
 
Due to the decreased fluorescence experienced by CM03 when quadruplexes are titrated 
into the sample solution, fluorescence quenching titrations were again performed to measure the 
binding affinity of CM03 to both DNA and RNA telomeric sequences. The insets in Figures 
B.12A & B.12B are the fluorescence scans from which the relative intensity values at λem = 570 
nm were plotted as a function of quadruplex concentration. The results in Figure B.12 show the
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Figure B.12 Fluorescence titrations of DNA and RNA with CM03 in 50 mM KCl. 
Fluorescence quenching measurements of CM03 with (A) HTel21 DNA quadruplex (B) TERRA or 
rHTel21 RNA quadruplex. Insets are of the direct fluorescence scan with a maximum λem = 570 
nm. CM03 concentrations were held near 50 nM in 10 mM Tris-HCl, 50 mM KCl in nuclease-free 
water (pH 7.4) with increasing concentrations of quadruplex. 
 
 
Figure B.13 Fluroescence titrations of DNA and RNA with CM03 in 200 mM KCl. 
Fluorescence quenching measurements of CM03 with (A) HTel21 DNA quadruplex (B) TERRA or 
rHTel21 RNA quadruplex. Insets are of the direct fluorescence scan with a maximum λem = 570 
nm. CM03 concentrations were held near 50 nM in 10 mM Tris-HCl, 200 mM KCl in nuclease-
free water (pH 7.4) with increasing concentrations of quadruplex. 
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decrease in fluorescence intensity for CM03 with HTel21 and rHTel21. Binding constants are 
listed in Table B.2. These values indicate CM03 has a 60-fold stronger preference for RNA over 
DNA with a KD < 1 nM. To determine a more accurate a binding constant for the RNA sequence, 
not in the subnanomolar range, salt concentrations were increased to 200 mM KCl with DNA and 
RNA and CM03. Fluorescence quenching results for CM03 with DNA and RNA quadruplexes are 
shown in Figures B.13 and binding constants listed in Table B.2. Based on the marked decrease 
in fluorescence intensity for CM03 with RNA compared to DNA, results using 200 mM KCl agree 
with those obtained in buffer with 50 mM KCl that CM03 interactions with RNA are stronger than 
with DNA (90-fold difference). 
Based on the calculated binding constants obtained by FP, both MM41 and CM03 show 
high affinity binding to DNA and RNA telomeric sequences. Interestingly, anisotropy values for 
MM41 with DNA and RNA quadruplexes indicate a binding mode different for RNA since the r-
value was double that of DNA at saturation (i.e. 0.3 to 0.15). At 50 mM KCl, both MM41 and 
CM03 are selective for the RNA quadruplex with nanomolar and subnanomolar binding constants, 
respectively. At 50 mM KCl, the DNA quadruplex was more selective for MM41 over CM03 with 
a binding constant. Higher salt concentrations were then used to obtain a more reasonable binding 
constant for CM03 with RNA and showed an even more marked preference for RNA over DNA. 
At this point, we can only speculate the observable differences in binding are due to differences in 
quadruplex structures between the DNA and RNA. An example of the NMR solution structures of 
both DNA and RNA are shown in Figure B.14. These structures suggest two very different 
conformations for the quadruplexes with an expected monomer system for DNA in green, (Figure 
B.14B) and a dimer system for RNA shown in blue. Superimposition of the two quadruplexes in 
Figure B.14C further illustrates the distinct conformational characteristics of RNA and DNA. 
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Figure B.14 Comparison of human DNA and RNA G-quadruplex structures. 
(A) NMR solution structures of DNA human G-quadruplex and TERRA RNA G-quadruplex, 
respectively. (B) Single structures of DNA quadruplex and TERRA. (C) Superimposition of DNA 
(green) and RNA (blue) quadruplexes to compare monomer and dimer quadruplexes. DNA PDB 
ID: 2kf8, TERRA PDB ID: 2m18. 
 
 
 
Figure B.15 ESI-MS spectrum of HTel21 DNA quadruplex.  
MW of HTel21 DNA is 6,653.3. Tallest peak corresponds to quadruplex DNA with two internal 
NH4
+ ions. HTel21 shown in the absence of quadruplex-binding compound. HTel21 DNA 
concentration is 20 µM and analyzed in negative ion mode. 
 
 
In an effort to determine if the anisotropy values for RNA and DNA were, in fact, accurate in 
predicting more than 1 to 1 stoichiometry, competition mass spectrometry was used. Both CM03 
and MM41 have different molecular weights and can, therefore, be combined in a single sample. 
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Figure B.16 ESI-MS spectra of ligand-DNA complexes. 
ESI-MS spectra of HTelo21 DNA (20 µM) in the presence of MM41 (40 µM) and CM03 (40 µM) 
at a [4 to 1] molar concentration ratio of [compound to DNA]. Top spectrum m/z ranges 6500 – 
9000. Blue inset shows free, unbound DNA. Red inset shows CM03-HTel21 and MM41-HTel21 
complexes of 1 to 1 stoichiometry. Green inset shows three systems with 2 to 1 stoichiometry of 2 
CM03-HTel21, a heterodimer of CM03-MM41-HTel21 (green arrow in center), and 2 MM41-
HTel21 complexes. 
 
The compounds compete for binding of the same quadruplex structure which allows determination 
of the preferred compound and stoichiometry. DNA HTel21 was first investigated in the absence 
and presence of the compounds. Figure B.15 of HTel21 is shown and analyzed in negative ion 
mode. The tallest peak corresponds to the quadruplex with two internal NH4
+ cations. Varying 
concentrations of compounds were then added to the DNA quadruplex, up to [4 to 1] molar 
concentration ratios, to study the competitive binding. At a [4 to 1] ratio, the tallest peak intensities
belong to a 1 to 1 binding stoichiometry for DNA-CM03 followed by 1 to 1 of DNA-MM41 
(Figure B.16). This was surprising to see since based on FP results, the DNA quadruplex showed 
stronger binding to MM41 over CM03. However, there was a significant difference in binding  
  
 
 
192 
 
Figure B.17 ESI-MS spectra of RNA in the absence of ligand. 
(A) ESI-MS spectrum of HTelo21 RNA (rHTel21) with (B) no detectable dimer system present. 
MW of rHTel21 is 6,905.2. Tallest peak corresponds to quadruplex RNA with one internal NH4
+ 
ion. rHTel21 shown here in the absence of quadruplex-binding compound at a concentration of 
20 µM and analyzed in positive ion mode. 
 
 
when salt concentrations were varied in studying the RNA. We can only postulate that since MS 
experiments require salt concentrations higher than 50 mM KCl (i.e. 150 mM NH4OAc) that 
perhaps the difference in ionic strength and salt may explain these differences. To our surprise, at 
these concentration 2 to 1 binding also occurs for 2 CM03 + DNA and 2 MM41 + DNA. More 
interesting is the heterodimer, 2 to 1 stoichiometry which occurs for 1 CM03 + 1 MM41 + DNA 
and the higher peak intensity over the homodimer systems. 
The interaction of CM03 and MM41 were next evaluated with the RNA telomeric sequence 
by competition mass spectrometry. Using the same conditions as described with the HTel21, 
various concentration ratios were examined up to a molar concentration ratio up to [4 to 1]. The 
first question regarding RNA quadruplex asks what stoichiometry the RNA is present in in solution 
since Phan and co-workers recently published an NMR solution structure of the TERRA sequence 
as a dimer complex.[13] To answer this, rHTel21 was first analyzed in the absence of compound. 
The m/z ranges in which both monomer and dimer conformations would be present revealed little  
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Figure B.18 ESI-MS spectra of ligand-RNA complexes. 
ESI-MS spectra of rHTelo21 RNA (20 µM) in the presence of MM41 (40 µM) and CM03 (40 µM) 
at a [4 to 1] molar concentration ratio of [compound to DNA]. Top spectrum of (A) m/z ranges 
6,500 – 9,000. Blue inset shows where free, unbound RNA would be. Red inset of (A) shows CM03-
rHTel21 and MM41-rHTel21 complexes of 1 to 1 stoichiometry with CM03-rHTel21 highly 
preferred over MM41 binding. (B)ESI-MS spectrum shows 2 to 1 stoichiometric binding of 2 
CM03-rHTel21. 
 
 
Figure B.19 ESI-MS spectra of ligand-RNA complexes. 
ESI-MS spectra of rHTelo21 RNA (20 µM) in the presence of MM41 (40 µM) and CM03 (40 µM) 
at a [4 to 1] molar concentration ratio of [compound to DNA]. Top spectrum m/z ranges 13,800 
– 15,600. Blue inset shows dimer RNA. Green inset shows three systems with 2 to 1 stoichiometry 
of 2 CM03-rHTel21, a heterodimer of CM03-MM41-rHTel21, and 2 MM41-rHTel21 complexes. 
Heterodimer binding of one CM03 and one MM41 to rHTel21 is preferred of the typical 2 to 1 
binding of ligand to RNA. 
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to no RNA dimer (Figure B.17A & B.17B). Upon addition of both CM03 and MM41 at a molar 
concentration ratio of [4 to 1], strong peak intensities were observed for RNA-CM03 complexes 
for both 1 to 1 and 2 to 1 stoichiometry in Figures B.18A & B.18B, respectively. When a 1 to 1 
and 1:2 to 1 complexes are formed between RNA and a ligand, there is a very clear and 
distinct preference for RNA to bind with CM03 as little to no complex is detectable for RNA with 
MM41. These results agree with those obtained using anisotropy. On the other hand, the m/z range 
from 13,850 – 15,600 reveals an interesting RNA dimer complex. Not only was a small amount of 
ligand-free-RNA-dimer detected but 2 to 2 stoichiometries were also present (i.e. 2 ligands + 2 
RNA) as shown in Figure B.19. In agreement with FP, CM03 binds much stronger to RNA than 
MM41 based on the relative peak intensities. More interesting, however, was the heterodimer 
complex formation for CM03 + MM41 with 2 RNA quadruplexes which had a higher peak 
intensity than the homodimer, 2:2 complexes. This phenomenon, as observed with DNA, indicates 
a binding mechanism unique to the combination of CM03 and MM41 with quadruplexes. 
B.7 Conclusions 
We investigated the binding of several small molecules with DNA and RNA quadruplexes. 
Fluorescence polarization experiments revealed the binding interactions of diamidine and 
morpholine-containing compounds with GC-rich quadruplexes with preferential binding of the 
quadruplexes to the compound CM03. The diamidine compounds DB1246 and DB1247, on the 
other hand, were generally weaker binding than the morpholine compounds. A second set of DNA 
and RNA quadruplexes, based on the human telomeric sequence (HTel21) were investigated with 
the morpholine compounds CM03 and MM41. The RNA quadruplex bound very strong with 
CM03. Fluorescence and competition mass spectrometry studies confirmed the existence of an 
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induced dimer for RNA. The unexpected selectivity of CM03 for RNA shows evidence of 
differences among quadruplexes and may provide significant therapeutic potential. 
B.8 References 
1. Wright WE, Tesmer VM, Huffman KE, Levene SD, Shay JW. Normal human 
chromosomes have long G-rich telomeric overhangs at one end. Genes Dev. 1997, 11 (21): 
2801-2809. 
 
2. Burge S, Parkinson GN, Hazel P, Todd AK, Neidle S. Quadruplex DNA: Sequence, 
topology and structure. Nucleic Acids Res. 2006, 34 (19): 5402-5415. 
 
3. Huppert JL. Structure, location and interactions of G-quadruplexes. FEBS J. 2010, 277 
(17): 3452-3458. 
 
4. Simone R, Fratta P, Neidle S, Parkinson GN, Isaacs AM. G-quadruplexes: Emerging roles 
in neurodegenerative diseases and the non-coding transcriptome. FEBS Lett. 2015, 589 
(14): 1653-1668. 
 
5. Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, Schymick JC, 
Laaksovirta H, van Swieten JC, Myllykangas L, Kalimo H, Paetau A, Abramzon Y, Remes 
AM, Kaganovich A, Scholz SW, Duckworth J, Ding J, Harmer DW, Hernandez DG, 
Johnson JO, Mok K, Ryten M, Trabzuni D, Guerreiro RJ, Orrell RW, Neal J, Murray A, 
Pearson J, Jansen IE, Sondervan D, Seelaar H, Blake D, Young K, Halliwell N, Callister 
JB, Toulson G, Richardson A, Gerhard A, Snowden J, Mann D, Neary D, Nalls MA, 
Peuralinna T, Jansson L, Isoviita VM, Kaivorinne AL, Hölttä-Vuori M, Ikonen E, Sulkava 
R, Benatar M, Wuu J, Chiò A, Restagno G, Borghero G, Sabatelli M; ITALSGEN 
Consortium, Heckerman D, Rogaeva E, Zinman L, Rothstein JD, Sendtner M, Drepper C, 
Eichler EE, Alkan C, Abdullaev Z, Pack SD, Dutra A, Pak E, Hardy J, Singleton A, 
Williams NM, Heutink P, Pickering-Brown S, Morris HR, Tienari PJ, Traynor BJ. A 
hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked 
ALS-FTD. Neuron 2011, 72 (2): 257-268. 
 
6. DeJesus-Hernandez M, Mackenzie IR, Boeve BF, Boxer AL, Baker M, Rutherford NJ, 
Nicholson AM, Finch NA, Flynn H, Adamson J, Kouri N, Wojtas A, Sengdy P, Hsiung 
GY, Karydas A, Seeley WW, Josephs KA, Coppola G, Geschwind DH, Wszolek ZK, 
Feldman H, Knopman DS, Petersen RC, Miller BL, Dickson DW, Boylan KB, Graff-
Radford NR, Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding 
region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72 (2): 
245-256. 
 
7. Azzalin CM, Reichenbach P, Khoriauli L, Giulotto E, Lingner J. Telomeric repeat 
containing RNA and RNA surveillance factors at mammalian chromosome ends. Science 
2007, 318 (5851): 798-801. 
 
  
 
 
196 
8. Schoeftner S, Blasco MA. Developmentally regulation transcription of mammalian 
telomeres by DNA-dependent RNA polymerase II. Nat. Cell Biol. 2008, 10 (2): 228-236. 
 
9. Greenwood J, Cooper JP. Non-coding telomeric and subtelomeric transcripts are 
differentially regulated by telomeric and heterchromatin assembly factors in fission yeast. 
Nucleic Acids Res. 2012, 40 (7): 2956-2963. 
 
10. Collie GW, Parkinson GN, Neidle S, Rosu F, De Pauw E, Gabelica V. Electrospray mass 
spectrometry of telomeric RNA (TERRA) reveals the formation of stable multimeric G-
quadruplex structures. J. Am. Chem. Soc. 2010, 132 (27): 9328-9334.  
 
11. Collie GW, Sparapani S, Parkinson GN, Neidle S. Structural basis of telomeric RNA 
quadruplex-acridine ligand recognition. J. Am. Chem. Soc. 2011, 133 (8): 2721-2728. 
 
12. Fasman GD. Handbook of Biochemistry and Molecular Biology. 3rd ed. CRC Press; 
Cleveland: 1975. 
 
13. Martadinata H, Phan AT. Structure of human telomeric RNA (TERRA): Stacking of two 
G-quadruplex blocks in K(+) solution. Biochemistry 2013, 52 (13): 2176-2183. 
